close

Medical products

Medical products

Why medical device maker Repligen may be a potential buy

  • The stock has returned 58.36% over the past three months
  • On a fundamental basis, strong growth in sales and earnings added to its strength
  • Now guiding towards overall revenue growth of 18-21%

There are many stages and partner companies involved in the production of any product in the pharmaceutical industry, and based in Massachusetts Repligen (NASDAQ: RGEN) plays a big role.

Technically, the stock has outperformed the broader market. On a fundamental basis, the strong growth in sales and earnings has enhanced its strength relative to others in its medical products industry.

The company develops and commercializes bioprocessing technologies used in the manufacturing process of biologic drugs. It serves an international clientele, mainly in North America.

The stock forms a deep cup pattern with handle which it started in October, after falling from a high of $327.32. As with just about every other stock, Repligen shares fell sharply on Tuesday, but held support at their 50-day moving average.

What is important in the 50 day support?

This shows that large institutional owners are not bailing out en masse. Back then, analysts and fund managers watched stock movements and rushed to buy a stock they were supporting when it fell to a key moving average.

Today, this function is more commonly fulfilled by algorithmic trading, but the idea remains the same. It’s a good sign that the big institutions have confidence in the stock and aren’t panicking by selling as the market declines.

Fundamentally, Repligen has grown earnings in each of the past three years, posting a three-year growth rate of 63%. Revenues grew at a rate of 54% during this period.

A d PressReach

A new era of DeFi in 2022

Canadian DeFi stock is heating up with massive acquisitions.

This translated into strong price appreciation. The stock has returned 58.36% over the past three months, as it rose 31.38% in July and posted more gains in August and September.

Revamped business model

The company has changed its business model in recent years, moving from a therapeutic approach to a manufacturer of bioprocess products. In 2012, the company divested from therapeutic assets. The company has grown both organically and through acquisition.

Analysts have a “buy” rating on the stock, according to data from MarketBeat. The price target is $276, which is a 21.57% upside.

With a market capitalization of $12.58 billion, Repligen is classified as a mid-cap. It is part of the S&P 400 mid-cap index.

The stock soared 11.68% after the company reported earnings in early August. The nascent post-earnings rally crumbled in mid-August, as did the mid-cap index and, for that matter, the large-cap S&P 500 as well. It’s true that equities tend to move with the broader market, although it’s always a good idea to identify which ones are holding up the best, as is the case with Repligen.

In the latest earnings report, the company beat analyst consensus on both sales and earnings, as you can see using earnings data from MarketBeat. In fact, Repligen has a history of top views dating back to May 2019. This is a good sign for investors considering taking a position in the stock.

However, the future potential is even greater. The company raised its sales forecast for the full year. It now forecasts revenue between $790 million and $810 million, down from a range of $770 million to $800 million.

Reinforced tips for the whole year

In the second quarter earnings release, the company said, “Our updated guidance reflects the expected increase in demand for our core business products, slightly offset by the slowdown in expected Covid-related revenue. We are now targeting overall revenue growth of 18-21% as reported, 22-25% at constant currency and organic growth of 19-22%.”

He added: “Our base revenue, which excludes Covid-related revenue and inorganic acquisition revenue from 2021 acquisitions, is expected to grow 31% to 33%, an increase from our previous guidance of 24% to 31%.”

In other words, even with declining Covid-related product sales, which are slowing as vaccine rates fall, and acquisition revenue, the sales outlook looks solid.

So, is this stock a buy? Assess your risk tolerance, financial goals and time horizon before choosing a stock. If you already have a number of biotech companies or medical product manufacturers in your portfolio, be careful when adding another stock from that industry.

But there are certainly plenty of bright spots, including earnings history, improved forward guidance, and the strength of the company’s existing core business.
Why medical device maker Repligen may be a potential buy

Companies mentioned in this article

Compare these actions Add these stocks to my watchlist

Before you consider Repligen, you’ll want to hear this.

MarketBeat tracks daily the highest rated and most successful research analysts on Wall Street and the stocks they recommend to their clients. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the market takes off…and Repligen didn’t make the list.

Although Repligen currently has a “Buy” rating among analysts, top-rated analysts believe these five stocks are better buys.

See the five actions here

read more
Medical products

Medical products company wins £900,000 contract in the Middle East

A Liverpool company manufacturing and distributing medical equipment and technology has won a £900,000 supply deal across the Middle East.

Algeos, based in Speke, specializes in the podiatry, rehabilitation and orthopedics markets.

Its contract, covering the GCC (Gulf Cooperation Council) region, includes diabetic shoes, orthotics and prostheses, foot orthotics and other patient-enhancing consumables to be distributed to local agents, distributors and hospitals. across the Middle East.

The company has been advertised as a UK supplier of diabetic footwear in six GCC member states – United Arab Emirates, Kingdom of Bahrain, Kingdom of Saudi Arabia, Sultanate of Oman, State of Qatar and the United Arab Emirates. State of Kuwait.

The award of this GCC contract is the result of Algeos’ focus on supporting, preventing and changing lives, which it delivers not only through its work with the NHS, private practice and hospitals across the UK, but also its national position in the podiatry, rehabilitation and orthopedics sector.

Diabetes is a rapidly growing disease affecting people around the world, particularly due to the rise in unhealthy lifestyles and increased levels of risk factors.

The Middle East has seen an increase in the incidence of diabetes and diabetic foot ulceration. Algeos’ products can enable diagnostic, preventative and lifesaving solutions to prevent diabetic foot ulcers in a number of hospitals across the six GCC states.

The company has also provided training to a number of Saudi clinicians on a diverse range of products.

Managing Director, Max Sherridan said: “It is a team effort to ensure we are successful and have worked with our local partners in the regions to ensure Algeos’ product range is the preferred choice. clinicians in the Middle East.

“We look forward to supporting our partners and clinicians to ensure patient outcomes are maximized through this RFP.”

Mustafa Mukbil, Commercial Director at Zimmo Co, said: “The solutions provided by Algeos are unlike anything we have ever seen before. We look forward to continuing to work with Max and Algeos in the future.

read more
Medical products

Partner Medical Products Inc. voluntarily ceases operations in Carson

Google map screenshot of the location of Partner Medical Productions Inc.


carson On August 21, 2022, Parter Medical Products, Inc. or Parter voluntarily shut down its ethylene oxide (EtO) operations until the facility can improve its air pollution controls.

Parter is located at 17015 Kingsview Avenue in Carson. EtO is a flammable, colorless gas used by the facility to sterilize medical devices.

Earlier this year, Carson City Council voted unanimously to request that air monitors be placed at various locations around the city to monitor air quality.

The town of Carson has been advised by the South Coast AQMD that a release of air pollutants by Parter could pose a health hazard around the end of July in the nearby industrial area.

South Coast AQMD conducted several on-site inspections at the facility and conducted field operations in the surrounding area. On July 29, 2022, a Notice of Violation was issued to Parter for public nuisance in violation of agency Rule 402 and California Health & Safety Code § 41700. This violation was based on elevated EtO emissions detected through air monitoring efforts outside the facility to an adjacent business.

South Coast AQMD is also investigating EtO emissions in nearby residential communities and the agency is working with the City of Carson to identify additional locations to collect 24-hour samples from the community and school. closer. So far, data from residential monitors shows EtO levels are within typical background levels.

Parter said its EtO equipment will remain closed until additional air pollution controls can be implemented, including modifications and upgrades to air pollution control equipment. air and temporary enclosures. The facility has initiated the authorization process for the upgrades and South Coast AQMD will review and approve these requests as quickly as possible.

During AQMD’s South Coast monitoring efforts at several commercial EtO sterilization facilities, the agency became aware of fugitive emissions from sources that were not previously known. The AQMD survey on the south coast has identified that existing pollution controls will need to be improved and that measures will be needed to reduce fugitive emissions.

South Coast AQMD is working on amending Rule 1405 – Control of ethylene oxide and chlorofluorocarbon emissions from sterilization or fumigation processes to strengthen requirements to control fugitive emissions, as well as provisions to further reduce EtO emissions from operations at these facilities.

For more information, contact the AQMD public advisor for the south coast at [email protected]. To receive notifications about Parter, please fill out the form at www.aqmd.gov/sign-up.

read more
Medical products

Medical device maker to double headcount with Alabama expansion

Welcome to Thomas Insights – every day we post the latest news and analysis to keep our readers up to date with what’s happening in the industry. Sign up here to get the day’s top stories straight to your inbox.

A maker of medical products and equipment plans to more than double its workforce in southeast Alabama, state and company officials said.

Georgia-based Global Resources International said its subsidiary Advanced Products Solutions should add 100 new jobs in Dothan, Alabama, and 10 other stations near Columbia, Alabama.

APS established the Dothan plant two years ago to manufacture injection molded medical products, personal protective equipment and other technical products. The expansion will focus on medical products for the human and animal health segments, local economic development officials said. The site was initially to have a workforce of 70 people.

In Colombia, meanwhile, APS will spend more than $1.8 million on a medical product sterilization facility. Company officials said hiring at both sites is expected to ramp up over the 90 days.

Global Resources designs, manufactures, distributes and sterilizes products for the health, animal care and industrial markets. Another GRI subsidiary, Eastern Technologies Inc., is based in Ashland, Alabama, and manufactures protective equipment for nuclear power, chemical processing, defense and other industrial applications.

Alabama Commerce Secretary Greg Canfield said the expansion will boost production of “much-needed goods” in Alabama and across the country.

Image Credit: yohaken surasak / Shutterstock.com

Plastic pipe maker invests $40 million in Texas factory Next story »

More trade and industry

read more
Medical products

Second Sight Medical Products announces the successful completion of its merger with Nano Precision Medical and its name change to Vivani Medical, Inc.

LOS ANGELES–(BUSINESS WIRE)–Second Sight Medical Products, Inc. (NASDAQ: EYES) (the “Company” or “Second Sight”), a leading developer of implantable vision prostheses intended to create an artificial form of useful vision for people who are blind, announced today the completion of its merger with Nano Precision Medical, Inc. (“NPM”). NPM is a biopharmaceutical company that develops miniaturized subcutaneous drug implants using its proprietary NanoPortal™ technology to enable long-term, near-constant rate delivery of a wide range of drugs to treat chronic diseases.

As part of the merger, Second Sight changed its name to Vivani Medical, Inc. (“Vivani”). The Company’s common stock will trade on the Nasdaq Capital Market under the symbol “VANI”. ThinkEquity acted as financial advisor to Second Sight in connection with the merger.

Upon completion of the merger, the Company has approximately $55 million in cash to advance the development of Vivani’s portfolio, which includes lead asset NPM-119 (exenatide implant), toward development in clinical stage for the treatment of patients with type 2 diabetes and to identify and execute strategic options to advance its Orion visual prosthesis to the clinical stage to treat people with blindness due to a wide range of underlying causes.

The company will operate under the direction of NPM CEO, Dr. Adam Mendelsohn, and his management team of seasoned industry veterans.

“The completion of the merger marks an important milestone for Vivani as we continue to grow the business with a strong team, sufficient funding and an attractive group of investors who support our goal of developing and commercializing a new portfolio of products. miniaturized drug implants that can effectively address medication nonadherence, a major challenge in the treatment of chronic diseases, including type II diabetes. We are also committed to identifying a sustainable path forward to bring Second Sight’s Orion Cortical Visual Prosthesis System to people who are blind due to a wide range of causes,” said Adam Mendelsohn, Ph.D., President and CEO. general of the company. “Our proprietary NanoPortal technology has broad potential across a wide range of therapeutic molecules. We anticipate that the first application of our technology will be ready to begin human evaluation later this year with NPM-119. Medication non-adherence in type II diabetic patients taking oral or injectable therapies is approximately 50%. We believe that a six-month implant may be an important alternative for non-adherent patients and the physicians who treat them.

About Vivani Medical, Inc.

Vivani Medical, Inc., soon to be trading under the Nasdaq symbol VANI, is the combination of Nano Precision Medical, Inc. and Second Sight Medical Products, Inc. The company leverages proprietary technologies to develop and commercialize drug implants and of devices that treat patients with chronic conditions with a high unmet medical need.

Prior to the merger, Nano Precision Medical, Inc. was a privately held biopharmaceutical company developing drug implants using its proprietary NanoPortal drug implant technology. These drug implants, designed to provide low-fluctuation drug profiles, will address medication nonadherence, which is a primary reason for the suboptimal clinical benefit associated with oral and injectable products that treat chronic disease. The company’s lead product, NPM-119, is a GLP-1 receptor agonist in development to treat patients with type 2 diabetes. More information is available at www.nanoprecisionmedical.com.

Vivani also develops implantable visual prostheses intended to provide useful artificial vision to blind people. Visual prosthetic developments are a continuation of the work carried out by Second Sight Medical Products, Inc. prior to the merger and renaming to Vivani Medical, Inc. The recognized world leader in neuromodulation devices for blindness, Vivani is s is committed to identifying and implementing the best strategic options that will enable its innovative technologies to treat the broadest population of visually impaired people. More information is available at secondight.com.

Vivani’s corporate headquarters are located in Emeryville, California. More information for investors is available at www.vivani.com.

Notice of Intention to Delist Warrants (Nasdaq: EYESW)

As part of Nasdaq’s approval of the merger transaction, the merged company is required to comply with Nasdaq’s listing rule 5110(a). This rule requires the post-merger company to meet all Nasdaq listing criteria. The Company has satisfied the listing requirements for the common shares of the combined company after the merger. Because the warrants (Nasdaq:EYESW) will not meet Nasdaq’s original listing standards upon closing of the merger, the company would not be in compliance with listing rule 5110(a) with respect to warrants only. Accordingly, the Company has voluntarily elected to delist the Warrants, which will enable the Company to otherwise comply with Nasdaq listing rules. The Company intends to file a Delisting Notification on Form 25 with the SEC on or about September 8, 2022, to withdraw the Warrants from trading on the Nasdaq Capital Markets. The delisting of the warrant class from the Nasdaq listing is effective 10 days after the Form 25 is filed.

Safe Harbor

This press release contains certain “forward-looking statements” within the meaning of the “safe harbor” provisions of the United States Private Securities Litigation Reform Act of 1995. Forward-looking statements may be identified by words such as: “target”, ” believe”, “expect”, “will”, “could”, “anticipate”, “estimate”, “would”, “position”, “future” and other similar expressions which, in this press release, refer to the Company’s post-merger strategy . Forward-looking statements are neither historical facts nor guarantees of future performance. Instead, they are based solely on the Company’s current beliefs, expectations and assumptions. Because forward-looking statements relate to the future, they are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict and many of which are beyond our control. Actual outcomes and results may differ materially from those indicated in the forward-looking statements. Accordingly, you should not rely on any such forward-looking statements. Important factors that could cause actual results and results to differ materially from those set forth in the forward-looking statements include, among others, the following: (1) our ability to recognize the anticipated benefits of the merger; (2) risks associated with the development and commercialization of NPM-119 (exenatide implant); (3) claims or legal proceedings relating to the termination of the MoU with Pixium Vision and related costs; (4) changes in applicable laws or regulations; (5) the Company’s ability to achieve or maintain profitability in the future; (3) the possibility that the Company will be adversely affected by other economic, business and/or competitive factors; (4) the impact of COVID-19 on the Company’s business; and (5) various other risks and uncertainties. There may be additional risks that the Company considers insignificant or that are unknown. An additional list and description of risks and uncertainties can be found in the company’s most recent Annual Report on Form 10-K, and in all subsequent quarterly filings on Form 10-Q with the Securities and Exchange Commission (the “Commission”), and the Company’s final proxy statement/prospectus filed with the Commission on June 24, 2022. Any forward-looking statements we make in this press release are based solely on information currently available to the Company and do not valid only on the date on which it is manufactured. The Company undertakes no obligation to update publicly any forward-looking statements, written or oral, which may be made from time to time, whether as a result of additional information, future developments or otherwise, except as required by law. requires it.

read more
Medical products

Utah Medical Products (NASDAQ:UTMD) Stock Price Crosses Above the 200-Day Moving Average of $87.52


Utah Medical Products, Inc. (NASDAQ:UTMDGet a rating) the stock price rose above its 200-day moving average during Tuesday’s session. The stock has a 200-day moving average of $87.52 and is trading as low as $91.11. Shares of Utah Medical Products last traded at $90.32, with a volume of 3,271 shares traded in hands.

Utah medical product inventory performance

The company has a 50-day moving average of $87.35 and a 200-day moving average of $87.52. The company has a market capitalization of $327.41 million, a price-earnings ratio of 20.72 and a beta of 0.26.

Utah Medical Products (NASDAQ:UTMDGet a rating) last released its quarterly earnings data on Tuesday, July 26. The medical device supplier reported EPS of $1.12 for the quarter. The company had revenue of $13.43 million for the quarter. Utah Medical Products had a net margin of 31.18% and a return on equity of 14.69%.

Utah Medical Products Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Wednesday, October 5. Shareholders of record on Friday, September 16 will receive a dividend of $0.29 per share. This represents a dividend of $1.16 on an annualized basis and a yield of 1.28%. The ex-dividend date is Thursday, September 15. Utah Medical Products’ dividend payout ratio (DPR) is currently 26.61%.

Institutional entries and exits

A number of hedge funds have recently increased or reduced their stakes in the company. Amalgamated Bank acquired a new position in Utah Medical Products stock during Q1 worth approximately $39,000. Acadian Asset Management LLC acquired a new position in Utah Medical Products during the first quarter valued at approximately $40,000. BNP Paribas Arbitrage SA increased its stake in Utah Medical Products by 97.7% in the second quarter. BNP Paribas Arbitrage SA now owns 779 shares of the medical device supplier valued at $67,000 after buying 385 additional shares last quarter. Lazard Asset Management LLC increased its position in Utah Medical Products shares by 21.3% during the first quarter. Lazard Asset Management LLC now owns 837 shares of the medical device supplier worth $75,000 after purchasing an additional 147 shares in the last quarter. Finally, MetLife Investment Management LLC increased its stake in Utah Medical Products shares by 57.0% during the 1st quarter. MetLife Investment Management LLC now owns 2,030 shares of the medical device supplier worth $182,000 after buying 737 additional shares in the last quarter. Institutional investors hold 71.44% of the company’s shares.

Utah Medical Products Company Profile

(Get a rating)

Utah Medical Products, Inc. develops, manufactures and distributes medical devices for the healthcare industry. The Company offers fetal monitoring accessories, vacuum assisted delivery systems and other labor and delivery tools; Respiratory hoods for newborns DISPOSA-HOOD; and DELTRAN PLUS blood pressure monitoring systems.

Featured Articles



Receive daily news and reviews for Utah medical products – Enter your email address below to receive a concise daily summary of breaking news and analyst ratings for Utah Medical Products and related companies with MarketBeat.com’s free daily email newsletter.

read more
Medical products

Zavation Medical Products Receives 510(k) Clearance from the FDA for the Varisync Anterior Cervical Plate and Spacer System





Two- and four-hole Varisync plates (Zavation)

Zavation Medical Products has received 510(k) clearance from the United States Food and Drug Administration (FDA) for Varisync, a cervical intervertebral fusion device.

The newest addition to the Zavation cervical spine portfolio, Varisync has been tested and approved for independent and synchronized use of its plate and spacer components. This allows surgeons to use plate and spacer options together as a system or pair individual components with one of Zavation’s existing cervical portfolio options.

The Varisync plate has attributes that include visual and tactile lock confirmation, ideal screw angulation, multiple insertion devices, and optimal spacer placement in the disc space, according to the company.

Jeffrey Johnson, CEO of Zavation, said, “Our product development team’s dedication to creatively combining simplicity and precision in robust product design has produced a product that we believe is the new benchmark in facilitating the merging of patients in a transparent and simplified procedure.

“With the many interbody offerings from Zavation, it makes sense that we would develop a device that allows surgeons to easily integrate and place a plate and spacer combination of their choice. This product is an example of Zavation’s commitment to Zavation to offer innovative and differentiated products in conjunction with market-leading customer service to better serve our surgeons and distributor network.








read more
Medical products

Pillar Biosciences Receives China National Medical Products Administration (NMPA) Approval for oncoRevealTM Dx Colon Cancer Test | Company

read more
Medical products

Pillar Biosciences Receives China National Medical Products Administration (NMPA) Approval for oncoRevealTM Dx Colon Cancer Test | Nation/World

NATICK, Mass.–(BUSINESS WIRE)–August 22, 2022–

Biosciences Pillar, the leader of Decision Medicine™, developers and distributors of next-generation sequencing (NGS) assays that localize testing and reduce time to treatment initiation and overall testing costs, today announced that its oncoReveal assay TM Dx Colon Cancer Assay has received approval from China National Medical Products Administration (NMPA). The IVD test is now commercially available in China, the United States and Europe as a companion diagnostic (CDx) to identify colorectal cancer patients whose tumors express wild-type KRAS status and may benefit treatment with specific targeted therapies.

“The oncoReveal™ Dx Colon Cancer Test localizes NGS testing and efficiently provides a highly accurate genetic profile of KRAS mutations in patients with metastatic colorectal cancer,” said Randy Pritchard, CEO of Pillar Biosciences. “This approval is important for oncologists across China who need a more streamlined, efficient and accurate way to identify the right treatment for their individual patients. By making testing more widely available and enabling faster results, we can significantly reduce the time it takes to initiate treatment and enable patients to continue with more confidence throughout their life course.

The oncoReveal™ Dx Colon Cancer Test is a companion diagnostic test that identifies patients with metastatic colorectal cancer who have KRAS wild-type tumor status and may benefit from treatment with approved therapies, Erbitux® (cetuximab) or Vectibix® (panitumumab). The test uses Pillar’s highly accurate and sensitive SLIMamp® NGS test technology to generate data that optimizes the selection of precision therapies for cancer patients. It is the company’s first NMPA-approved diagnostic product. Pillar’s oncoReveal™ Dx Lung & Colon Cancer Assay previously received CE-IVD certification in Europe in April 2020 and Premarketing Approval (PMA) from the U.S. Food and Drug Administration (FDA) in July 2021.

About Pilar Biosciences

Pillar Biosciences is the leader in Decision Medicine™, which uses highly accurate and sensitive next-generation sequencing (NGS) assay technology to generate data that optimizes the selection of precision therapies for cancer patients, from profiling of the tumor to therapy selection and recurrence monitoring. Pillar’s NGS testing solutions, including the FDA-cleared oncoReveal™ Dx lung and colon cancer test, are powered by the company’s proprietary SLIMamp® and PiVAT® technologies, and decentralize the testing process, reducing diagnostic costs and improving access and efficiency of complex NGS tests for pathologists, prescribers and patients worldwide. The company has more than 20 NGS test products available in IVD or RUO formats, and several more in various stages of development, including an oncoReveal™ CDx pan-cancer test and two liquid biopsy offerings. Pillar’s patented technologies have been shown to deliver accurate, actionable data in as little as 48 hours, allowing physicians to select appropriate therapies and monitor patient response. Pillar Biosciences has operations in Natick, MA and Shanghai, China. For more information, visit www.pillar-biosciences.com.

Show source version on businesswire.com:https://www.businesswire.com/news/home/20220822005134/en/

CONTACT: Investor Contact:

Dawn Schottlandt

Slang Partners

212-600-1902

[email protected]

Media Contact:

Joshua R. Mansbach

Slang Partners

212-600-1902

[email protected]

KEYWORD: MASSACHUSETTS CHINA UNITED STATES NORTH AMERICA ASIA PACIFIC

INDUSTRY KEYWORD: BIOTECHNOLOGY PHARMACEUTICALS MEDICAL SUPPLIES ONCOLOGY GENERAL HEALTH HEALTH GENETICS CLINICAL TRIALS

SOURCE: Biosciences Pillar

Copyright BusinessWire 2022.

PUBLISHED: 08/22/2022 07:00 / DISK: 08/22/2022 07:02

http://www.businesswire.com/news/home/20220822005134/en

Copyright BusinessWire 2022.

read more
Medical products

Sorrento Therapeutics Announces China National Medical Products Administration (NMPA) IND Clearance for STI-1558, an Oral Mpro Inhibitor for Phase I Trial in Patients with COVID-19

  • STI-1558, an oral major protease of SARS-CoV-2 (Mpro), which can block viral replication, is specifically designed as a stand-alone treatment for COVID-19 without ritonavir as a booster.
  • The single ascending dose (SAD) portion of the phase I study in healthy subjects was completed in Australia with the maximum dose of 2000 mg. There were no serious adverse events (SAEs) or treatment-related serious adverse events (TEAEs) and the pharmacokinetics (PK) were dose-proportional.
  • In the phase I trial in China authorized by the NMPA, STI-1558 will be administered to subjects with COVID-19 in multiple ascending doses (MAD) with three dose cohorts, including 300 mg BID, 600 mg BID and 800 mg BID, to assess safety, tolerability and efficacy, to be conducted alongside the MAD portion of the study in healthy subjects in Australia.

SAN DIEGO, Aug. 19, 2022 (GLOBE NEWSWIRE) — Sorrento Therapeutics, Inc. (Nasdaq: SRNE, “Sorrento”) today announced NMPA clearance for a Phase I study of its oral lead viral protease (Mpro) inhibitor, STI-1558, in subjects with COVID-19 in a MAD study in China.

In a previously announced Australian phase I study in healthy subjects, the SAD part with four dose cohorts (300 mg, 600 mg, 1200 mg and 2000 mg) was completed. The MAD portion of the study is commencing and STI-1558 has been well tolerated to date with only a few associated adverse events, which have been transient and mild in severity. The PK profile matched predicted values ​​based on animal studies and confirms that STI-1558 is readily absorbed by humans with high bioavailability and no need for ritonavir, a potent cytochrome P450 3A4 inhibitor, to block metabolic clearance in order to maintain effective blood circulation. levels. In the NMPA-authorized Phase I trial, STI-1558 will be administered to subjects with COVID-19 with mild or no symptoms in this MAD study, allowing evaluation of safety, tolerability and the efficacy of STI-1558 as a stand-alone treatment without ritonavir as a booster.

In the double-blind, placebo-controlled MAD study, a total of 56 patients with mild or no symptoms will be enrolled in three dose cohorts (active: placebo, 3:1), 300 mg BID (n=8), 600 mg BID (n=24) and 800 mg twice daily (n=24). In addition to the safety and tolerability assessment, viral load in patients will be examined to assess the antiviral activity of STI-1558 treatment in subjects with COVID-19 compared to placebo treatment. The trial will support the application for an Emergency Use Authorization (EUA) approval in China and will be conducted by ACEA Therapeutics, Inc., a Sorrento company, and Shenzhen Third Hospital in Shenzhen, China. Dr. Lu Hangzhou, professor and fellow of the American Academy of Microbiology and president of Shenzhen Third Hospital, is leading the trial in China.

“The trial in China will allow us to assess the antiviral activity of STI-1558 in patients as well as the safety, tolerability and pharmacokinetics at different doses. We look forward to seeing results in patients with COVID-19, which should facilitate our planned Phase II/III trials of STI-1558 in Mexico and the United States,” said Henry Ji, Ph.D. ., President and CEO of Sorrento. .

About Sorrento Therapeutics, Inc.

Sorrento is a clinical and commercial-stage biopharmaceutical company developing novel therapies to treat cancer, pain (non-opioid treatments), autoimmune diseases and COVID-19. Sorrento’s multi-modal, multi-pronged approach to fighting cancer is enabled by its extensive immuno-oncology platforms, including key assets such as fully human antibodies (“G-MAB™ library”), immunocellular therapies (“DAR-T™”), antibody-drug conjugates (“ADCs”) and oncolytic viruses (“Seprehvec™”). Sorrento is also developing potential antiviral therapies and coronavirus vaccines, including Abivertinib, COVISHIELD™ and COVI-MSC™; and diagnostic testing solutions, including COVIMARK™.

Sorrento’s commitment to therapies that improve patients’ lives is also demonstrated by our efforts to advance a first-in-class, non-opioid pain management small molecule (TRPV1 agonist), resiniferatoxin (“RTX”) and SP-102 (10 mg, dexamethasone sodium phosphate viscous gel) (SEMDEXA™), a new viscous gel formulation of a corticosteroid widely used for epidural injections to treat lumbosacral radicular pain, or sciatica, and to market ZTlido® (topical lidocaine system) 1.8% for the treatment of postherpetic neuralgia (PHN). RTX has been cleared for a phase II trial in refractory pain associated with cancer and a phase II trial in patients with osteoarthritis. Positive final results from the CLEAR program of the pivotal Phase III trial for SEMDEXA™, its new non-opioid product for the treatment of lumbosacral radicular pain (sciatica), were announced in March 2022. ZTlido® was approved by the FDA on February 28, 2018.

For more information, visit www.sorrentotherapeutics.com

Forward-looking statements

This press release and all statements made for and during any presentation or meeting contain forward-looking statements relating to Sorrento Therapeutics, Inc., under the safe harbor provisions of Section 21E of the Private Securities Litigation Reform Act of 1995 and subject to risks and uncertainties. which could cause actual results to differ materially from those projected. Forward-looking statements include statements regarding STI-1558, including the potential antiviral profile of STI-1558 with respect to SARS-CoV-2 and its variants; preclinical testing of STI-1558; the potential safety and efficacy of STI-1558; the possibility that no co-administration is necessary with STI-1558; the oral bioavailability of STI-1558; the potential success of Phase I trials in Australia and China; phase II/III trials in Mexico and the United States; the possibility that the trial will help obtain EUA approval in China; the position of STI-1558 and Sorrento in the antiviral industry; the expected formulation, dosage and/or route of administration for STI-1558; and preparing for a worldwide commercial supply of STI-1558. Risks and uncertainties that could cause our actual results to differ materially and adversely from those expressed in our forward-looking statements include, but are not limited to: risks relating to Sorrento’s technologies and prospects, including, but not to limit the risks associated with the safety and effectiveness of STI-1558 and seek regulatory approval for STI-1558; clinical development risks, including risks relating to the progress, timing, cost and results of clinical trials and product development programs; risk of difficulties or delays in obtaining regulatory approvals; the risks that the results of a clinical study may not meet any or all of the clinical study endpoints and that the data generated by such studies may not support a regulatory submission or approval; the risks that the results of prior tests, studies and trials, including PK modeling and values ​​obtained therefrom, will not be replicated in ongoing or future studies and trials; risks associated with the manufacture and supply of pharmaceutical products; the risks of using the expertise of its employees, subsidiaries, affiliates and partners to assist Sorrento in executing its product candidate strategies; risks related to the global impact of COVID-19; and other risks described in Sorrento’s most recent periodic reports filed with the Securities and Exchange Commission, including Sorrento’s Annual Report on Form 10-K for the fiscal year ended December 31, 2021 and subsequent quarterly reports on Form 10-Q filed with the Securities and Exchange Commission and Exchange Commission, including the risk factors set forth in those documents. Investors are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this press release, and we undertake no obligation to update any forward-looking statements in this press release unless the law requires it.

Media and investor relations
Contact: Brian Cooley
E-mail: [email protected]

Sorrento® and the Sorrento logo are registered trademarks of Sorrento Therapeutics, Inc.

G-MAB™, DAR-T™, Seprehvec™, SOFUSA™, COVISHIELD™, COVIDROPS™, COVI-MSC™, COVIMARK™ and Fujovee™ are registered trademarks of Sorrento Therapeutics, Inc.

SEMDEXA™ (SP-102) is a registered trademark of Semnur Pharmaceuticals, Inc. Proprietary name review by the FDA is pending.

ZTlido® is a registered trademark owned by Scilex Pharmaceuticals Inc.

All other trademarks are the property of their respective owners.

©2022 Sorrento Therapeutics, Inc. All rights reserved.


main logo

read more
Medical products

Zavation Medical Products, LLC, Receives 510K Clearance from the FDA for Varisync™ Anterior Cervical Plate and Spacer System to Complement its Cervical Spine Portfolio

FLOWOOD, Miss., August 18, 2022 /PRNewswire/ — Zavation Medical Products (“Zavation” or the “Company”), an innovative designer and manufacturer of high-quality spinal implants, instruments, MIS procedure kits and biologics, headquartered in in Flowood, MS, announced FDA 510K clearance of Varisync™, a cervical intervertebral fusion device.

Varisync™, the newest addition to Zavation’s cervical spine portfolio, has been tested and approved for independent and synchronized use of its plate and spacer components. This allows Zavation partner surgeons to use these plate and spacer options together as a system or pair individual components with one of Zavation’s existing cervical portfolio options. The Varisync™ Plate has been carefully designed and has attributes that include visual and tactile lock confirmation, ideal screw angulation, multiple insertion devices, and optimal spacer placement in the disc space.

Zavation’s market share and active surgeon base continue to grow rapidly given the company’s ability to adapt to surgeon/patient needs, constantly upgrade instruments and design devices with simplicity. and unparalleled precision. Zavation’s continued investment in research and development will further improve its technologies and accelerate market share and base earnings of active surgeons.

“Our product development team’s dedication to creatively blending simplicity and precision into robust product design has produced a product that we believe is the new benchmark in facilitating patient fusion in the setting of ‘a seamless and streamlined procedure,’ said Jeffrey Johnson, Managing Director, ‘With the many interbody offerings Zavation has to offer, it only makes sense that we would develop a device that allows surgeons to easily integrate and place a combination plate and spacer of their choice. “This product is an example of Zavation’s commitment to offering innovative and differentiated products in conjunction with market-leading customer service to better serve our surgeons and distributor network.”

INDICATIONS FOR USE

The VariSync™ Plate is intended for anterior screw fixation to the cervical spine (C2-C7) for the following indications: Degenerative disc disease (as defined by cervical pain of disc origin with disc degeneration confirmed by patient history and radiographic studies), trauma (including fractures), tumors, deformity (defined as kyphosis, lordosis or scoliosis), non-union, anterior fusion failure, spondylolisthesis and spinal stenosis.

The VariSync™ spacer is an interbody fusion device intended for use in mature skeletal patients with degenerative disc disease (DDD) of the cervical spine (C2-T1) at one level. DDD is defined as disc pain with disc degeneration confirmed by history and radiographic studies. These patients must be skeletally mature and have had at least six (6) weeks of non-operative treatment. The VariSync™ spacer should be filled with autograft or allogeneic bone graft consisting of cancellous and/or corticocellous bone graft in skeletally mature patients. These devices are intended for use with an additional fixation such as the Zavation VariSync™ Plate, Zavation Midline Plate, Zavation EZ Plate, or Zavation Cervical Plate Systems. When used with the VariSync™ plate, the assembly mirrors the indications of the VariSync™ spacer, with the VariSync™ plate serving as an additional fixation.

ABOUT ZAVATION MEDICAL PRODUCTS, LLC.

Based in Flowood, MS, Zavation designs, engineers and manufactures a portfolio of spinal hardware and biologics covering key areas including cervical, thoracolumbar, interbody fusion, interventional spine and minimally invasive surgery. Founded in 2012, Zavation has experienced exceptional growth and created a nationwide network of numerous distributors across the United States. The Company has marketed more than 25 product families since its creation. Zavation operates a new 75,000 square foot vertically integrated facility in Flowood, MS. To learn more about Zavation and the company’s product line, visit www.zavation.com.

Related links
www.zavation.com

SOURCE Zavation Medical Products, LLC.

read more
Medical products

Fake test kits, seized medical products

Police show off falsely labeled ATKs, face masks and other goods seized in raids on premises in Nakhon Pathom and Nonthaburi on Thursday. (Photo: Wassayos Ngamkham)

Fake Covid-19 antigen test kits and other medical equipment, worth around 2 million baht, were seized in raids by police in Nakhon Pathom and Nonthaburi provinces on Thursday.

Teams of Consumer Protection Police Division (CPPD) officers and Food and Drug Administration (FDA) officials first searched a commercial building in tambon Naraphirom of Bang Len district in Nakhon Pathom .

They seized tens of thousands of antigen test kits (ATKs) that were falsely labeled with brand names such as Testsealabs Gica, Testsealabs Nex and Zybio, along with face masks and other products.

A woman identified only as Anusara admitted to owning the goods and the building, Central Bureau of Investigation Commissioner Lt. Gen. Jirabhob Bhuridej said.

The second raid took place at a tambon Bang Khen house in Muang district of Nonthaburi. There they seized ATKs falsely labeled as Testsealab Gia, Testsealabs Nex, Greenspring, Singclean, Seinofy, Hip, Deepblue, Humansis, Bioteke and Ustar, as well as medical gloves, oximeters and Chinese herbal products.

A woman identified only as Patyaphorn admitted to owning the house and property.

The items seized from the two locations were worth around 2 million baht in total, the CIB chief said.

The raids followed complaints that unscrupulous people were selling unapproved products falsely labeled with FDA-approved brand names.

CPPD Branch 4 Chief Pol Col Neti Wongkulab said a police investigation revealed that falsely labeled ATKs were being sold at low prices through Facebook accounts run by the two women since April. They sold ATKs for 40 to 45 baht each, cheaper than brands normally sold, Pol Col Neti said.

The police posed as customers, buying the ATKs from a shop near the site of the first raid in Nakhon Pathom. They then searched the nearby commercial building and found the same products packaged and ready for distribution. This led to the raid on the house in Nonthaburi.

Pol Col Neti said the next step would be to arrest the Chinese national who allegedly supplied these counterfeit products. Investigators believed at least four people were involved.

FDA Secretary General Paisarn Dunkum said oximeters and ATKs are medical devices. Tampering with medical equipment affects quality and safety and poses a danger to medical staff and patients.

Tampering with medical equipment is punishable by up to 10 years in prison and/or a fine of one million baht, Dr Paisarn said.

read more
Medical products

Growing medical device maker with 110 new jobs in Houston County

Mark Fellows, vice president of GRI-APS, said the additional 110 jobs in Houston County will increase over the next 90 days.

“These growth plans for Global Resources International and Advanced Product Solutions represent a significant development for the Wiregrass region,” said Greg Canfield, Secretary of the Alabama Department of Commerce.

“This expansion will enhance domestic production of much-needed products for Alabama and nationwide customers, while strengthening GRI-APS’ presence in Wiregrass.”

GROWTH PLANS

In a joint statement, Dothan Mayor Mark Saliba and Houston County Commission Chairman Mark Culver praised GRI-APS’ continued investment and said they are “incredible examples of partners community trade”.

Columbia Mayor Cas Haddock said the GRI-APS project is a “breath of fresh air” for the Houston County community of 800.

“We are grateful that they chose Columbia, Alabama for this sophisticated operation,” he added.

GRI, headquartered in Flowery Branch, Georgia, is a privately held manufacturing and supply company specializing in the design, manufacture, sterilization and distribution of products for the healthcare, medical and medical markets. industry and animal care.

A long-standing GRI affiliate, based in Ashland, Alabama Eastern Technologies Inc.. produces protective equipment for workers in industries such as nuclear power, chemicals and defence. (Learn more about ETI’s efforts at the start of the pandemic.)

A broad partnership of state and local agencies supported the project. At the state level, these include the governor’s office; the Alabama Department of Commerce; AIDT, the state’s main workforce development agency; and Southeastern Alabama works.

The City of Dothan, Houston County Commission, City of Columbia, Dothan Industrial Development Council, and Dothan Chamber/Grow Dothan Development Team also supported the project, as did Dothan Utilities, Alabama Municipal Electric Authority. and Southeast Gas.

read more
Medical products

UPS acquires medical products company Bomi

United Parcel Service has agreed to acquire Bomi Group, an Italian distributor of medical products.

Why is this important: COVID-19 has highlighted the importance of reliable and efficient distribution of medical products. Bomi plays in an important and growing sector of the increasingly targeted market: temperature-controlled transport.

  • Pharmaceutical and biologic therapies rely on cold chain systems that monitor temperature and extend shelf life during transport.

Details: Via Bomi, UPS gains temperature-controlled facilities in 14 countries, inheriting a fleet of more than 350 temperature-controlled vehicles and four million square feet.

  • Bomi facilitates the delivery of pharmaceuticals and medical supplies to hospitals, clinics, laboratories, pharmacies and patients at home.
  • The company employs 3,000 people and serves more than 150 multinational customers worldwide.
  • Financial terms were not disclosed. JP Morgan Securities advised UPS.

The context: UPS Healthcare has already doubled its global footprint since 2020 to meet increased demand, according to a press release.

  • The division has new healthcare facilities built in Germany and Australia, and expanded footprints in Hungary and the Netherlands.
  • It recently beefed up its UPS Premier technology-driven tracking service to improve the quality of logistics.

State of play: Bomi has been carried away by a global logistics strategy, but many private equity investors are also building players in temperature-controlled transportation.

  • In June, EQT and Mubadala purchased Envirotainer — a world leader in active cold chain technologies for the air transport of pharmaceuticals — in a $3 billion deal.
  • CSafe Global, backed by Thomas H. Lee and Frazier Healthcare Partners, in December purchased Softbox Systemswhich produces passive temperature-controlled packaging systems.
  • Global packaging company Sonoco is also playing in the field of passive cold chain logistics with its ThermoSafe unit.

Yes and: Investors invest their money in health care infrastructure in other ways as well.

  • Medline, a giant in the distribution of uncomplicated products to hospitals such as scrubs or sterilized trays — last year ordered an enterprise value of $34 billion with its leveraged buyout by Hellman & Friedman, Carlyle and Blackstone.
  • Shortly thereafter, Bain Capital acquired PartSource, which can be likened to a “healthcare Amazon” from a B2B perspective, in a transaction valued at $1.25 billionsources then told Sarah.

read more
Medical products

Inequalities in access to COVID-19 medical products persist as corporate power expands : Peoples Dispatch

Cases of COVID-19 persist around the world, raising particular concern in regions with low immunization rates due to unequal access to vaccines. As the pandemic continues, analyzes of the global response continue to underscore the dangers of prevailing multi-partisan campaigns. One of the latest of these analyzes is a report published by Transnational Institute and Friends of the Earth International in July. It examines how transnational corporations (TNCs) seized the opportunity to gain more power over international institutions and expand markets during the COVID-19 pandemic.

During the launch of the report, Lauren Paremoer of the People’s Health Movement pointed out that the capture of the multilateral system by TNCs and private philanthropies was already underway before the pandemic, but extraordinary circumstances have led to an unforeseen expansion. In the report itself, Harris Gleckman, former head of the New York office of the United Nations (UN) Conference on Trade and Development, highlights how a response to the pandemic is building on multi-stakeholder initiatives such as the The COVID-19 Tool Access Accelerator (ACT-A) has essentially resulted in an international response driven by TNC interests rather than global solidarity.

As demonstrated in previous instances, the report says the COVID-19 pandemic has been a source of record profits for major pharmaceutical and biotech producers. Most strikingly, this suggests that the inclusion of TNCs in pandemic response mechanisms, in combination with their quest to protect and expand markets, has resulted in the prioritization of market opportunities over people’s lives.

In addition to issues around access to COVID-19 vaccines in the Global South, the report highlights examples of inequitable access to COVID-19 tests, personal protective equipment (PPE) and therapeutics – from Essential products highly inaccessible in developing countries due to prohibitive prices. Also among those products is medical oxygen, which about 15% of all COVID-19 patients need while on treatment, according to the nonprofit organization PATH.

In low- and middle-income countries, this translates to around 500,000 people needing a million cylinders of oxygen every day, an amount that exceeds what was defined in contracts signed before the start of COVID-19. . Since the start of the pandemic, oxygen shortages have been recorded in Jordan, Nigeria, Pakistan and Zimbabwe, among others. And although the shortages presented a direct threat to the health and lives of thousands of people in the Global South, some oxygen producers continued to insist on contractual clauses prohibiting the supply of oxygen from other sources. sources, including local extraction.

Among other things, ACT-A was supposed to examine and close the gaps between oxygen supply and need through an emergency task force coordinated by Unitaid, an intergovernmental funding agency, and the Wellcome Foundation based United Kingdom. But instead of developing approaches that would ensure rapid and accessible deployments of supplemental oxygen supplies when needed, the task force “focused on arranging grants and loans from OECD countries, from the World Bank, regional development banks and private foundations to enable local health authorities to purchase supplemental oxygen.

According to the report, there is concern that a similar procedure may have been put in place with regard to the purchase and distribution of PPE through ACT-A. A strategic plan from October 2021 to October 2022 remains silent on the more practical aspects of delivering PPE to the 92 priority countries. Reviewing the oxygen supply experience, the report states that it is “reasonable to assume that this objective and the related market expansion would be achieved, if at all, by increased debt or grants to institutions in developing countries”.

As Gleckman pointed out at the launch, this is a well-known pattern of the COVID-19 vaccine procurement process: countries that lacked the resources to pay the high prices set by producers vaccines were forced to take out loans around the world. Bank and the International Monetary Fund. This means that they will have to allocate even more money to debt service instead of strengthening health and social security systems, which will compromise their ability to respond to future crises.

Due to the effects of loans from international financial institutions on the stability of health systems in developing countries, debt and debt cancellation should be a major focus in future phases of the COVID-19 discussion, suggested Lauren Paremoer. With this element missing from the conversation, developing countries face the same grim no-access scenario they faced in the case of vaccines.

Read more articles from the latest edition of the People’s Health Dispatch and subscribe to the newsletter here.

read more
Medical products

Kenya and Novo Nordisk sign MoU to provide medical products to children with diabetes

The Government of Kenya and Novo Nordisk, a Danish multinational pharmaceutical company, have signed a memorandum of understanding for the supply of medical products to improve the treatment and self-management of type 1 diabetes in children.

Speaking at the ceremony, Cabinet Secretary for Health Mutahi Kagwe said the long-term aspiration of the program was not only to improve the lives of children enrolled in the project, but also to find ways to integrate the components of the program into the delivery of health care in the country.

He said the parties have entered into a partnership to use their respective skills and strengths to improve the well-being of people living with diabetes in Kenya through sustainable partnerships and collaborations, as well as to improve the diabetes care for children with type 1 diabetes in Kenya. the country.

“We welcome you and thank you for your support. Your partnership is important and we value it. We invite you to think about investing in the country in terms of manufacturing,” said the Health CS.

To reach more children with diabetes, Kenya needs to establish additional type 1 diabetes clinics and build the capacity of health workers, with Novo Nordisk committing two billion shillings to support the program for the next 3 years.

The two parties have agreed on how to improve and establish the infrastructure of diabetes clinics and the provision of medical and laboratory equipment, training and education of health professionals working on diabetes in type 1 in children and adolescents, the provision of human insulin and blood glucose monitoring equipment and supplies at no cost to children and adolescents. They also agreed to educate children and teens with type 1 diabetes and their families, create a registry for children and teens with type 1 diabetes, and share ideas and results for improvement. Continuation of the Changing Diabetes in Children Project between parties. .

In the agreement, the Government of Kenya will be obliged, among other things, to gradually integrate the Changing Diabetes in Children program into the national health system and to ensure that diabetes and specifically type 1 diabetes is included in the national non-communicable disease agenda. consistent with the Sustainable Development Goals.

Novo Nordisk, in turn, will have to provide the diagnostic, screening and monitoring equipment necessary for the organization and operation of diabetes clinics and the patient registry, provide free human insulin to cover diabetes treatment needs type 1 in children and adolescents up to 25 years old in the health structures supported by the CDiC project.

The company will also have to support the training of health professionals in the management of type 1 diabetes in children and adolescents, support awareness campaigns in collaboration with various stakeholders, support education on diabetes self-management for children, adolescents and their families, including development The CDiC project provides educational materials to patients and supports the improvement of infrastructure in some of the diabetes clinics, as determined by the ministry of Health.

The MoU was signed by Vinay Ransiwal, Managing Director and Vice President on behalf of Novo Nordisk and CS Mutahi Kagwe on behalf of the Government of Kenya and in the presence of Danish Ambassador to Kenya Ole Thonke.

The Changing Children’s Diabetes program was launched in Kenya in 2012 to ensure that children with type 1 diabetes have access to appropriate treatment and support. The partnership was between Novo Nordisk, the Government of Kenya, Roche Diabetes and the Kenya Diabetes Management and Information Center (DMI). It was created to identify solutions that can lead to an integrated approach to the diagnosis, treatment and control of diabetes in children with type 1 diabetes.

(With contributions from APO)

read more
Medical products

Physical testing for 3D printed medical products

Image Credit: Stable Micro Systems Ltd

3D printing has become a niche manufacturing method, allowing consumers to design and manufacture their own products. As such, it now occupies an important place in the manufacturing industry. Objects can be constructed in almost any format the consumer desires, and this has overcome the early limitations of certain groups of polymers as a building material. It’s now a potential tool in many industries, including bone and organ replacements, meat manufacturing, and even customizable baking.

Stable Micro Systems manufactures instruments that measure the tensile and compressive properties of 3D printed parts. As with any manufacturing innovation, the final product must go through a quality control process to assess its physical properties. A Texture Analyzer is a crucial part of this procedure, providing a reliable way to test the mechanical properties of 3D printed objects by applying a choice of compression, tension, extrusion, adhesion, bending or cutting tests to measure the resistance of a product physical properties for example tensile strength, flexural modulus, fracturability, compressibility, to name but a few.

3D Printing Materials Test Example – Extrusion

The printability of materials used in extrusion 3D printing is one of the most important properties, especially when manufacturing objects with architectural complexities. This parameter is influenced by several factors (temperature, components and additives), which makes a thorough evaluation and classification difficult. Interest in 3D printing for biomedical applications is growing and the pharmaceutical industry is beginning to explore how 3D printing can help us deliver better medicines. Achieving reproducibility in 3D printing of biomaterials requires a robust polymer synthesis method to reduce batch-to-batch variation as well as methods to ensure thorough characterization throughout the manufacturing process. In particular, biomaterial inks containing large solid fractions such as ceramic particles, often required for bone tissue engineering applications, are prone to inhomogeneity from improper mixing or particle aggregation which can lead to inconsistent print results. The production of such ink can be optimized to ensure consistent and repeatable print results by using a TA.XTPlusC Texture Analyzer to perform extrusion force measurements to predict the printability of inks. To read a sample post of this texture analyzer app at ETH Zurich, Click here.

Direct extrusion test on a texture analyzer. Image Credit: Stable Micro Systems Ltd

3D Printing Materials Test Example – Compression

Due to the low price of 3D printing equipment and its versatility, materials such as antioxidant PLA composites containing lignin can be used in hospitals to print dressings for patients on demand. 3D printing can also benefit plastic and reconstructive surgeries by fabricating patient-specific tissue substitutes with tissue-like functions and mechanical properties. A texture analyzer can be used to perform compression test on samples to characterize their mechanical properties which are important for their structural integrity. To read a sample post of this Texture Analyzer app at the University of Nottingham, Click here.

Unconfined compression on a texture analyzer. Image Credit: Stable Micro Systems Ltd

3D Printing Materials Test Example – Bending and Bending

3D printing offers a new approach to the fabrication of drug-eluting implantable medical devices, as it allows complex and custom shapes of tissue scaffolds to be flexibly extruded. Given the simplicity, it can be easily transferred to a clinical setting, where implants could be designed on demand to meet patient needs after surgery. These implants may be suitable for administering drugs for localized treatment. For example, chemotherapy agents, antibiotics or local anesthetics. Alternatively, they could be adapted by coating them for prolonged administration of drugs for the treatment of chronic diseases.

Compared to other printable biomaterials, polyurethane elastomers have several advantages, including excellent mechanical properties and good biocompatibility. However, some intrinsic behaviors, especially high melting point and slow degradation rate, hinder their application in 3D printed tissue engineering. The development of a 3D printable amino acid modified biodegradable water-based polyurethane means that the flexibility of this material provides better tissue compliance during implantation and prevents high modulus grafts from scratching tissue surrounding. The use of a texture analyzer to perform flexibility measurements (three-point curvature) on 3D printed samples allows to evaluate if this can be used as an alternative biomaterial for tissue engineering with low temperature printing, biodegradability and compatibility. To read a sample post of this texture analyzer app at Beijing Science and Technology University, Click here Where Click here to see similar work at Queen’s University Belfast.

3-point flexibility and bending test on a texture analyzer. Image Credit: Stable Micro Systems Ltd

Example of testing 3D printing materials – Perforation, Elongation and Tension:

Orodispersible films (ODF) are promising dosage forms for children or the elderly who may have swallowing problems with solid oral dosage forms. By printing active pharmaceutical ingredients on orodispersible films, the flexibility of drug dosing is increased and offers potential for personalized drugs. Warfarin is an example of a drug with a narrow therapeutic index which requires a personalized dosage which is not currently achieved by marketed products. 3D printing by extrusion can be used to produce transparent, smooth and thin, yet flexible and resistant orodispersible films containing therapeutic doses. Using a texture analyzer, films can measure their properties of burst strength and flexibility as part of their critical physical characteristics that could impact their usability.

To read a sample post of this texture analyzer app at Heinrich Heine University Dusseldorf Click hereWhere Click here for similar work done at Åbo Akademi University.

Bursting strength, tensile strength and film flexibility on a texture analyzer. Image Credit: Stable Micro Systems Ltd

How a Texture Analyzer Can Assess the Flow of Base Powder

Texture analysis can also be used at other stages of the 3D printing process, not just to measure the properties of the final product. For example, the properties of the base powder used in selective laser sintering affect the sintering process as well as the properties of the final product. The flow of the powder is one of these properties. As each new layer of powder is swept over the sinter bed, the layer should be even and of the correct thickness and distribution. A Powder flow analyzer (PFA) is a very useful addition to a Texture Analyzer Plus to help measure these flow properties.

PFA proves to be an accurate and reliable method for measuring the flow characteristics of dry and wet powders, with the ability to measure cohesion, clumping and velocity flow dependence as well as bulk density and other properties. It can be quickly retrofitted to a TA.XTPlusC Texture Analyzer, allowing manufacturers to assess and avoid typical issues such as batch and source variation of ingredients, clumping during storage/transportation and problems unloading hoppers or bins, as well as 3D printing. specific properties of the powder. The powder is conditioned at the start of each test to eliminate any load variation and the patented precision blade is then rotated through the sample causing a controlled flow.

Image Credit: Stable Micro Systems Ltd

The need to measure dimensional profiles

If you designed a product and then print it, one of the concerns will be whether what was printed matches what you designed. In many cases you will need your printed object to be dimensionally accurate and printing iterations of your design are almost inevitable to adjust the print settings to achieve a dimensionally accurate product. A precise numerical evaluation of the physical dimensions thus becomes a necessity. A Volscan Profiler provides such a solution – a benchtop laser scanner that measures the volume, density and dimensional profiles of solid products. Rapid three-dimensional scanning of products allows for the automatic calculation of several detailed dimension-related parameters, the results of which can be mathematically manipulated for immediate use or future retrieval in a variety of data formats for your printed objects.

Volscan Profiler models for measuring volume, density and dimensional profiles. Image Credit: Stable Micro Systems Ltd

Bone sample ready for scanning and an archived scan of the sample. Image Credit: Stable Micro Systems Ltd

The medical industry is increasingly dependent on the TA.XTmoreC Texture Analyzer as a tool for measuring all types of physical/mechanical properties.

See a wider range of test and measurement possibilities in this area.

read more
Medical products

Sentinel Node Biopsy Market Is Booming Globally | Devicor Medical Products, Inc., CR Bard, Inc. (USA), INTRAMEDICAL IMAGING LLC (USA)

Global Sentinel lymph node biopsy The market report is an objective and in-depth study of the current state aimed at the key drivers, Sentinel Node Biopsy market strategies and growth of Sentinel Node Biopsy key players. The Sentinel Node Biopsy study also involves the significant achievements of the Sentinel Node Biopsy market, Sentinel Node Biopsy research and development, Sentinel Node Biopsy new product launch, Sentinel Node Biopsy product responses and Sentinel Node Biopsy industry regional growth of key competitors operating in the market globally and locally. The structured analysis contains a graphical and schematic representation of the global Sentinel Node Biopsy market with its specific geographical regions.

[Due to the pandemic, we have included a special section on the pre-post Impact of COVID 19 on the @ Market which would mention How the Covid-19 is Affecting the Sentinel Node Biopsy

Get Sentinel Node Biopsy sample copy of report @ jcmarketresearch.com/report-details/73152/sample

** The Values marked with XX is confidential data. To know more about Sentinel Node Biopsy industry CAGR figures fill in your information so that our JCMR business development executive can get in touch with you.

Global Sentinel Node Biopsy (Thousands Units) and Revenue (Million USD) Market Split by following coverage:- 

[Segments]

The Sentinel Node Biopsy research study is segmented by Application such as Laboratory, Sentinel Node Biopsy Industrial Use, Sentinel Node Biopsy Utilities and Others with historical and projected market share and a compound annual growth rate.
Global Sentinel Node Biopsy by Region (2022-2030)

Sentinel Node Biopsy Market Segmentation By Regions 2015 2017 2019 2020 CAGR (%) (2022-2030)
North America xx xx xx xx% xx%
Europe xx xx xx xx% xx%
AEM xx xx xx xx% xx%
APAC and rest of the world xx xx xx xx% xx%
Total xx xx xx xx% xx%

Geographically, this Sentinel Node Biopsy report is segmented into several key Regions, with production, consumption, revenue (Million USD) and market share of Sentinel Node Biopsy and growth rate of Sentinel Node Biopsy of the sentinel lymph node in these regions, from 2015 to 2030 (forecast) covering .

Additionally, sentinel node biopsy export and import policies can have an immediate impact on sentinel node biopsy. This Sentinel Node Biopsy study contains an EXIM* related chapter on Sentinel Node Biopsy Market and all its associated companies with their profiles, which provides valuable data regarding their outlook in terms of industry financials Node Biopsy, Sentinel Node Biopsy Product Portfolios, Sentinel Node Biopsy Investment Plans, Sentinel Node Biopsy Marketing and Sentinel Node Biopsy Business Strategies. The Sentinel Node Biopsy report is an important document for all market enthusiasts, policy makers, investors, and players.

Key questions answered in this Sentinel Node Biopsy Industry Report – 2030 Data Survey Report

What will be the size of the Sentinel Node Biopsy market in 2030 and what will be the growth rate?
What are the key trends in the Sentinel Node Biopsy market?
What motivates sentinel lymph node biopsy?
What are the growth challenges of the Sentinel Node Biopsy market?
Who are the leading providers of sentinel lymph node biopsy in space?
What are the key market trends impacting the growth of Sentinel Node Biopsy?
What are the main results of the analysis of the five forces of the sentinel lymph node biopsy?

Get Attractive Discount on Sentinel Node Biopsy Report with Extra Customization @ jcmarketresearch.com/report-details/73152/discount

There are 15 chapters to view Sentinel Node Biopsy.

Chapter 1, to describe Definition, Specifications and Classification of Sentinel Node Biopsy, Applications of Sentinel Node Biopsy, Market Segment by Regions;

Chapter 2, to analyze the Sentinel Node Biopsy manufacturing cost structure, Sentinel Node Biopsy raw material and suppliers, Sentinel Node Biopsy manufacturing process, manufacturing chain structure sentinel lymph node biopsy industry;

Chapter 3, to view the Technical Data and Manufacturing Plants Analysis of Sentinel lymph node biopsysentinel node biopsy capacity and commercial production date, distribution of sentinel node biopsy manufacturing plants, sentinel node biopsy R&D status and technology source, sentinel node biopsy raw material source analysis;

Chapter 4, to show the Global Sentinel Node Biopsy Market Analysis, Sentinel Node Biopsy Capacity Analysis (Company Segment), Sentinel Node Biopsy Sales Analysis (Company Segment), Sentinel Node Biopsy Sales Price Analysis (Company Segment);

Chapter 5 and 6, to show the Regional Sentinel Node Biopsy Market Analysis that includes North America, Europe, Asia-Pacific etc, Market Analysis of Biopsy Segment from the sentinel lymph node by various segments;

Chapter 7 and 8, to analyze the Sentinel Node Biopsy Segment Market Analysis (by Application) Major Manufacturers Analysis of Sentinel Node Biopsy;

Chapter 9, Sentinel Node Biopsy Market Trend Analysis, Regional Market Trend, Market Trend by Product Types, Market Trend by Applications;

Chapter 10, Sentinel Node Biopsy Regional Marketing Type Analysis, Sentinel Node Biopsy International Trade Type Analysis, Sentinel Node Biopsy Supply Chain Analysis;

Chapter 11, to analyze consumer analysis of sentinel lymph node biopsy;

Chapter 12, to describe Sentinel Node Biopsy Research Findings and Conclusion, Appendix, methodology and data source;

Chapter 13, 14 and 15, to describe Sentinel Node Biopsy sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source.

Purchase an instant copy of the full Sentinel Node Biopsy Research Report: @ jcmarketresearch.com/checkout/73152

Find more research reports on Sentinel node biopsy industry. By JC Market Research.

Thank you for reading this article; you can also get individual chapter wise section or region wise report version like North America, Europe or Asia.

About the Author:
JCMR’s global research and market intelligence consulting organization is uniquely positioned to not only identify growth opportunities, but also to empower and inspire you to create visionary growth strategies for the future, through our extraordinary depth and breadth of thought leadership, research, tools, events and experience. that help you make goals a reality. Our understanding of the interplay between industry convergence, megatrends, technologies and market trends provides our clients with new business models and opportunities for expansion. We are focused on identifying the “Accurate Forecast” in each industry we cover so that our clients can reap the benefits of being early market entrants and can achieve their “Goals and Objectives”.

Contact us:
JCMARKETRESEARCH
Mark Baxter (Business Development Manager)
Call:
+1 (925) 478-7203
Email: [email protected]

Connect with us at – LinkedIn

read more
Medical products

Pharmaceuticals and medical products boosted Irish exports by a third in May – The Irish Times

The value of Irish goods exports jumped by a third to €18 billion in May from the same month last year, driven mainly by growth in exports of medical and pharmaceutical products, according to the latest data. from the Central Statistics Office.

The data also shows that the year-on-year value of merchandise exports for the first five months of 2022 increased by a third to 88.1 billion euros.

Exports of medical and pharmaceutical products increased by almost two-thirds to reach 7.1 billion euros. This represented 39 percent of total exports. Exports of professional, scientific and control devices increased by a third to 733 million euros.

Exports of food and live animals increased by 28% to €1.3 billion, while exports of machinery, appliances, appliances and electrical parts increased by 19% to €1.2 billion .

Strong increases were also seen on the import side, with the unadjusted value rising by 46% to €12.8 billion. The value of goods imports for the period from January to May increased by 36% to 53.6 billion euros.

Imports from Great Britain increased by 71% to reach 2 billion euros. CSO statistician Ciarán Counihan said this was partly explained by the relatively low level of imports in May 2021, which was the fifth month in which post-Brexit customs documentation was required for UK trade.

The value of goods imports from Britain in the first five months of the year is 76% higher than last year, at 9.3 billion euros.

Exports to Great Britain increased by 27% to reach 1.5 billion euros. The main change was an increase in exports of chemicals and related products, as well as machinery and transport equipment. Exports to Britain accounted for 8% of total exports in May. The value of goods exports to Britain from January to May rose 32% to €6.9 billion.

Imports from Northern Ireland were up 23% on a year ago in the five months to May, to 1.9 billion euros. Exports to Northern Ireland for the same period increased by 42% to €2 billion.

The European Union accounted for 35% of total merchandise exports in May, of which 2 billion euros went to Germany, 1.3 billion euros to the Netherlands and 1.2 billion euros to the Belgium. Total EU exports increased by 15% compared to May 2021.

The United States was the main destination outside the EU, accounting for 30 percent of total exports. The EU accounted for 27%, an increase of 1% from May 2021.

The United Kingdom with 2.4 billion euros (19%), the United States with 1.9 billion euros (15%) and China with 1.6 billion euros (12%) were main sources of non-EU imports.

read more
Medical products

US Treasury says agricultural and medical products not part of Russian sanctions

The US Treasury Department clarified on Thursday that it had not imposed any sanctions on the production, manufacture, sale or transport of agricultural products (including fertilizers), agricultural equipment or drugs linked to Russia.

In a fact sheet released by the department, he said the Treasury’s Office of Foreign Assets Control (OFAC) issued a Broad General License (GL) to authorize certain transactions related to agricultural commodities, farm equipment, drugs and medical devices.

“The United States strongly supports United Nations efforts to bring Ukrainian and Russian grain to world markets and to reduce the impact of Russia’s unprovoked war against Ukraine on world food supplies and prices. … The agricultural and medical trade is not the target of sanctions imposed by the United States on Russia for its atrocities in Ukraine.”

The fact sheet pointed out that the provision of insurance or reinsurance for the transport of agricultural products was also not prohibited.

“The United States has imposed a ban on the importation into the United States of fish, seafood and their preparations originating in the Russian Federation. This ban does not limit the importation of fish, seafood and of their preparations originating in the Russian Federation from Russia to countries other than the United States,” he added.

He also said that US financial institutions could conduct transactions related to the items mentioned, adding that the state-owned Russian Agricultural Bank was not on OFAC’s Specially Designated Nationals list, but that transactions were subject to certain debt and equity restrictions.

The fact sheet reflected US policy, which exempts humanitarian, medical and agricultural products from sanctions, with certain restrictions.

The United States issued a memo in February saying its sanctions regime does not prohibit the import or export of agricultural products, drugs and medical devices to Afghanistan, the Wall Street Journal reported.

read more
Medical products

Utah Medical Products (NASDAQ:UTMD) and Treace Medical Concepts (NASDAQ:TMCI) Financial Comparison


Utah Medical Products (NASDAQ:UTMDGet a rating) and Treace Medical Concepts (NASDAQ: TMCIGet a rating) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their analyst recommendations, dividends, earnings, profitability, institutional ownership, valuation and risk.

Risk and Volatility

Utah Medical Products has a beta of 0.24, meaning its stock price is 76% less volatile than the S&P 500. Comparatively, Treace Medical Concepts has a beta of -0.6, meaning its stock price is 160% less volatile than the S&P 500. .

Analyst Recommendations

This is a summary of recent ratings and recommendations for Utah Medical Products and Treace Medical Concepts, as reported by MarketBeat.

Sales Ratings Hold odds Buy reviews Strong buy odds Rating
Utah Medical Products 0 0 0 0 N / A
Tracee Medical Concepts 0 0 4 0 3.00

Treace Medical Concepts has a consensus target price of $28.50, suggesting a potential upside of 75.82%. Given the likely higher upside of Treace Medical Concepts, analysts clearly believe that Treace Medical Concepts is more favorable than Utah Medical Products.

Insider and Institutional Ownership

71.4% of Utah Medical Products shares are held by institutional investors. By comparison, 34.8% of shares in Treace Medical Concepts are held by institutional investors. 6.6% of Utah Medical Products stock is held by insiders. By comparison, 41.9% of Treace Medical Concepts’ shares are held by insiders. Strong institutional ownership indicates that hedge funds, endowments, and large fund managers believe a stock will outperform the market over the long term.

Profitability

This table compares the net margins, return on equity and return on assets of Utah Medical Products and Treace Medical Concepts.

Net margins Return on equity return on assets
Utah Medical Products 30.34% 14.14% 13.03%
Tracee Medical Concepts -25.92% -28.57% -19.15%

Valuation and benefits

This table compares the gross revenue, earnings per share (EPS), and valuation of Utah Medical Products and Treace Medical Concepts.

Gross revenue Price/sales ratio Net revenue Earnings per share Price/earnings ratio
Utah Medical Products $49.05 million 6.09 $14.79 million $4.18 19.61
Tracee Medical Concepts $94.42 million 9.49 -$20.55 million ($0.50) -32.42

Utah Medical Products has higher revenue, but lower revenue than Treace Medical Concepts. Treace Medical Concepts trades at a lower price-to-earnings ratio than Utah Medical Products, indicating that it is currently the more affordable of the two stocks.

Summary

Utah Medical Products beats Treace Medical Concepts on 8 of 13 factors compared between the two stocks.

Utah Medical Products Company Profile (Get a rating)

Utah Medical Products, Inc. develops, manufactures and distributes medical devices for the healthcare industry. The Company offers fetal monitoring accessories, vacuum assisted delivery systems and other labor and delivery tools; Respiratory hoods for newborns DISPOSA-HOOD; and DELTRAN PLUS blood pressure monitoring systems. It also supplies GESCO umbilical vessel catheters; DIALY-NATE disposable peritoneal dialysis sets; PALA-NATE Silicone Mouthguards; URI-CATH urinary drainage systems; NUTRI-CATHNUTRI-LOK feeding device; MYELO-NATE Lumbar Sampling Kits; HEMO-NATE disposable filters; and catheterization procedure tray of instruments and supplies. Additionally, the Company offers the LETZ System for excision of cervical intraepithelial neoplasia and other lower genital tract lesions; FINESSE+ generators; loop, ball and needle electrodes; FILTRESSE spillways; other electrodes and specialized supplies and gynecological tools; Femcare trocars, cannulas, laparoscopic instruments and accessories; and EPITOME and OptiMicro electrosurgical devices. In addition, it provides Filshie Clip female surgical contraceptive devices; PATHFINDER PLUS endoscopic irrigation devices; suprapubic catheterization; LIBERTY Urinary Incontinence Treatment and Control Systems; ENDOCURETTE, a curette for the removal of uterine endometrial tissue; TVUS/HSG-Cath to assess abnormal or dysfunctional uterine bleeding and other abnormalities of the uterus; and the LUMIN tool for manipulating the uterus in laparoscopic procedures. Additionally, the company offers DELTRAN, a disposable pressure transducer; and pressure monitoring accessories, components and other castings. It serves neonatal intensive care units, labor and delivery wards, women’s health centers in hospitals, outpatient clinics and physicians’ offices through direct customer service and a force sales representatives, independent consultants and manufacturer representatives. The company was incorporated in 1978 and is headquartered in Midvale, Utah.

Treace Medical Concepts Company Profile (Get a rating)

Treace Medical Concepts, Inc., an orthopedic medical device company, is engaged in the design, manufacture and marketing of medical devices for foot and ankle surgeons in the United States. It offers a lapiplasty procedure that allows podiatric surgeons to treat all three dimensions of the bunion, providing patients with cosmetic and medical improvement. The company also provides the Precision Lapiplasty Mini-Incision System. In addition, it offers products to address ancillary surgical procedures, including akin osteotomies, Weil osteotomies, intercuneiform stabilization, inferior tarso-metatarsal joint fusions and autograft bone harvesting, as well as fusion MTP. Treace Medical Concepts, Inc. was founded in 2013 and is headquartered in Ponte Vedra Beach, Florida.



Receive daily news and reviews for Utah medical products – Enter your email address below to receive a concise daily summary of breaking news and analyst ratings for Utah Medical Products and related companies with MarketBeat.com’s free daily email newsletter.

read more
Medical products

Drones ready to deliver medical products to Washington State in 2024

The drones will begin carrying medical supplies to addresses in Tacoma, Wash., starting in 2024, two companies behind the project announced Thursday. It’s the latest example of using unmanned aircraft to move critical cargo faster than conventional transportation.

Startup Zipline drone maker and healthcare provider MultiCare said the service would transport lab samples, medications and test kits among local Multicare facilities, the companies told CNET exclusively. MultiCare expects the partnership to mean that its healthcare providers, with their own on-demand delivery system, will be able to improve the care patients receive.

Project Tacoma still requires regulatory approval for flight operations details, including whether the Zipline drones will fly autonomously, as they do in the company’s other operations.

“Ensuring our providers have what they need, when they need it, is a critical part of providing affordable and accessible care to patients,” said Florence Chang, president of MultiCare, in a statement.

Project Tacoma marks the latest use of drones to speed up deliveries, which can be slowed by increasingly congested roads. The World Economic Forum expects the use of delivery trucks will increase by 78% by 2030 without alternative shipping approaches, adding 11 minutes to average travel times.

Drones are already in limited operation in the United States. Wing, operated by Alphabet, Google’s parent company, has begun deliveries in the Dallas-Fort Worth area of ​​Texas. In parts of North Carolina, Flytrex drones deliver food from Just Wings, Chili’s Grill & Bar and Maggiano’s Little Italy to homes. Amazon Prime Air plans to test drone deliveries south of Sacramento, California.

Based south of San Francisco Zipline has made nearly 345,000 deliveries to date, primarily with nationwide programs in Rwanda and Ghana, and delivers an average of one package every two minutes. It began an expansion into the United States last year, shipping packages for retail giant Walmart in Pea Ridge, Arkansas. In June, it began delivering medical supplies from a distribution center in Kannapolis, North Carolina, for Novant Health, Magellan Rx Management and Cardinal Health.

In June, Zipline cleared a regulatory hurdle in the United States by winning certification from the Federal Aviation Administration that allows flights up to 26 miles.

read more
Medical products

Providing lifesaving medical products and expert advice for over 32 years

Healthgear Medical & Safety team teaches customers how to properly and safely use their medical products

Founded by James W. Mills, CSF, CFO, Healthgear Medical & Safety has served the District of Algoma and Sault Ste Marie for over 32 years, with competitive pricing and the widest product line in the North. They carry all types of medical products for individuals, hospitals and nursing homes.

Born with spina bifida, Jim had a strong desire to help others with their mobility issues from an early age. Also a former competitive swimmer and provincial weightlifter, Jim strives to stock all the best sports medicine products, braces and health supports, for both able-bodied and disabled athletes.

Doctors and physiotherapists refer their patients to Healthgear Medical & Safety because of the certified staff and wide variety of products.

Healthgear Medical & Safety sells items such as:

  • blood pressure monitors,
  • walkers,
  • compression hose,
  • TENS,
  • lifting chairs,
  • ostomy supplies,
  • bath safety equipment,
  • FIRST AID,
  • pain control devices,
  • scooters
  • and stair railings,

Not only that, but they also service all makes and models with their comprehensive aftermarket service, with parts and reasonable hourly rates.

Healthgear Medical & Safety will show you the correct usage of your device or product with every purchase, so you know you’re getting the right information.

All customers get a very private full experience when purchasing their product, whether it is custom made knee brace, foot orthotics, back brace, ankle support , wrist or cervical. If you need your medical product delivered, there is no charge in the District of Algoma.

A solidarity company

For five consecutive years, Healthgear Medical & Safety has been voted the top medical provider in the Sault by opinion polls. Healthgear Medical & Safety is an authorized provider for WSIB, Social Agencies, NIHB Program and can bill most insurance companies where applicable. They can make home and hospital visits when needed.

Healthgear Medical & Safety is a community-minded company. During the pandemic, Jim and staff have been able to secure thousands of dollars in supplies donated to nonprofits here in Sault Ste Marie and abroad. When hospitals and nursing homes struggled to find fair prices on PPE supplies, Healthgear Medical & Safety staff were able to source these items from the United States. They always had ample supplies for the public and never ran out, while maintaining fair prices and offering free shipping.

Healthgear Medical & Safety is here to serve the residents of Sault Ste Marie and the District of Algoma.

They are open Monday through Friday from 8:30 a.m. to 5:30 p.m. and Saturday from 9 a.m. to 1 p.m., and also offer free shipping anywhere in the Algoma area. After hours, call 705-257-8049 for emergency appointments or fittings. They are located across from Memorial Gardens at 262 Queen Street East.

You can also visit them online here.

read more
Medical products

Prescriptions for medical cannabis products increased almost tenfold in 2021

According to figures released by the Care Quality Commission (CQC), prescriptions for unauthorized medical cannabis in the private healthcare sector have increased by nearly 1,000% over a 12-month period.

The health and social services regulator’s report — ‘Managing Controlled Medications Safer: 2021 Annual Update‘, published in July 2022 – indicates that 37,634 cannabis medical products (CBMPs) were prescribed by non-NHS health services between January and November 2021, compared to 3,636 over the same period in 2020.

Conversely, during the same period, NHS prescribing of CBMP in England was so low that data could not be reported.

“The number of items prescribed in the NHS is so small that it could potentially affect patient confidentiality,” the report said.

On April 25, 2022, in response to a written question on the assessment made of the adequacy of access to medical cannabis for those eligible, Pharmacy Minister Maria Caulfield said: “Licensed cannabis medicines are regularly available on the NHS.

“However, clinical guidelines from the National Institute for Health and Care Excellence demonstrate a clear need for more evidence to support routine prescribing and funding decisions for cannabis products not authorized for medical use. until this evidence base is built, prescribers will remain reluctant to prescribe and no decisions can be made by the NHS on routine funding.

In July 2020, a CQC report found that in 2019 – the first year CBMPs were legally available – 18 NHS prescriptions were issued in England.

Then, in October 2020, the National Institute for Health Research confirmed that no government-funded medical cannabis trials were underway, despite a call for applications.

Several private health clinics capable of providing CBMPs have been established since the legalization of medical cannabis in November 2018.

At the time of publication of the latest CQC update, there were 15 registered providers of unlicensed CBMP in England, with more being assessed for registration.

Sapphire Medical Clinic was the first dedicated medical cannabis clinic in the UK to be registered by the CQC on October 3, 2019.

Commenting on the recent increase in CBMP prescriptions, Simon Erridge, Head of Research and Access at Sapphire Medical Clinics, said: “Since 2020, we have seen an 846% increase in the number of patients accessing our specialist service. .

“The prescribing of unlicensed cannabis medicines through the NHS has not seen the same growth. The most important reason behind this is the National Institute for Health and Care Excellence guideline issued in 2019, which has not showed sufficient clinical benefit over the costs then associated with these drugs.

“There is also a lack of randomized controlled trials showing the effectiveness of CBMPs compared to other licensed drugs.”

Read more: Medical cannabis has yet to live up to the hype

read more
Medical products

Swabs Market Expected to Drive Future Growth by 2030 | Puritan Medical Products, Sarstedt, MWE – Brits in Kenya

Swabs Market Report Coverage: Key Growth Drivers and Challenges, Regional Segmentation and Outlook, Key Industry Trends and Opportunities, Competitive Analysis, COVID-19[feminine] Impact analysis and projected recovery, and market sizing and forecasting.

Latest research launched on Global swab market, it provides a detailed analysis with presentable graphs, charts and tables. This report covers an in-depth study of the Swabs Market size, growth and share, trends, consumption, segments, application and forecast 2030. Through qualitative and quantitative analysis, we help you to carry out an in-depth and comprehensive research on the global swabs market. This report has been prepared by experienced and knowledgeable market analysts and researchers. Each section of the research study is specially prepared to explore key aspects of the global Swabs market. Buyers of the report will have access to accurate information PESTLE, SWOT and other types of analysis on the global swabs market. In addition, it offers very precise estimates on the CAGR, market share and market size of key regions and countries.

Major Key Players profiled in the report include:
Puritan Medical Products, Sarstedt, MWE, SARSTEDT, Clean Cross, GPC Medical, Citotest Labware Manufacturing, Q-TIPS, ELMEX

Download Free Sample PDF including COVID19 Impact Analysis, Full TOC, Tables & Figures @
Get a FREE sample PDF copy of the report @ https://marketstrides.com/request-sample/swab-market

Do not miss the trading opportunities on Swab Market. Talk to our analyst and get key industry insights that will help your business grow when you create sample PDF reports.

Segmental analysis:
The report categorized the global swabs market into segments comprising product type and application. Each segment is assessed based on its share and growth rate. Additionally, analysts have studied the potential regions that could prove rewarding for Swab makers in the coming years. The regional analysis includes reliable predictions about value and volume, helping market players to gain insightful insights into the overall Swab industry.

Market is split by Type, can be split into:
Absorbent cotton, Non-absorbent cotton

The market is split by Application, can be split into:
Pharmaceutical, Microbiological, Laboratory, Others

Share your budget and get an exclusive discount @
Check the discount for this report: https://marketstrides.com/check-discount/swab-market

The report authors have analyzed the developing and developed regions considered for research and analysis of the global Swabs market. The regional analysis section of the report provides an in-depth study of different regional and country-level Swab industries to assist players in planning effective expansion strategies.

Regions Covered in Global Swabs Market:
The Middle East and Africa (Saudi Arabia, United Arab Emirates, Egypt, Nigeria and South Africa)
North America (United States, Mexico and Canada)
South America (Brazil, Argentina, Colombia, etc.)
Europe (Turkey, Germany, Russia UK, Italy, France, etc.)
Asia Pacific (Vietnam, China, Malaysia, Japan, Philippines, Korea, Thailand, India, Indonesia and Australia)

Years considered to estimate the market size:
Historical year: 2019-2020
Year of reference : 2021
Estimated year: 2022
Forecast year: 2022-2030

Detailed TOC of Swabs Market Report 2022-2030:
Chapter 1: Swabs Market Overview
Chapter 2: Economic impact on industry
Chapter 3: Market competition by manufacturers
Chapter 4: Production, revenue (value) by region
Chapter 5: Supply (production), consumption, export, import by regions
Chapter 6: Production, Revenue (Value), Price Trend by Type
Chapter 7: Market analysis by application
Chapter 8: Manufacturing cost analysis
Chapter 9: Industrial Chain, Sourcing Strategy and Downstream Buyers
Chapter 10: Marketing Strategy Analysis, Distributors/Traders
Chapter 11: Analysis of market effect factors
Chapter 12: swab market Provide
Continued……

Get Buy this Swabs Market Report 2022-2030: Choose License Type

What market dynamics does this report cover?
The report shares key information on:
Current market size
Market forecasts
Market opportunities
Main Drivers and Constraints
Regulatory scenario
Industry trend
New product approvals/launch
Promotion and marketing initiatives
Price analysis
Competitive landscape
It helps companies make strategic decisions.

Does this report offer customization?
Personalization helps organizations better understand specific market segments and areas of interest. Therefore, Market strides provides customized reporting information based on business needs for mission-critical calls.

About Us:

Market Strides is a global aggregator and publisher of market intelligence development reports, stock reports, database directories and economic reports. Our repository is diverse, covering virtually every industry sector and even more so all categories and sub-categories within the industry.

Our pre-integration strategy for publishers is perhaps what sets us apart in the market. The publishers & their market share, the reports are meticulously validated by our panel of internal consultants, before being posted on our website. These in-house consultants are also responsible for ensuring that our website features only the most up-to-date reports.

You have a question ? Ask our experts

Market Strides has a team of professionals who assist you in many advanced industry-specific trends, content and test different strategies and implement the most productive one for the business.

For more information, Email – [email protected]

Contact us: +1 856 677 8909 (USA)

Follow us on social networks:

Facebook || LinkedIn || Twitter || pinterest || tumblr || instagram || Medium

Other list of trend reports:
https://sjindependent.org/regional-news/hcm-software-market-comprehensive-study-explores-huge-growth-in-future-cornerstone-ondemand-webhr-zoho-corporation/
https://www.tgbbj.com/global-home-healthcare-software-market-trends-and-developments-forecast-by-2030/
https://sjindependent.org/report/microwave-ablation-systems-market-industry-size-in-depth-qualitative-insights/
https://www.designerwomen.co.uk/apheresis-market-size-2022-analysis-by-2030-asahi-kasei-medical-nikkiso-fresenius-kabi/

read more
Medical products

Comparison of Globus Medical (NYSE: GMED) and Utah Medical Products (NASDAQ: UTMD)


Globus Medical (NYSE: GMEDGet a rating) and Utah Medical Products (NASDAQ:UTMDGet a rating) are two medical companies, but which is the best investment? We will compare the two companies based on their risk strength, earnings, analyst recommendations, institutional ownership, valuation, dividends and profitability.

Volatility and risk

Globus Medical has a beta of 1.11, suggesting that its stock price is 11% more volatile than the S&P 500. In comparison, Utah Medical Products has a beta of 0.24, suggesting that its stock price is stock is 76% less volatile than the S&P 500.

Profitability

This table compares the net margins, return on equity and return on assets of Globus Medical and Utah Medical Products.

Net margins Return on equity return on assets
Globus Medical 14.77% 11.95% 10.69%
Utah Medical Products 30.34% 14.14% 13.03%

Institutional and insider ownership

67.2% of Globus Medical shares are held by institutional investors. By comparison, 71.4% of Utah Medical Products’ shares are held by institutional investors. 16.5% of Globus Medical shares are held by insiders of the company. By comparison, 6.6% of Utah Medical Products’ stock is held by company insiders. Strong institutional ownership indicates that large fund managers, hedge funds, and endowments believe a company will outperform the market over the long term.

Analyst Recommendations

This is a summary of current ratings and recommendations for Globus Medical and Utah Medical Products, as provided by MarketBeat.

Sales Ratings Hold odds Buy reviews Strong buy odds Rating
Globus Medical 0 1 9 0 2.90
Utah Medical Products 0 0 0 0 N / A

Globus Medical currently has a consensus target price of $83.18, suggesting a potential upside of 44.11%. Given the likely higher upside of Globus Medical, stock analysts clearly believe that Globus Medical is more favorable than Utah Medical Products.

Benefits and evaluation

This chart compares revenue, earnings per share, and valuation of Globus Medical and Utah Medical Products.

Gross revenue Price/sales ratio Net revenue Earnings per share Price/earnings ratio
Globus Medical $958.10 million 6.13 $149.19 million $1.36 42.44
Utah Medical Products $49.05 million 6:30 p.m. $14.79 million $4.18 20.27

Globus Medical has higher revenues and profits than Utah Medical Products. Utah Medical Products trades at a lower price-to-earnings ratio than Globus Medical, indicating that it is currently the more affordable of the two stocks.

Summary

Globus Medical beats Utah Medical Products on 7 out of 13 factors compared between the two stocks.

About Globus Medical (Get a rating)

Globus Medical, Inc., a medical device company, develops and markets healthcare solutions for patients with musculoskeletal disorders in the United States and around the world. It offers spine products, such as traditional fusion implants comprising screw and pedicle rod systems, plating systems, intervertebral spacers and corpectomy devices for the treatment of degenerative conditions, deformities, tumors and trauma; treatment options for motion-preserving technologies that consist of dynamic stabilization, total disc replacement, and interspinous distraction devices; interventional pain management solutions to treat vertebral compression fractures; and regenerative biologics including allografts and synthetic alternatives. The Company also offers products for the treatment of orthopedic trauma, including fracture plates, compression screws, intramedullary nails and external fixation systems; and solutions for the hip and knee joints, including modular hip stems and acetabular cups, as well as posterior stabilization and cruciate ligament retention knee arthroplasty implants. In addition, it distributes human cells, tissues, and cell and tissue products. Globus Medical, Inc. was incorporated in 2003 and is headquartered in Audubon, Pennsylvania.

About Utah Medical Products (Get a rating)

Utah Medical Products, Inc. develops, manufactures and distributes medical devices for the healthcare industry. The Company offers fetal monitoring accessories, vacuum assisted delivery systems and other labor and delivery tools; Respiratory hoods for newborns DISPOSA-HOOD; and DELTRAN PLUS blood pressure monitoring systems. It also supplies GESCO umbilical vessel catheters; DIALY-NATE disposable peritoneal dialysis sets; PALA-NATE Silicone Mouthguards; URI-CATH urinary drainage systems; NUTRI-CATHNUTRI-LOK feeding device; MYELO-NATE Lumbar Sampling Kits; HEMO-NATE disposable filters; and catheterization procedure tray of instruments and supplies. Additionally, the Company offers the LETZ System for excision of cervical intraepithelial neoplasia and other lower genital tract lesions; FINESSE+ generators; loop, ball and needle electrodes; FILTRESSE spillways; other electrodes and specialized supplies and gynecological tools; Femcare trocars, cannulas, laparoscopic instruments and accessories; and EPITOME and OptiMicro electrosurgical devices. In addition, it provides Filshie Clip female surgical contraceptive devices; PATHFINDER PLUS endoscopic irrigation devices; suprapubic catheterization; LIBERTY Urinary Incontinence Treatment and Control Systems; ENDOCURETTE, a curette for the removal of uterine endometrial tissue; TVUS/HSG-Cath to assess abnormal or dysfunctional uterine bleeding and other abnormalities of the uterus; and the LUMIN tool for manipulating the uterus in laparoscopic procedures. Additionally, the company offers DELTRAN, a disposable pressure transducer; and pressure monitoring accessories, components and other castings. It serves neonatal intensive care units, labor and delivery wards, women’s health centers in hospitals, outpatient clinics and physicians’ offices through direct customer service and a force sales representatives, independent consultants and manufacturer representatives. The company was incorporated in 1978 and is headquartered in Midvale, Utah.



Get news and reviews for Globus Medical Daily – Enter your email address below to receive a concise daily summary of breaking news and analyst ratings for Globus Medical and related companies with MarketBeat.com’s free daily email newsletter.

read more
Medical products

Disposable Hemostats Market Statistical Forecast, Trade Analysis 2022 – DaySpring Medical Products, Bard Medical, Alpha Industries, Towne Brothers, Fine Science Tools, Ydm, Hu-Friedy, Ted Pella, Teleflex Medical – Instant Interview

The Latest published a market study on Disposable hemostat Market provides an overview of current market dynamics in the Disposable Hemostat space, as well as what our survey respondents – all outsourcing decision makers – predict the market will look like in 2028. The study divides the market in terms of revenue and volume (if applicable) and price history to estimate size and trend analysis and identify gaps and opportunities. Some of the actors covered by the study are DaySpring Medical Products, Bard Medical, Alpha Industries, Towne Brothers, Fine Science Tools, Ydm, Hu-Friedy, Ted Pella, Teleflex Medical

Prepare to identify the pros and cons of the regulatory framework, local reforms and its impact on the industry. Find out how the leaders in disposable hemostat are staying ahead with our latest survey analysis

Click for Sample PDF Copy of Disposable Hemostat Market Research Here @ https://www.maccuracyreports.com/report-sample/459498

Main highlights of the study as well as the most frequently asked questions:

1) What makes this disposable hemostat review so unique?

Market Factor Analysis: In this economic downturn, the impact on various industries is enormous. Moreover, the increase in the gap between demand and supply resulting from the slow supply chain and production chain has made the market interesting to observe. It also discusses technological, regulatory and economic trends affecting the market. It also explains the key drivers and regional dynamics of the global market and current trends within the industry.

Market concentration: Includes C4 Index, HHI, Disposable Hemostats (YoY) Market Share Benchmarking, Major Companies, Emerging Players with Heatmap Analysis

Market entropy: The randomness of the market highlights the aggressive steps players are taking to overcome the current scenario. Developmental activities and milestones such as expansions, technological advancements, mergers and acquisitions, joint ventures, launches are highlighted here.

Patent Analysis: Comparison of patents issued by each player per year.

Peer review: An assessment of players by financial metrics such as EBITDA, net profit, gross margin, total revenue, segmented market share, assets, etc. to understand the management efficiency, functioning and state of liquidity.

2) Why are only a few companies featured in the report?
Industry standards such as NAICS, ICB, etc. are considered the most important manufacturers. The focus is more on SMEs that are emerging and evolving in the market with their product presence and improved technology modes, the current version includes players such as DaySpring Medical Products, Bard Medical, Alpha Industries, Towne Brothers, Fine Science Tools, Ydm, Hu-Friedy, Ted Pella, Teleflex Medical etc and many more.

**Companies reported may vary due to rebranding/merger etc.

Access full report description, table of contents, table of figures, chart, etc. : https://www.maccuracyreports.com/report-sample/459498

3) What details will the competitive landscape provide?
A chapter on the value proposition to assess the disposable hemostats market. 2-page profiles of all listed companies with 3-5 year financial data to track and compare company overview, product specifications, etc.

4) What did all the regional segmentations cover? Can a specific country of interest be added?
The countries included in the analysis are North America, United States, Canada, Mexico, Europe, Germany, France, United Kingdom, Italy, Russia, countries Nordics, Benelux, Rest of Europe, Asia, China, Japan, South Korea, Southeast Asia, India, Rest of Asia, South America, Brazil, Argentina , Rest of South America, Middle East and Africa, Turkey, Israel, Saudi Arabia, United Arab Emirates and Rest of Middle East and Africa
** Countries of primary interest can be added if missing.

5) Is it possible to limit/adapt the scope of the study to the applications we are interested in?
Yes, the general version of the study is broad, but if you have a limited application in your scope and target, the study can also be customized just for those applications. It now covers Aeronautics, Airports & Other applications.

** Depending on the requirement, delivery time may vary.

To mainly understand the global Disposable Hemostats market dynamics, the global Disposable Hemostats market is analyzed across major regions of the world. Custom study by specific region or country can be provided, usually customer prefer below

  • North America: United States of America (USA), Canada and Mexico.
    • South and Central America: Argentina, Chile, Colombia and Brazil.
    • Middle East and Africa: Kingdom of Saudi Arabia, United Arab Emirates, Turkey, Israel, Egypt and South Africa.
    • Europe: United Kingdom, France, Italy, Germany, Spain, NORDIC countries, BALTIC countries, Russia, Austria and rest of Europe.
    • Asia: India, China, Japan, South Korea, Taiwan, Southeast Asia (Singapore, Thailand, Malaysia, Indonesia, Philippines and Vietnam, etc.) and rest
    • Oceania: Australia and New Zealand

Basic segmentation details
Types of Deep Disposable Hemostats: Disposable straight hemostat, Disposable curved hemostat, other.

Main Applications/End Users of Disposable Hemostat: Hospital, Clinic, Family, Other

Geographical analysis: North America, USA, Canada, Mexico, Europe, Germany, France, UK, Italy, Russia, Nordics, Benelux, Rest of Europe, Asia, China, Japan, South Korea, South Asia – East, India, Rest of Asia, South America, Brazil, Argentina, Rest of South America, Middle East and Africa, Turkey, Israel, Saudi Arabia, United Arab Emirates and Rest of Middle East and Africa and rest of the world

For an in-depth analysis of the Disposable Hemostats market size, a competitive analysis is provided, which includes Revenue (M USD) by Players (2022-2028) and Market Share (%) by Players (2022 -2028) supplemented by the concentration rate.

Full Purchase of 2022 Disposable Hemostat Report at Revised Suggested Price @ https://www.maccuracyreports.com/checkout/459498

Actual figures and in-depth analysis of the Disposable Hemostats market size estimate and trends available in the full version of the report.

Thank you for reading this article, you can also shop by section or opt for a regional report limiting the scope to North America, ANZ, Europe or MENA countries, Eastern Europe. is or the European Union.




read more
Medical products

Essentials of Preparing for Medical Product Inspection

DAVID L. CHESNEY is the Managing Director of DL Chesney Consulting, LLC, providing GMP and GCP compliance consulting and training services to clients worldwide. Previously, he served for more than twenty years as Vice President, Strategic Compliance Services for PAREXEL Consulting. Prior to joining PAREXEL Consulting, he worked for twenty-three years with the FDA as an investigator, supervising investigator, director of investigations, and ultimately district manager in San Francisco, managing all FDA operations in California. North, Nevada and Hawaii. Chesney holds a master’s degree in jurisprudence, focusing on pharmaceutical and medical device law, from Seton Hall University School of Law, a bachelor’s degree in biology from California State University, Northridge, as well as three years of graduate studies in biology at CSU Northridge and CSU San Diego. Chesney is a member of the Parenteral Drug Association, where he serves on the faculty of the PDA Training and Research Institute. He is a guest lecturer for the Maine Regulatory and Ethics Training Center, University of Maine School of Law, and is also active with the Food and Drug Law Institute and RAPS.

read more
Medical products

Pediatric Pulse Oximeter Market Statistical Forecast, Trade Analysis 2022 – Devon Medical Products, Carewell, Acare, Heal Force, Bistos, Medplant, IN4 Technology, Armstrong Medical, Advanced Instrumentations, Holtex, Medical Econet, Tenko Medical Systems, Solaris Medical Technology, Sunset Healthcare Solutions – Indian Defense News

The Pediatric Pulse Oximeters The report is an in-depth examination of the overall global Pediatric Pulse Oximeters consumption structure, development trends, sales techniques, and major nations sales. The research covers well-known vendors in the global Pediatric Pulse Oximeter industry along with market segmentation, competition, and macroeconomic climate. A comprehensive analysis of Pediatric Pulse Oximeters takes into account a number of aspects, including a country’s population and business cycles, as well as market-specific microeconomic consequences. The global market study also includes a specific section on the competition landscape to help you better understand the Pediatric Pulse Oximeter industry. This information can help stakeholders make informed decisions before investing.

Key Players in Pediatric Pulse Oximeters including:

Devon Medical Products, Carewell, Acare, Heal Force, Bistos, Medplant, IN4 Technology, Armstrong Medical, Advanced Instruments, Holtex, Medical Econet, Tenko Medical Systems, Solaris Medical Technology, Sunset Healthcare Solutions

Sample Free Report + All Related Charts & Graphs @ https://www.maccuracyreports.com/report-sample/400582

The report is categorized into several sections which consider competitive environment, latest market events, technological developments, countries and regional details related to Pediatric Pulse Oximeters. The section that details the pandemic impact, recovery strategies and post-pandemic market performance of each player is also included in the report. Major opportunities that may support Pediatric Pulse Oximeters are identified in the report. The report focuses specifically on near-term opportunities and strategies to realize one’s full potential. Crucial uncertainties for market players to understand are included in the Pediatric Pulse Oximeters report.

Due to these issues, the pediatric pulse oximeter industry has been hampered. Due to the small number of significant companies in the industry, the field of pediatric pulse oximeters is heavily targeted. Customers would benefit from this research as they would be informed about the current scenario of pediatric pulse oximeters. The latest innovations, product news, product variants, and in-depth updates from industry specialists who have effectively exploited the position of pediatric pulse oximeters are all included in this research study. Many companies would benefit from a research study of Pediatric Pulse Oximeters to identify and expand their global demand. Micro and macro trends, significant developments, and their usage and penetration among a wide variety of end users are also included in the Pediatric Pulse Oximeters segment.

Market analysis done with statistical tools also helps to analyze many aspects including demand, supply, storage costs, maintenance, profit, sales and production details of the market. In addition, the global Pediatric Pulse Oximeter research report provides details about Pediatric Pulse Oximeter share, import volume, export volume, and company gross margin.

Pediatric Pulse Oximeter Segmentation by Type:

Wrap sensors, clip sensors.

Pediatric Pulse Oximeter Segmentation by Application:

Hospitals, EHPAD, Clinics, Others

The Pediatric Pulse Oximeters report answers a few key questions:

  • What is the expected growth of global pediatric pulse oximeters after the discovery of a vaccine or treatment for covid-19?
    • What new business practices can be implemented post-pandemic to remain competitive, agile, customer-centric, and collaborative in the world of pediatric pulse oximeters?
    • Which specific sectors are expected to drive the growth of the Global Pediatric Pulse Oximeters Market?
    • What are the key government policies and interventions implemented by the world’s leading pediatric pulse oximeter countries to drive the adoption or growth of pediatric pulse oximeters.
    • How have the market players or leading global pediatric pulse oximeter companies dealt with the challenges faced during the pandemic?
    • What growth opportunities do global pediatric pulse oximeters offer?

Access full report description, table of contents, table of figure, chart, etc. @ https://www.maccuracyreports.com/reportdetails/reportview/400582

Report Highlights:

  • The report provides pediatric pulse oximeter industry demand trends in the first and second quarters of 2021.
    • Individual circumstances of pediatric pulse oximeter segments are discussed in the report.
    • The report contains forward-looking information about risks and uncertainties.
    • The report studies the consumer driven sectors of Pediatric Pulse Oximeters.
    • Business scenarios for products and services in particular segments are detailed in the report along with regulations, taxes and tariffs.
    • Trends which are impacting Pediatric Pulse Oximeters in recent years are discussed in the report.
    • The report studies the potential impact of the Covid-19 pandemic on the Pediatric Pulse Oximeters sector economy and the performance of market players in the same context.

Contents:

1 Scope of the report
1.1 Market Overview
1.2 Research objectives
1.3 Years considered
1.4 Market research methodology
1.5 Economic indicators
1.6 Currency considered
2 Executive summary
3 Global Pediatric Pulse Oximeters by Players
4 Pediatric Pulse Oximeters by Regions
4.1 Pediatric Pulse Oximeter Size by Regions
4.2 Americas Pulse Oximeter Size Growth
4.3 APAC Pediatric Pulse Oximeter Size Growth
4.4 Europe Pediatric Pulse Oximeter Size Growth
4.5 Middle East & Africa Pediatric Pulse Oximeter Size Growth
5 Americas
6 APACs
7Europe
8 Middle East and Africa
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market trends
10 Global Pediatric Pulse Oximeter Predictions
Analysis of the 11 key players
12 Research findings and conclusion

Please click here today to purchase the full report @ https://www.maccuracyreports.com/checkout/400582

MR Accuracy Reports is the world’s largest publisher and has published over 2 million reports worldwide. Fortune 500 companies work with us. Also help small players to know the market and focus on advice.




read more
Medical products

Personal Mobility Devices Market Size, Scope and Forecast

New Jersey, United States – The personal mobility device market The research report examines the market in detail over the predicted period. The research is divided into sections, each of which includes analysis of market trends and changes. Drivers, limitations, opportunities, and barriers, as well as the impact of numerous aspects on the industry, are all variables of market dynamics.

The report provides participants with essential information as well as specific recommendations for gaining a competitive advantage in the global business world. It studies how different players compete in the global market and shows how they compete differently. The market size for the Personal Mobility Devices market is calculated using a projected period included in the research study. Current market status and trends, along with business growth drivers, industry share, sales volume, interesting BI dashboards, and market forces are all explored.

Get Sample Full PDF Copy of Report: (Including Full TOC, List of Tables & Figures, Chart) @ https://www.verifiedmarketresearch.com/download-sample/?rid=37564

Key Players Mentioned in the Personal Mobility Devices Market Research Report:

NOVA Medical Products, Performance Health, Drive DeVilbiss Healthcare, Medline Industries Invacare Corporation, Carex Health Brands Kaye Products Rollz International, GF HEALTH PRODUCTS and Briggs Healthcare

Our analysts have performed a qualitative and quantitative analysis of the microeconomic and macroeconomic components of the Personal Mobility Devices market. This study will also help to understand changes in Personal Mobility Devices market industrial supply chain, manufacturing processes and costs, sales scenarios and market dynamics.

This analysis highlights significant mergers and acquisitions, business expansion, differences in goods or services, market structure, competitive conditions in the Personal Mobility Devices market and market size by participant.

Personal Mobility Devices Market Segmentation:

Personal Mobility Devices Market, By Product

• Wheel chairs
• Scooters
• Walking aids

Inquire for a discount on this Premium Report @ https://www.verifiedmarketresearch.com/ask-for-discount/?rid=37564

Scope of the Personal Mobility Devices Market Report

ATTRIBUTES DETAILS
ESTIMATED YEAR 2022
YEAR OF REFERENCE 2021
FORECAST YEAR 2029
HISTORICAL YEAR 2020
UNITY Value (million USD/billion)
SECTORS COVERED Types, applications, end users, and more.
REPORT COVER Revenue Forecast, Business Ranking, Competitive Landscape, Growth Factors and Trends
BY REGION North America, Europe, Asia-Pacific, Latin America, Middle East and Africa
CUSTOMIZATION SCOPE Free report customization (equivalent to up to 4 analyst business days) with purchase. Added or changed country, region and segment scope.

Answers to key questions in the report:

1. Who are the top five players in the personal mobility device market?

2. How will the personal mobility device market evolve in the next five years?

3. Which products and applications will capture the lion’s share of the personal mobility device market?

4. What are the drivers and restraints of the Personal Mobility Devices Market?

5. Which regional market will show the strongest growth?

6. What will be the CAGR and size of the Personal Mobility Devices market throughout the forecast period?

For more information or query or customization before buying, visit @ https://www.verifiedmarketresearch.com/product/personal-mobility-devices-market/

Visualize the Personal Mobility Devices Market Using Verified Market Intelligence:-

Verified Market Intelligence is our BI platform for market narrative storytelling. VMI offers in-depth forecast trends and accurate insights on over 20,000 emerging and niche markets, helping you make critical revenue-impacting decisions for a bright future.

VMI provides a global overview and competitive landscape with respect to region, country and segment, as well as key players in your market. Present your market report and findings with an integrated presentation feature that saves you over 70% of your time and resources for presentations to investors, sales and marketing, R&D and development of products. VMI enables data delivery in Excel and interactive PDF formats with over 15+ key market indicators for your market.

Visualize the Personal Mobility Devices Market using [email protected] https://www.verifiedmarketresearch.com/vmintelligence/

About Us: Verified Market Research®

Verified Market Research® is a leading global research and advisory firm that for over 10 years has provided advanced analytical research solutions, personalized advice and in-depth data analysis to individuals and businesses seeking accurate research, reliable and up to date. data and technical advice. We provide insight into strategic and growth analytics, the data needed to achieve business goals, and help make critical revenue decisions.

Our research studies help our clients make superior data-driven decisions, understand market forecasts, capitalize on future opportunities, and maximize efficiency by working as a partner to deliver accurate and valuable insights. The industries we cover span a wide spectrum, including technology, chemicals, manufacturing, energy, food and beverage, automotive, robotics, packaging, construction, mining and the gas. Etc.

At Verified Market Research, we help in understanding holistic market indicator factors and most current and future market trends. Our analysts, with their deep expertise in data collection and governance, use industry techniques to gather and review data at all stages. They are trained to combine modern data collection techniques, superior research methodology, subject matter expertise and years of collective experience to produce informative and accurate research.

Having served over 5000 clients, we have provided reliable market research services to over 100 Global Fortune 500 companies such as Amazon, Dell, IBM, Shell, Exxon Mobil, General Electric, Siemens, Microsoft, Sony and Hitachi. We have co-consulted with some of the world’s leading consulting firms such as McKinsey & Company, Boston Consulting Group, Bain and Company for custom research and consulting projects for companies around the world.

Contact us:

Mr. Edwyne Fernandes

Verified Market Research®

USA: +1 (650)-781-4080
UK: +44 (753)-715-0008
APAC: +61 (488)-85-9400
US toll free: +1 (800)-782-1768

E-mail: [email protected]

Website:- https://www.verifiedmarketresearch.com/

read more
Medical products

Tongue Depressor Consumption Market Size and Forecast to 2028 | Puritan Medical Products, Agaplastic, DTR Medical, Fazzini, FL Medical

The Global”Tongue Depressor Consumer Market » The report provides an in-depth analysis of emerging trends, market drivers, development opportunities and market restraints that may impact the market dynamics of the industry. Each market sector is examined in-depth in Market Research Intellect, including products, applications, and competitive analysis.

The report was created using three different recognition systems. The first step requires conducting in-depth primary and secondary research on a wide range of topics. Approvals, ratings and findings based on accurate data obtained by industry specialists are the next steps. The research derives an overall estimate of the market size using top-down methodologies. Finally, the research assesses the market for a number of sections and subsections using information triangulation and market separation techniques.

The main purpose of the report is to educate business owners and help them make a wise investment in the market. The study highlights regional and sub-regional perspectives with corresponding factual and statistical analysis. The report includes the latest first-hand data, obtained from the company’s website, annual reports, industry-recommended journals, and paid resources. The Tongue Depressor consumption report will help business owners to understand the current market trend and make profitable decisions.

Profiled Market Leaders:

  • Puritan Medical Products
  • Agaplastic
  • DTR Medical
  • Fazzini
  • FL Medical
  • FASA GROUP
  • Francois Mensch
  • Parburch Medical Developments
  • PLASTI LABORATORY
  • Dental Shufa
  • timesco
  • American Ophthalmic
  • A. Algeo
  • DENTAL SAA

Report Analysis and Segments:

Tongue Depressor consumption is segmented by product type, application, and geography. All segments of the Tongue Depressor consumption are carefully analyzed with respect to market share, CAGR, growth in value and volume, and other significant factors. We have also provided Porter’s Five Forces and PESTLE analysis for further study of tongue depressor consumption. The report also outlines recent developments undertaken by key market players, including new product launches, partnerships, mergers, acquisitions, and other latest developments.

Based on Tongue Depressor Product Type Consumption is segmented into –

  • wooden tongue depressor
  • Metal tongue depressor
  • plastic tongue depressor
  • Other

On the basis of Tongue Depressor application, consumption is segmented into –

  • Hospitals
  • Clinics
  • Academic and research institutes
  • Others

The report provides information about the following pointers:

1️⃣ Market Penetration: Comprehensive information on the product portfolios of major tongue depressor consumption players.

2️⃣ Product Development/Innovation: detailed information on upcoming technologies, R&D activities and product launches in the market.

3️⃣ Competitive Assessment: In-depth assessment of market strategies and geographic and business segments of major market players.

4️⃣ Market development: comprehensive information on emerging markets. This report analyzes the market for various segments across geographies.

5️⃣ Market Diversification: Comprehensive information on new products, untapped geographies, recent developments, and investments in Tongue Depressor consumption.

Schedule a consultation call with our industry analysts/experts to find a solution for your business @ https://www.marketresearchintellect.com/ask-for-discount/?rid=414745

Various analyzes covered:

The regional assessment of Tongue Depressor consumption was conducted in six key regions, namely North America, Asia-Pacific, Europe, Latin America, Middle East and South America. Africa. Moreover, the report also provides in-depth information about ongoing research and development activities, revenue, innovative services, real demand and supply status, and pricing strategy. In addition to that, this report also provides details of consumption figures, export/import supply and gross margin by region. In short, this report provides a valuable source of advice and clear direction for the trader and the party interested in the market.

North America (US, Canada)
Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
Latin America (Brazil, Mexico, Others)
The Middle East and Africa

Frequently Asked Questions:

  • What are the key drivers of global tongue depressor consumption?
  • What are the main challenges for the global consumption of tongue depressors?
  • Who are the key market players?
  • What has been the effect of the COVID-19 pandemic on global tongue depressor consumption?
  • What are the latest market trends?
  • What is the compound annual growth rate of global tongue depressor consumption?

About Us: Market Research Intellect

Market Research Intellect provides syndicated and customized research reports to clients across various industries and organizations with the aim of providing functional expertise. We provide reports for all industries including Energy, Technology, Manufacturing & Construction, Chemicals & Materials, Food & Beverage, and more. These reports provide an in-depth study of the market with industry analysis, market value of regions and countries, and industry-relevant trends.

Contact us:
Mr. Steven Fernandes
Market research intelligence
New Jersey (USA)
Tel: +1-650-781-4080

Email: [email protected]

Website: –https://www.marketresearchintellect.com/

read more
Medical products

Women’s Health Rehabilitation Products Market Size, Scope and Forecast

New Jersey, United States – The Women’s Health Rehabilitation Products Market The research report examines the market in detail over the predicted period. The research is divided into sections, each of which includes analysis of market trends and changes. Drivers, limitations, opportunities, and barriers, as well as the impact of numerous aspects on the industry, are all variables of market dynamics.

The report provides participants with essential information as well as specific recommendations for gaining a competitive advantage in the global business world. It studies how different players compete in the global market and shows how they compete differently. The market size for the Women’s Health Rehabilitation Products Market is calculated using a projected period included in the research study. Current market status and trends, along with business growth drivers, industry share, sales volume, interesting BI dashboards, and market forces are all explored.

Get Sample Full PDF Copy of Report: (Including Full TOC, List of Tables & Figures, Chart) @ https://www.verifiedmarketresearch.com/download-sample/?rid=22158

Key Players Mentioned in the Women’s Health Rehabilitation Products Market Research Report:

Accord Medical Products, BSN medical, Carib Rehab, Cornerstone Chiropractic, DeRoyal, EMS Physio, GE Healthcare, GPC Medical, Meyer Physical Therapy, Midtown Chiropractic, PROSPINE Health and Injury Center, Pelvic Health and Rehabilitation, Pure Health Chiropractic, Sportstek, Win Health Medical, Zynex

Our analysts have performed a qualitative and quantitative analysis of the microeconomic and macroeconomic components of the Women’s Health Rehabilitation Products market. This study will also help to understand changes in Women’s Health Rehabilitation Products market industry supply chain, manufacturing processes and costs, sales scenarios and market dynamics.

This analysis highlights significant mergers and acquisitions, business expansion, differences in goods or services, market structure, competitive conditions in the Women’s Health Rehabilitation Products market, and size of the market by the participant.

Women’s Health Rehabilitation Products Market Segmentation:

Women’s Health Rehabilitation Products Market by Product

• Orthopedic care
• Urinary incontinence
• Breast cancer care
• Pregnancy and postpartum care

Women’s Health Rehabilitation Products Market By Application

• Hospitals
• Clinics

Inquire for a discount on this Premium Report @ https://www.verifiedmarketresearch.com/ask-for-discount/?rid=22158

Scope of the Women’s Health Rehabilitation Products Market Report

ATTRIBUTES DETAILS
ESTIMATED YEAR 2022
YEAR OF REFERENCE 2021
FORECAST YEAR 2029
HISTORICAL YEAR 2020
UNITY Value (million USD/billion)
SECTORS COVERED Types, applications, end users, and more.
REPORT COVER Revenue Forecast, Business Ranking, Competitive Landscape, Growth Factors and Trends
BY REGION North America, Europe, Asia-Pacific, Latin America, Middle East and Africa
CUSTOMIZATION SCOPE Free report customization (equivalent to up to 4 analyst business days) with purchase. Added or changed country, region and segment scope.

Answers to key questions in the report:

1. Who are the top five players in the Women’s Health Rehabilitation Products Market?

2. How will the women’s health rehabilitation products market develop in the next five years?

3. Which product and application will occupy the lion’s share of the women’s health rehabilitation products market?

4. What are the drivers and restraints of the Women’s Health Rehabilitation Products Market?

5. Which regional market will show the strongest growth?

6. What will be the CAGR and size of the Women’s Health Rehabilitation Products market throughout the forecast period?

For more information or query or customization before buying, visit @ https://www.verifiedmarketresearch.com/product/women-health-rehabilitation-products-market/

Visualize Women’s Health Rehabilitation Products Market Using Verified Market Intelligence:-

Verified Market Intelligence is our BI platform for market narrative storytelling. VMI offers in-depth forecast trends and accurate insights on over 20,000 emerging and niche markets, helping you make critical revenue-impacting decisions for a bright future.

VMI provides a global overview and competitive landscape with respect to region, country and segment, as well as key players in your market. Present your market report and results with an integrated presentation function that saves you more than 70% of your time and resources for presentations to investors, sales and marketing, R&D and product development. products. VMI enables data delivery in Excel and interactive PDF formats with over 15+ key market indicators for your market.

Visualize the Women’s Health Rehabilitation Products Market using [email protected] https://www.verifiedmarketresearch.com/vmintelligence/

About Us: Verified Market Research®

Verified Market Research® is a leading global research and advisory firm that for over 10 years has provided advanced analytical research solutions, personalized advice and in-depth data analysis to individuals and businesses seeking accurate research, reliable and up to date. data and technical advice. We provide insight into strategic and growth analytics, the data needed to achieve business goals, and help make critical revenue decisions.

Our research studies help our clients make superior data-driven decisions, understand market forecasts, capitalize on future opportunities, and maximize efficiency by working as a partner to deliver accurate and valuable insights. The industries we cover span a wide spectrum, including technology, chemicals, manufacturing, energy, food and beverage, automotive, robotics, packaging, construction, mining and the gas. Etc.

At Verified Market Research, we help in understanding holistic market indicator factors and most current and future market trends. Our analysts, with their deep expertise in data collection and governance, use industry techniques to gather and review data at all stages. They are trained to combine modern data collection techniques, superior research methodology, subject matter expertise and years of collective experience to produce informative and accurate research.

Having served over 5000 clients, we have provided reliable market research services to over 100 Global Fortune 500 companies such as Amazon, Dell, IBM, Shell, Exxon Mobil, General Electric, Siemens, Microsoft, Sony and Hitachi. We have co-consulted with some of the world’s leading consulting firms such as McKinsey & Company, Boston Consulting Group, Bain and Company for custom research and consulting projects for companies around the world.

Contact us:

Mr. Edwyne Fernandes

Verified Market Research®

USA: +1 (650)-781-4080
UK: +44 (753)-715-0008
APAC: +61 (488)-85-9400
US toll free: +1 (800)-782-1768

E-mail: [email protected]

Website:- https://www.verifiedmarketresearch.com/

read more
Medical products

Utah Medical Products (NASDAQ:UTMD) Stock Price Breaks Below 200-Day Moving Average of $90.62


Utah Medical Products, Inc. (NASDAQ:UTMDGet a rating) the stock price fell below its 200-day moving average during Monday’s trading. The stock has a 200-day moving average of $90.62 and is trading as low as $83.65. Shares of Utah Medical Products last traded at $83.65, with a volume of 255 shares traded in hands.

Separately, StockNews.com began covering Utah Medical Products in a report on Thursday, March 31. They issued a “Strong Buy” rating for the company.

The stock has a market capitalization of $304.90 million, a P/E ratio of 20.01 and a beta of 0.24. The stock has a 50-day moving average price of $84.88 and a 200-day moving average price of $90.62.

Utah Medical Products (NASDAQ:UTMDGet a rating) last reported results on Tuesday, April 26. The medical device supplier reported earnings per share of $0.96 for the quarter. The company had revenue of $12.32 million in the quarter. Utah Medical Products had a return on equity of 14.14% and a net margin of 30.34%.

The company also recently announced a quarterly dividend, which will be paid on Wednesday, July 6. Shareholders of record on Friday, June 17 will receive a dividend of $0.29 per share. The ex-dividend date is Thursday, June 16. This represents an annualized dividend of $1.16 and a dividend yield of 1.39%. Utah Medical Products’ dividend payout ratio (DPR) is currently 27.75%.

In other Utah Medical Products news, Director Barbara A. Payne sold 2,000 shares of the company in a trade on Wednesday, May 11. The stock was sold at an average price of $85.20, for a total value of $170,400.00. Following the sale, the director now directly owns 5,338 shares of the company, valued at $454,797.60. The transaction was disclosed in a filing with the Securities & Exchange Commission, available at this hyperlink. Insiders hold 6.60% of the shares of the company.

A number of institutional investors have recently bought and sold shares of UTMD. HealthInvest Partners AB increased its position in Utah Medical Products by 40.0% during the first quarter. HealthInvest Partners AB now owns 56,000 shares of the medical device supplier valued at $5,032,000 after acquiring an additional 16,000 shares in the last quarter. JPMorgan Chase & Co. increased its position in Utah Medical Products shares by 16.9% in the first quarter. JPMorgan Chase & Co. now owns 101,769 shares of the medical device supplier worth $9,145,000 after buying an additional 14,693 shares last quarter. Ancora Advisors LLC increased its position in Utah Medical Products shares by 51.1% during the first quarter. Ancora Advisors LLC now owns 40,338 shares of the medical device supplier worth $3,494,000 after buying an additional 13,649 shares last quarter. LSV Asset Management purchased a new stake in shares of Utah Medical Products during the first quarter for a value of approximately $1,177,000. Finally, FMR LLC increased its position in Utah Medical Products shares by 2.4% during the first quarter. FMR LLC now owns 488,255 shares of the medical device supplier worth $43,089,000 after purchasing an additional 11,248 shares last quarter. Institutional investors hold 71.44% of the company’s shares.

About Utah Medical Products (NASDAQ:UTMD)

Utah Medical Products, Inc. develops, manufactures and distributes medical devices for the healthcare industry. The Company offers fetal monitoring accessories, vacuum assisted delivery systems and other labor and delivery tools; Respiratory hoods for newborns DISPOSA-HOOD; and DELTRAN PLUS blood pressure monitoring systems.

Read more



Receive daily news and reviews for Utah medical products – Enter your email address below to receive a concise daily summary of breaking news and analyst ratings for Utah Medical Products and related companies with MarketBeat.com’s free daily email newsletter.

read more
Medical products

bttn medical products market raises $20 million

Bttn was launched in March 2021 to help meet demand from healthcare professionals and healthcare facilities for pandemic-related personal protective equipment, or PPE. The company says it now has more than 7,000 customers and offers more than 2.5 million products from branded manufacturers such as 3M, Abbott, Cardinal Health and Medtronic.

Now bttn, who is on the web at bttnusa.com, is poised for continued growth after receiving $20 million in funding last week. That brings his valuation to $110 million, according to the company.

“Bttn was founded with a mission to provide a modern digital approach to purchasing medical supplies, ultimately addressing a much sought after need in this very outdated market,” says JT Garwood, CEO. He co-founded bttn with Jack Miller, the product manager. “The Series A investment will help us scale and accelerate growth.”

The funding was led by world tigerwith the participation of the previous investor Fuse.

In April, bttn added eight distribution and fulfillment centers to its supply chain. This helped reduce its average order delivery time to less than three days, according to the company.

Bttn says it specializes in serving “other site” health care providers who operate outside of hospitals. This includes dermatologists, dentists, physicians, and professionals in long-term care facilities.

Register

Sign up for a free subscription to Digital Commerce 360 ​​B2B News, published 4x/week. It covers technology and business trends in the growing B2B e-commerce industry. Contact the publisher Paul Demery at [email protected] and follow him on Twitter @pdemery.

follow us on LinkedIn and be the first to know when new Digital Commerce 360 ​​B2B News content is released.

Favorite

read more
Medical products

Veress Needle Market Size, Scope and Forecast

New Jersey, United States – The Veress needle market The research report examines the market in detail over the predicted period. The research is divided into sections, each of which includes analysis of market trends and changes. Drivers, limitations, opportunities, and barriers, as well as the impact of numerous aspects on the industry, are all variables of market dynamics.

The report provides participants with essential information as well as specific recommendations for gaining a competitive advantage in the global business world. It studies how different players compete in the global market and shows how they compete differently. The market size for the Veress Needle Market is calculated using a projected period included in the research study. Current market status and trends, along with business growth drivers, industry share, sales volume, interesting BI dashboards, and market forces are all explored.

Get Sample Full PDF Copy of Report: (Including Full TOC, List of Tables & Figures, Chart) @ https://www.verifiedmarketresearch.com/download-sample/?rid=212073

Key Players Mentioned in the Veress Needle Market Research Report:

CONMED, Fairmont Medical Products Pty Ltd, GRI-Alleset, Grena Ltd., 3-Dmed, Advin Health Care, Changzhou Ankang Medical Instruments Co., Ltd., Duomed Group, Endomed Systems GmbH, Zhejiang Geyi Medical Instrument Co., Ltd. , LOCAMED LIMITED.

Our analysts have performed a qualitative and quantitative analysis of the microeconomic and macroeconomic components of the Veress Needle market. This study will also help to understand the changes in the Veress Needle market industrial supply chain, manufacturing processes and costs, sales scenarios and market dynamics.

This analysis highlights significant mergers and acquisitions, business expansions, differences in goods or services, market structure, competitive conditions in the Veress Needle market and market size by participant .

Segmentation of the Veress needle market:

Veress Needles Market, By Type

• 120mm
• 150mm
• Others

Veress Needles Market, By Application

• Gynecological surgery
• Urological surgery
• General surgery

Inquire for a discount on this Premium Report @ https://www.verifiedmarketresearch.com/ask-for-discount/?rid=212073

Scope of the Veress Needles Market Report

ATTRIBUTES DETAILS
ESTIMATED YEAR 2022
YEAR OF REFERENCE 2021
FORECAST YEAR 2029
HISTORICAL YEAR 2020
UNITY Value (million USD/billion)
SECTORS COVERED Types, applications, end users, and more.
REPORT COVER Revenue Forecast, Business Ranking, Competitive Landscape, Growth Factors and Trends
BY REGION North America, Europe, Asia-Pacific, Latin America, Middle East and Africa
CUSTOMIZATION SCOPE Free report customization (equivalent to up to 4 analyst business days) with purchase. Added or changed country, region and segment scope.

Answers to key questions in the report:

1. Who are the top five players in the Veress Needle market?

2. How will the Veress needle market evolve over the next five years?

3. Which product and application will occupy the lion’s share of the Veress needle market?

4. What are the drivers and restraints of the Veress Needle Market?

5. Which regional market will show the strongest growth?

6. What will be the CAGR and size of the Veress Needle market throughout the forecast period?

For more information or query or customization before buying, visit @ https://www.verifiedmarketresearch.com/product/veress-needle-market/

Visualize the Veress Needle Market Using Verified Market Intelligence:-

Verified Market Intelligence is our BI platform for market narrative storytelling. VMI offers in-depth forecast trends and accurate insights on over 20,000 emerging and niche markets, helping you make critical revenue-impacting decisions for a bright future.

VMI provides a global overview and competitive landscape with respect to region, country and segment, as well as key players in your market. Present your market report and findings with an integrated presentation feature that saves you over 70% of your time and resources for presentations to investors, sales and marketing, R&D and development of products. VMI enables data delivery in Excel and interactive PDF formats with over 15+ key market indicators for your market.

Visualize the Veress needle market using [email protected] https://www.verifiedmarketresearch.com/vmintelligence/

About Us: Verified Market Research®

Verified Market Research® is a leading global research and advisory firm that for over 10 years has provided advanced analytical research solutions, personalized advice and in-depth data analysis to individuals and businesses seeking accurate research, reliable and up to date. data and technical advice. We provide insight into strategic and growth analytics, the data needed to achieve business goals, and help make critical revenue decisions.

Our research studies help our clients make superior data-driven decisions, understand market forecasts, capitalize on future opportunities, and maximize efficiency by working as a partner to deliver accurate and valuable insights. The industries we cover span a wide spectrum, including technology, chemicals, manufacturing, energy, food and beverage, automotive, robotics, packaging, construction, mining and the gas. Etc.

At Verified Market Research, we help in understanding holistic market indicator factors and most current and future market trends. Our analysts, with their deep expertise in data collection and governance, use industry techniques to gather and review data at all stages. They are trained to combine modern data collection techniques, superior research methodology, subject matter expertise and years of collective experience to produce informative and accurate research.

Having served over 5000 clients, we have provided reliable market research services to over 100 Global Fortune 500 companies such as Amazon, Dell, IBM, Shell, Exxon Mobil, General Electric, Siemens, Microsoft, Sony and Hitachi. We have co-consulted with some of the world’s leading consulting firms such as McKinsey & Company, Boston Consulting Group, Bain and Company for custom research and consulting projects for companies around the world.

Contact us:

Mr. Edwyne Fernandes

Verified Market Research®

USA: +1 (650)-781-4080
UK: +44 (753)-715-0008
APAC: +61 (488)-85-9400
US toll free: +1 (800)-782-1768

E-mail: [email protected]

Website:- https://www.verifiedmarketresearch.com/

read more
Medical products

Proctology Chart Market Size 2022-2029

New Jersey, United States,-The Global Proctology Table Market research report provides a comprehensive outlook on industry growth, an overview of market size and value, and a survey of existing business trends. The proctology tables studies also provide insight into various market demand factors. The Proctology Table research report details numerous variables that have led to the rise of the global Proctology Table markets. The Proctology Table market analysis includes an in-depth assessment of global technological developments and trends. Proctology table industry research based on volume, performance, and valuation calculates an accurate market share. Global Emotion Detection and Recognition Market size prediction and calculation is done using bottom-up and top-down technologies.

Get | Download a sample copy with table of contents, graphics and list of [email protected] https://www.marketresearchintellect.com/download-sample/?rid=308775

The term-based Proctology Table market research provides useful insights such as the study of the effects on significant aspects, alternatives, and restraints. Graphical analysis of the Emotion Detection and Recognition demand forecasts for the predicted periods can demonstrate the financial requirements of the global Emotion Detection and Recognition industry. Likewise, the study highlights the characteristics which limit the growth in demand, adequately predict the Proctology Table market quantities and have long term effects over the predicted period.

The impact of the Corona 19 outbreak on the global Emotion Sensing and Awareness industry, growth rates, correct supply chain analysis, scale in various scenarios, and responses Corporate critiques of the outbreak are all examined in research on emotion sensing and sensitization. The research focuses on emotion detection and recognition in global markets, particularly in North America, Europe and the Asia-Pacific region, as well as South America, the Middle East and Africa. The study divides the market into four parts: manufacturer, region, type and application.

Major Players Covered in Proctology Table Markets:

  • AR-EL MEDICAL PRODUCTS
  • promotional
  • INDUSTRIAL ECHOME
  • SCHMITZ and. Sohne
  • B?Çakc?lar
  • NQR
  • Wardray premise

Proctology Table Market Split By Type:

  • Adjustable Proctology Table
  • Non-Adjustable Proctology Table

Proctology Table Market Split By Application:

  • Hospital
  • Clinical
  • Ambulatory surgery centers

The Proctology Table Market report has been segregated into distinct categories such as product type, application, end-user, and region. Each segment is valued based on CAGR, share, and growth potential. In the regional analysis, the report highlights the prospective region, which is expected to generate opportunities in the global Proctology Tables market in the coming years. This segmental analysis will surely prove to be a helpful tool for readers, stakeholders, and market players to get a comprehensive picture of the global Proctology Tables market and its growth potential in the coming years.

Get | Discount on the purchase of this report @ https://www.marketresearchintellect.com/ask-for-discount/?rid=308775

Scope of the Proctology Tables Market Report

Report attribute Details
Market size available for years 2022 – 2029
Base year considered 2022
Historical data 2019 – 2021
Forecast period 2022 – 2029
Quantitative units Revenue in USD Million and CAGR from 2023 to 2029
Segments Covered Types, applications, end users, and more.
Report cover Revenue Forecast, Business Ranking, Competitive Landscape, Growth Factors and Trends
Regional scope North America, Europe, Asia-Pacific, Latin America, Middle East and Africa
Scope of customization Free report customization (equivalent to up to 8 analyst business days) with purchase. Added or changed country, region and segment scope.
Pricing and purchase options Take advantage of personalized purchasing options to meet your exact research needs. Explore purchase options

The Regional Proctological Table Market Analysis can be represented as follows:

Each regional sector of the Proctological Table is carefully studied to understand its current and future growth scenarios. This helps players strengthen their position. Use market research to get a better perspective and understanding of the market and target audience and ensure you stay ahead of the competition.

On the basis of geography, the global Proctology Table market has been segmented as follows:

    • North America includes the United States, Canada and Mexico
    • Europe includes Germany, France, UK, Italy, Spain
    • South America includes Colombia, Argentina, Nigeria and Chile
    • Asia Pacific includes Japan, China, Korea, India, Saudi Arabia and Southeast Asia

For more information or query or customization before buying, visit @ https://www.marketresearchintellect.com/product/global-proctologic-table-market-size-and-forecast/

About Us: Market Research Intellect

Market Research Intellect provides syndicated and customized research reports to clients from various industries and organizations, in addition to the goal of providing customized and in-depth research studies. range of industries including energy, technology, manufacturing and construction, chemicals and materials, food and beverage. Etc. Our research studies help our clients to make decisions based on higher data, to admit deep forecasts, to grossly capitalize with opportunities and to optimize efficiency by activating as their belt in crime to adopt a mention precise and essential without compromise. clients, we have provided expert behavior assertion research facilities to more than 100 Global Fortune 500 companies such as Amazon, Dell, IBM, Shell, Exxon Mobil, General Electric, Siemens, Microsoft, Sony and Hitachi.

Contact us:
Mr. Edwyne Fernandes
USA: +1 (650)-781-4080
UK: +44 (753)-715-0008
APAC: +61 (488)-85-9400
US Toll Free: +1 (800)-782-1768

Website: –https://www.marketresearchintellect.com/

read more
Medical products

Pad Printing Ink for Medical Products Market Size, Share Analysis, Key Companies and Forecast to 2028

Pad Printing Ink For Medical Products Market 2022

NEW YORK, NY, USA, June 15, 2022 /EINPresswire.com/ — This report examines the Pad printing ink for the medical products market along with numerous industry aspects such as market size, market status, market trends and forecasts, the report also provides brief information about competitors and specific growth opportunities with key drivers in the market. Find comprehensive analysis of Pad Printing Inks for Medical Products market segmented by companies, region, type and applications in the report.

The report offers valuable insights into the Medical Pad Printing Ink market progress and approaches related to the Medical Pad Printing Ink market with an analysis of each region. The report goes on to talk about the dominant aspects of the market and examine each segment.

Top Key Players: Marabu GmbH & Co. KG, Coates Screen, Printcolor, Colorcon Specialty Markets, RucoINX, Inkcups, ITW, DUBUIT Inks, Proell and Tampoprint

Sample request with complete table of contents and figures and graphs: https://www.reportsandmarkets.com/sample-request/global-pad-printing-ink-for-medical-products-market-4393772?utm_source=Ein&utm_medium=47

Global Medical Pad Printing Inks market segmented by Company, Region (Country), by Type and by Application. Players, stakeholders, and other participants in the global Medical Pad Printing Ink market will be able to gain the upper hand as they use the report as a powerful resource. The industry analysis focuses on revenue and forecast by region (country), by type and by application for the period 2022-2028.

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, United Arab Emirates, Egypt, Nigeria and South Africa)

Research objectives:
To study and analyze the global Medical Pad Printing Inks market size by key regions/countries, product type and application, history data from 2013 to 2017, and forecast to 2026.
To understand the structure of Pad Printing Inks for Medical Products market by identifying its various subsegments.
Focuses on the key global Medical Pad Printing Ink players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans. development over the next few years.
To analyze the Medical Pad Printing Ink with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information on key factors influencing market growth (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the size of Medical Pad Printing Ink submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches and acquisitions in the market.
Build a strategic profile of key players and thoroughly analyze their growth strategies.
Build a strategic profile of key players and thoroughly analyze their growth strategies.

The report lists key players in the regions and their respective market shares based on global revenue. It also explains their strategic moves over the past few years, investments in product innovation and leadership changes to stay ahead of the competition. This will give the reader an edge over others as an informed decision can be made by looking at the holistic picture of the market.

Key questions answered by this report
What will be the market size in 2027 and what will be the growth rate?
What are the main market trends?
What drives this market?
What are the challenges to market growth?
Who are the main suppliers in this market space?
What are the market opportunities and threats facing the major vendors?
What are the strengths and weaknesses of the main suppliers?

Table of Contents: Pad Printing Ink for the Medical Products Market
• Part 1: Market overview of pad printing inks for medical products
• Part 2: Pad Printing Ink for Medical Carts: Global Market Status and Forecast by Region
• Part 3: Global Market Status and Forecast by Types
• Part 4: Global Market Status and Forecast by Downstream Sector
• Part 5: Analysis of market drivers
• Part 6: State of Market Competition by Major Manufacturers
• Part 7: Major Manufacturers Overview and Market Data
• Part 8: Upstream and downstream market analysis
• Part 9: Cost and Gross Margin Analysis
• Part 10: Analysis of the state of marketing
• Part 11: Conclusion of the market report
• Part 12: Pad printing ink for medical products: research methodology and reference

Get a full report: https://www.reportsandmarkets.com/sample-request/global-pad-printing-ink-for-medical-products-market-4393772?utm_source=Ein&utm_medium=47

REPORT THAT YOU MIGHT BE INTERESTED

Global Screen protector for the electronics market Growth 2022-2028

Global Vaporized hydrogen peroxide disinfection equipment for medical devices (VHP Disinfection Equipment for Medical Devices) Market Growth 2022-2028

About Us:

Reports and Markets is not just another company in this field, but part of a group of veterans called Algoro Research Consultants Pvt. ltd. It offers top quality progressive statistical surveys, market research reports, analysis and forecast data for a wide range of industries for both government and private agencies around the world. The company database is updated daily. Our database contains a variety of industry verticals including: Food, Beverage, Automotive, Chemicals & Energy, IT & Telecom, Consumer, Healthcare & More. others. Each report goes through the proper research methodology, Verified by professionals and analysts.

Contact us:

Sanjay Jain
Reports and Markets
+1 3523530818
write to us here

read more
Medical products

Catheter Bands Market Worth $7.3 Billion by 2027 -Dale Medical Products, HTS MED?KAL TIBB? MALZE, Shenzheng Ruide Medical Technology, Nippon Tokushukan MFG, Sungwon Medical, Well Lead Medical – Indian Defense News

The Catheter bands The report is an in-depth examination of the overall global Catheter Tapes consumption structure, development trends, sales techniques, and major nations sales. The research covers well-known vendors in the global Catheter Bands industry along with market segmentation, competition, and macroeconomic climate. A comprehensive analysis of catheter strips takes into account a number of aspects, including a country’s population and economic cycles, as well as market-specific microeconomic consequences. The global market study also includes a specific section on the competition landscape to help you better understand the Catheter Tapes industry. This information can help stakeholders make informed decisions before investing.

Key players in Catheter Bands including:

Dale Medical Products, HTS MED?KAL TIBB? MALZE, Shenzheng Ruide Medical Technology, Nippon Tokushukan MFG, Sungwon Medical, Well Lead Medical

Sample Free Report + All Related Charts & Graphs @ https://www.accuracyreports.com/report-sample/15560

The report is categorized into several sections which consider competitive environment, latest market events, technological developments, countries and regional details related to Catheter Tapes. The section that details the pandemic impact, recovery strategies and post-pandemic market performance of each player is also included in the report. Major opportunities that may support Catheter Bands are identified in the report. The report focuses specifically on near-term opportunities and strategies to realize one’s full potential. Crucial uncertainties for market players to understand are included in the Catheter Tapes report.

Due to these issues, the catheter tape industry has been hampered. Due to the small number of significant companies in the industry, the catheter band area is heavily targeted. Customers would benefit from this research as they would be made aware of the current scenario of catheter bands. The latest innovations, product news, product variations, and in-depth updates from industry specialists who have effectively exploited the position of catheter bands are all included in this research study. Many companies would benefit from a research study of Catheter Bands to identify and expand their worldwide demand. Micro and macro trends, significant developments, and their usage and penetration among a wide variety of end users are also included in the Catheter Tapes segment.

Market analysis done with statistical tools also helps to analyze many aspects including demand, supply, storage costs, maintenance, profit, sales and production details of the market. In addition, the global Catheter Bands research report provides details about Catheter Bands share, import volume, export volume and gross margin of companies.

Catheter Tape Segmentation by Type:

Venous catheter strip, endotracheal intubation strip, catheter strip, wound drainage catheter strip, other.

Catheter Tape Segmentation by Application:

Hospital, Clinic, Other

The Catheter Bands report answers a few key questions:

  • What is the expected growth of catheter bands worldwide after the discovery of a vaccine or treatment for covid-19?
    • What are the new business practices that can be implemented post-pandemic to remain competitive, agile, customer-centric, and collaborative in global catheter bands?
    • Which specific sectors are expected to drive growth in global catheter tapes?
    • What are the major government policies and interventions implemented by major countries around the world regarding catheter rings to drive the adoption or growth of catheter rings.
    • How have market players or leading global Catheter Bands companies coped with the challenges faced during the pandemic?
    • What growth opportunities do global catheters offer?

Access full report description, table of contents, table of figure, chart, etc. @ https://www.accuracyreports.com/reportdetails/reportview/15560

Report Highlights:

  • The report provides catheter band industry demand trends in the first and second quarters of 2021.
    • The individual circumstances of Catheter Bands segments are discussed in the report.
    • The report contains forward-looking information about risks and uncertainties.
    • The report studies the consumer driven sectors of catheter strips.
    • Business scenarios of products and services in particular segments are detailed in the report along with regulation, taxes and tariffs.
    • Trends that impact catheter strips in recent years are discussed in the report.
    • The report studies the potential impact of Covid-19 pandemic on the Catheter Tapes industry economy and the performance of market players in the same context.

Contents:

1 Scope of the report
1.1 Market Overview
1.2 Research objectives
1.3 Years considered
1.4 Market research methodology
1.5 Economic indicators
1.6 Currency considered
2 Executive Summary
3 global catheter bands per players
4 catheter strips per region
4.1 Catheter Tape Size by Regions
4.2 Americas Catheter Tape Size Growth
4.3 APAC catheter band size growth
4.4 Europe Catheter Belts Size Growth
4.5 Middle East & Africa Catheter Tape Size Growth
5 Americas
6 APACs
7Europe
8 Middle East and Africa
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market trends
10 Global Catheter Band Predictions
Analysis of the 11 key players
12 Research findings and conclusion

Please click here today to purchase the full report @ https://www.accuracyreports.com/checkout/15560

Accuracy Reports is the world’s largest publisher and has published over 2 million reports worldwide. Fortune 500 companies work with us. Also help small players to know the market and focus on advice.




read more
Medical products

Zavation Medical Products, LLC, receives 510K clearance from the FDA for the eZspand™ Lateral Cage to complement its eZspand™ Interbody System.

The Lateral eZspand™, part of the Zavation eZspand™ interbody system, offers unparalleled stretch precision combined with continuous expansion to provide an optimized fit for each patient. This optimized fit allows for improved structural stability and better sagittal balance. eZspand™ Lateral does not require secondary locking, minimizing procedural steps. The cage has a lordosis of up to 15° and the ability to backfill with bone grafting. Each implant extends up to 6mm from insertion height to create a large graft window that facilitates fusion. The benefits of continuous height adjustment, up to 6mm of expansion combined with the absence of a secondary locking step, separates eZspand™ Lateral from its competitors.

Zavation’s market share and active surgeon base continues to grow rapidly given the company’s ability to adapt to surgeon/patient needs, constantly upgrade its instruments and design devices with simplicity. and unparalleled precision. Zavation’s continued investment in research and development will further enhance its expandable technologies and accelerate market share and base earnings of active surgeons.

“Our product development team’s dedication to creatively combining simplicity and precision in a robust product design has produced a scalable product that we believe is the new benchmark in facilitating patient fusion in the setting.” transparent and streamlined process,” said Jeffrey Johnson, CEO. “As alignment restoration is of critical importance, the eZspand™ Lateral was developed to help surgeons manage stability and sagittal alignment, while maximizing lordotic correction. This product is an example of the Zavation’s commitment to deliver innovative and differentiated products in conjunction with a market-leading customer to best serve our surgeons and distributor network.”

INDICATIONS FOR USE

Zavation eZspand™ Interbody System Implants are indicated for spinal fusion procedures for use with autogenous bone grafting in skeletally mature patients. Zavation eZspand™ Interbody System Implants are intended for use at contiguous single or bi-level in the lumbar spine, from L2 through S1, for the treatment of degenerative disc disease (DDD) with spondylolisthesis up to Grade I. DDD is defined as low back pain of disc origin with disc degeneration confirmed by history and radiographic studies. The device is intended for use in patients who have had six months of non-operative treatment.

Zavation eZspand™ Interbody System Implants are intended for use with additional internal fixation appropriate to the implanted level, including the Zavation Spinal System.

ABOUT ZAVATION MEDICAL PRODUCTS, LLC.

Situated at Flowood, MS, Zavation designs, engineers and manufactures a portfolio of spinal hardware and biologics covering key areas including cervical, thoracolumbar, interbody fusion, interventional spine and minimally invasive surgery. Founded in 2012, Zavation has experienced exceptional growth and has created a nationwide network of numerous distributors across the United States. The Company has marketed more than 25 product families since its creation. Zavation operates a new 75,000 square foot vertically integrated facility in Flowood, MS. To learn more about Zavation and the company’s product line, visit www.zavation.com.

Related links
www.zavation.com

SOURCE Zavation Medical Products, LLC.

read more
Medical products

StatLab Medical Products acquires CellPath Ltd.


News and research before you hear about it on CNBC and others. Claim your one week free trial for StreetInsider Premium here.


StatLab Expands Global Reach and Core Manufacturing Capabilities with Acquisition of CellPath Ltd.

MCKINNEY, Texas–(BUSINESS WIRE)–
StatLab Medical Products (StatLab)a portfolio company of Audax Private Equity and Linden Capital Partners and a leading developer and manufacturer of medical diagnostic supplies and equipment, today announced the acquisition CellPath Ltd. (CellPath), a UK manufacturer and supplier of products and services focused on the histology and cytology markets. This addition of new manufacturing capabilities and an established customer base in the UK both strengthens the core business and positions StatLab for international growth and market expansion.

This press release is multimedia. See the full version here: https://www.businesswire.com/news/home/20220607006320/en/

Based in the UK, CellPath was founded in 1969 by Peter Webber as a histology consumables company known as Bethlehem Instruments, and quickly expanded into equipment. Today, CellPath is an established market leader in Europe, providing key products and services to the cytology and histology market segments. With this acquisition, StatLab expands its reach in Europe, adds key injection molding manufacturing capabilities, and acquires proprietary products, including the CellNass archiving service.

“We have long respected CellPath for its well-earned reputation for providing innovative products that solve lab problems, and we are proud to welcome them to the StatLab family of brands,” said Mike Karsonovich, CEO of StatLab. the acquisition of UK-based equipment manufacturer Pyramid Innovation in 2021, CellPath’s established position in the European market and its complementary portfolio will enable significant international growth in the histology sector.

Philip Webber, co-CEO of CellPath with his brother Paul, adds, “StatLab is a perfect fit for us; their access to the US market and business infrastructure will jointly help expand customer access to products and services as a global market leader. We also appreciate their leadership commitment to ensure that we maintain the high levels of service and quality for which the family business is known, as we combine into one organization.

CellPath will continue to operate in the same locations and under the existing management structure to avoid any business disruption.

About StatLab Medical Products

Founded in 1976, StatLab Medical Products is at the forefront of developing and manufacturing high quality histology, cytology and immunohistochemistry diagnostic products. We partner with pathology laboratories to provide easy access to over 3,500 high-quality diagnostic products and equipment at excellent prices, delivered with expert support. When you work with StatLab, we are part of your team and you are part of our family. Learn more about StatLab.com.

About CellPath Ltd.

CellPath Limited is a UK based company specializing in the manufacture and global supply of products, consumables and services to the Cell Pathology industry. The CellPath name is synonymous with innovative and proven products, manufactured to very high standards. With state-of-the-art in-house injection molding capability, they manufacture many of the plastic products used in the modern histology and cytology laboratory, and their ability to sell directly from manufacture to the end user helps reduce costs without compromise on quality and services.

Jessica Baer

[email protected]

Source: StatLab Medical Products

read more
Medical products

USTR Expands Section 301 Tariff Exclusions for Medical Products; New Tariff Relief Under Consideration | White & Case srl

On May 27, 2022, the Office of the United States Trade Representative (USTR) issued a Federal Register Notice expanding Section 301 tariff exclusions for certain Chinese-origin medical products needed to address the COVID-19 pandemic.1 The USTR notice extends 81 specific product exclusions for a period of six months (i.e. until December 1, 2022). Separately, Biden administration officials and members of Congress continue to consider further Section 301 tariff relief, though no final decision has been made..

Exclusions extended for COVID-related products

Latest USTR Notice Expands Tariff Exclusions for Certain Types of Personal Protective Equipment; devices used in magnetic resonance imaging (MRI), x-ray and computed tomography (CT) equipment; microscopes and various types of plastic containers, tubes and liners used in medical settings, among other products. The USTR first granted exclusions for these products in December 2020, then extended the exclusions in November 2021. The exclusions were previously set to expire on May 31, 2022 and will now be extended for an additional six months.

In addition to the COVID-related exclusions covered by the latest USTR notice, the USTR reinstated 352 other product exclusions in a separate action announced in March 2022.2 However, the vast majority of product exclusions granted by the USTR in the Section 301 action have expired and the USTR is not currently accepting new exclusion requests.

Discussions on further tariff relief

Over the past several weeks, senior Biden administration officials have indicated that they are actively considering providing further relief from Section 301 tariffs, either through additional debarment processes or by other actions. On May 18, U.S. Treasury Secretary Janet Yellen said interagency discussions on this topic were underway, and she expressed support for removing some of the Section 301 tariffs “not just because of the inflation, but because there would be benefits for consumers and businesses”.[.]”3 Secretary Yellen argued that some of the Section 301 tariffs “seem to impose more harm on consumers and businesses and are not very strategic in the sense of addressing the real issues we have with China.”[.]However, she acknowledged that some administration officials had different views on the merits of further tariff relief. “very, very keen to take steps to be responsive to today’s challenges . . . that would undermine our longer-term strategic approaches” to preserving U.S. competitiveness.4

The USTR is currently conducting a review of the need for Section 301 tariffs before their fourth anniversary, as required by Section 307(c) of the Commerce Act.5 Section 307(c) provides that Section 301 actions expire four years after they take effect, unless the petitioner or a representative of the domestic industry benefiting from the action submits ‘USTR request for further action. The USTR exam is conducted in two stages:

  • In the first stage, which is ongoing, domestic industries that benefit from “actions” under Section 301 (i.e. Schedules 1 and 2 tariff schedules “as amended ” by Lists 3 and 4A) may request continuation of the actions. If the USTR receives such requests, it will announce further relevant actions. To date, the USTR has received 17 submissions under the first stage of the procedure, but has not made the submissions public. The deadline for applications to continue List 1 action is July 5, 2022; the deadline for applications to continue the remaining actions is August 22, 2022.
  • During the second stage (and assuming that the USTR continues each action under Section 301), the USTR will undertake a review of each action. As part of this review, the USTR intends to allow “interested persons” to submit comments on, among other things, the effectiveness of the action in achieving the objectives of Section 301, other actions that might be taken and the effects of those actions on the US economy, including consumers. This procedure would likely provide interested persons (including importers) with the ability to request the elimination of Section 301 duties on particular products, among other changes. USTR officials said an upcoming Federal Register notice will specify criteria that commenters must meet when requesting changes to Section 301 actions.

On May 25, USTR General Counsel Ms. Greta Peisch said that the USTR’s “necessity review” would likely take several months. However, Ms. Peisch pointed out that the USTR may provide further tariff relief before this review is complete, and is currently considering that possibility. Ms. Peisch said that establishing a new exclusion process or changing rates “is something we are looking at outside of the review . . . [i]It is certainly possible that an exclusion process or other action will proceed before this review is complete.”

Meanwhile, the U.S. Congress continues to debate legislation that would provide limited Section 301 tariff relief. On May 12, members of the U.S. Senate and House of Representatives formally convened a conference committee that will seek reconcile the differences between the US Innovation and Competition Act (S. 1260) and the US COMPETES Act (HR 4521). Among other notable differences, Section 1260 includes provisions that would reinstate certain Section 301 tariff exclusions and require the USTR to accept new exclusion requests, while HR 4521 omits these provisions. This is expected to be one of the most difficult issues to resolve at the conference. Democratic congressional leaders hope to reach agreement on a conference bill by July 4, but participants have made little progress in resolving differences between the trade titles of the two bills, including in what regarding Section 301 tariffs.

1 The USTR opinion can be viewed here.
2 Please refer to White & Case US Trade Alert dated March 24, 2022.
3 Transcript of Treasury Secretary Janet L. Yellen’s press conference in Bonn, GermanyUS Treasury Department, May 18, 2022.
4 Testimony of Ambassador Katherine Tai before the House Ways and Means CommitteeMarch 30, 2022.
5 For more information on the USTR review process, please see the White & Case US Trade Alert dated May 4, 2022.

[View source.]

read more
Medical products

Guard Therapeutics Receives Approval from Swedish Medical Products Agency to Conduct Clinical Study of RMC-035 in Kidney Transplantation

Nearly 100,000 kidney transplants are performed worldwide each year. In kidney transplantation, especially with a deceased donor, tissue damage often occurs due to lack of oxygen because the organ is outside the body and without blood supply. Despite successful surgery, the injury often leads to deterioration in the quality and function of the transplanted kidney in the short and long term. If the transplanted kidney does not function properly after transplantation, dialysis treatment is sometimes necessary, which also reduces the expected survival of the kidney and impairs the long-term prognosis.

Therapeutic custodyThe investigational drug RMC-035 has shown in previous studies a high potential to prevent tissue damage related to limited oxygen supply, called ischemia-reperfusion injury. RMC-035 is currently being evaluated in a global phase 2 study (AKITA) for the prevention and treatment of acute kidney injury associated with cardiac surgery. With the planned Phase 1b study, the clinical development program is now expanding into another indication with significant unmet medical need and potential for orphan drug designation.

The phase 1b study of RMC-035 is open-label and without a control group, and is expected to enroll 8 to 12 patients undergoing kidney transplantation in the Karolinska University Hospital at Huddinge. Initially, eight patients will be enrolled in two dose groups, and after an interim pharmacokinetic analysis, a decision will be made whether to proceed with an optional third dose group. The primary endpoint includes key pharmacokinetic properties of RMC-035, and the results will form the basis for the design of a possible subsequent Phase 2 (efficacy) study to improve renal function following a kidney transplant from a deceased donor. The study is expected to begin in the third quarter of this year and full study results will be available in the first half of 2023.

“We are happy that the Medical Products Agency approved our application to conduct this first clinical study of RMC-035 in patients undergoing kidney transplantation. In United States around 90,000 patients alone are currently on the waiting list for a new kidney, so every successful transplant makes a big difference. We see high potential for RMC-035 to limit potential tissue damage after kidney transplantation, and thus an opportunity to improve the treatment of these patients with high unmet medical needs,” said Therapeutic custody CEO, Tobias Agervald.

read more
Medical products

USTR Expands Section 301 Tariff Exclusions for Medical Products; Other tariff relief under consideration

On May 27, 2022, the Office of the United States Trade Representative (USTR) issued a Federal Register Notice expanding Section 301 tariff exclusions for certain Chinese-origin medical products needed to address the COVID-19 pandemic.1 The USTR notice extends 81 specific product exclusions for a period of six months (i.e. until December 1, 2022). Separately, Biden administration officials and members of Congress continue to consider further Section 301 tariff relief, though no final decision has been made..

Exclusions extended for COVID-related products

Latest USTR Notice Expands Tariff Exclusions for Certain Types of Personal Protective Equipment; devices used in magnetic resonance imaging (MRI), x-ray and computed tomography (CT) equipment; microscopes and various types of plastic containers, tubes and liners used in medical settings, among other products. The USTR first granted exclusions for these products in December 2020, then extended the exclusions in November 2021. The exclusions were previously set to expire on May 31, 2022 and will now be extended for an additional six months.

In addition to the COVID-related exclusions covered by the latest USTR notice, the USTR reinstated 352 other product exclusions in a separate action announced in March 2022.2 However, the vast majority of product exclusions granted by the USTR in the Section 301 action have expired and the USTR is not currently accepting new exclusion requests.

Discussions on further tariff relief

Over the past several weeks, senior Biden administration officials have indicated that they are actively considering providing further relief from Section 301 tariffs, either through additional debarment processes or by other actions. On May 18, U.S. Treasury Secretary Janet Yellen said interagency discussions on this topic were underway, and she expressed support for removing some of the Section 301 tariffs “not only because of the inflation, but because there would be benefits for consumers and businesses”.[.]”3 Secretary Yellen argued that some of the Section 301 tariffs “seem to impose more harm on consumers and businesses and are not very strategic in the sense of addressing the real issues we have with China.”[.]However, she acknowledged that some administration officials had different views on the merits of further tariff relief. “very, very keen to take steps to be responsive to today’s challenges . . . that would undermine our longer-term strategic approaches” to preserving U.S. competitiveness.4

The USTR is currently conducting a review of the need for Section 301 tariffs before their fourth anniversary, as required by Section 307(c) of the Commerce Act.5 Section 307(c) provides that Section 301 actions expire four years after they take effect, unless the petitioner or a representative of the domestic industry benefiting from the action submits to the ‘USTR request for further action. The USTR exam is conducted in two stages:

  • In the first stage, which is ongoing, domestic industries that benefit from “actions” under Section 301 (i.e. Schedules 1 and 2 tariff schedules “as amended ” by Lists 3 and 4A) may request continuation of the actions. If the USTR receives such requests, it will announce further relevant actions. To date, the USTR has received 17 submissions under the first stage of the procedure, but has not made the submissions public. The deadline for applications to continue List 1 action is July 5, 2022; the deadline for applications to continue the remaining actions is August 22, 2022.
  • During the second stage (and assuming that the USTR continues each action under Section 301), the USTR will undertake a review of each action. As part of this review, the USTR intends to allow “interested persons” to submit comments on, among other things, the effectiveness of the action in achieving the objectives of Section 301, other actions that might be taken and the effects of those actions on the US economy, including consumers. This procedure would likely give interested persons (including importers) the ability to request the elimination of Section 301 duties on particular products, among other changes. USTR officials said an upcoming Federal Register notice will specify the criteria that commenters must meet when requesting changes to Section 301 actions.

On May 25, USTR General Counsel Ms. Greta Peisch said that the USTR’s “necessity review” would likely take several months. However, Ms. Peisch pointed out that the USTR may provide further tariff relief before this review is complete, and is currently considering that possibility. Ms. Peisch said that establishing a new exclusion process or changing rates “is something we are looking at outside of the review . . . [i]It is certainly possible that an exclusion process or other action will proceed before this review is complete.”

Meanwhile, the U.S. Congress continues to debate legislation that would provide limited Section 301 tariff relief. On May 12, members of the U.S. Senate and House of Representatives formally convened a conference committee that will seek reconcile the differences between the US Innovation and Competition Act (S. 1260) and the US COMPETES Act (HR 4521). Among other notable differences, Section 1260 includes provisions that would reinstate certain Section 301 tariff exclusions and require the USTR to accept new exclusion requests, while HR 4521 omits these provisions. This is expected to be one of the most difficult issues to resolve at the conference. Democratic congressional leaders hope to reach agreement on a conference bill by July 4, but participants have made little progress in resolving differences between the trade titles of the two bills, including in what regarding Section 301 tariffs.

1 The USTR opinion can be viewed here.
2 Please refer to White & Case’s US Trade Alert dated March 24, 2022.
3 Transcript of Treasury Secretary Janet L. Yellen’s press conference in Bonn, GermanyUS Treasury Department, May 18, 2022.
4 Testimony of Ambassador Katherine Tai before the House Ways and Means CommitteeMarch 30, 2022.
5 For more information on the USTR review process, please see White & Case US Trade Alert dated May 4, 2022.

This publication is provided for your convenience and does not constitute legal advice. This publication is protected by copyright.
© 2022 White & Case LLP

read more
Medical products

Proctology Table Market Trend and Forecast | Key Players – AR-EL MEDICAL PRODUCTS, Promotal, ECHOMED INDUSTRIAL, SCHMITZ u. Söhne, B?Çakc?lar

New Jersey, United States,- The Global”Proctology table Market” report provides global trade insights along with valuable facts and figures. This analysis study intimately explores the global market such as industry chain structures, product suppliers, and production. The Proctologic Table sales market examines the major segments of the GPS Bike Computer Scale market. This good study provides historical knowledge as well as a forecast from 2022 to 2028.

The entire price chain and demanding downstream and upstream components are examined during this report. This market report covers the technical knowledge, production facility analysis, and supplied item analysis for the Proctology Tables business and conjointly explains the product has the best penetration, profit margins, and market share.

Main Drivers and Obstacles:

High impacting factors and rendering drivers are studied in the Proctology Table market report to aid in reader perception of the development. Additionally, the report contains restrictions and challenges that will fulfill the gamers method. this can make it easier for the user to listen and build informed professional choices. The experts have jointly verified the following trading prospects.

Click the link for a sample copy of the report: https://www.marketresearchintellect.com/download-sample/?rid=308775

Market segmentation :

Key players:

  • AR-EL MEDICAL PRODUCTS
  • promotional
  • INDUSTRIAL ECHOME
  • SCHMITZ and. Sohne
  • B?Çakc?lar
  • NQR
  • Wardray premise

Segment by types:

  • Adjustable Proctology Table
  • Non-Adjustable Proctology Table

Segment by applications:

  • Hospital
  • Clinical
  • Ambulatory surgery centers

Get | Discount on the purchase of this report @ https://www.marketresearchintellect.com/ask-for-discount/?rid=308775

Scope of Proctology Table Market Report:

Report attribute Details
Market size available for years 2022 – 2029
Base year considered 2021
Historical data 2018 – 2021
Forecast period 2022 – 2029
Quantitative units Revenue in USD Million and CAGR from 2022 to 2029
Segments Covered Types, applications, end users, and more.
Report cover Revenue Forecast, Business Ranking, Competitive Landscape, Growth Factors and Trends
Regional scope North America, Europe, Asia-Pacific, Latin America, Middle East and Africa
Scope of customization Free report customization (equivalent to up to 8 analyst business days) with purchase. Added or changed country, region and segment scope.
Pricing and purchase options Take advantage of personalized purchasing options to meet your exact research needs. Explore purchase options

Regional Analysis For Proctology Table Market:

The global Proctology Table Market research report details current market trends, development outline, and several research methodologies. It illustrates the key factors that directly manipulate the market, for example, production strategies, development platforms, and product portfolio. According to our researchers, even minor changes in product profiles could lead to huge disruptions in the factors mentioned above.

North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia and Italy)
Asia Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia, etc.)
Middle East and Africa (Saudi Arabia, United Arab Emirates, Egypt, Nigeria and South Africa)

Post-covid-19 outlook:

Readers of the section will understand how the proctology table market scenario has changed across the globe during the pandemic and post pandemic. The study is carried out keeping in mind the changes in aspects such as production, demand, consumption and supply chain. The market experts have also highlighted the key factors which will help create opportunities for the players and stabilize the overall market in the coming years.

What insights does the Proctology Table market report provide readers?

➜ Fragmentation of the proctology table according to product type, end use and region
➜ Comprehensive assessment of upstream raw materials, downstream demand and current market landscape
➜ Collaborations, R&D projects, acquisitions and product launches of each Proctologic Table player
➜ The various regulations imposed by governments on the consumption of Proctology Table in detail
➜ Impact of modern technologies, such as big data and analytics, artificial intelligence, and social media platforms on the global Proctology Table Market.

For more information or query or customization before buying, visit: https://www.marketresearchintellect.com/product/global-proctologic-table-market-size-and-forecast/

There are 13 Sections to show the global Proctology Table market:

Chapter 1: Market Overview, Drivers, Restraints and Opportunities, Segmentation Overview

Chapter 2: Market Competition by Manufacturers

Chapter 3: Production by regions

Chapter 4: Consumption by Regions

Chapter 5: Production, by Types, Revenue and Market Share by Types

Chapter 6: Consumption, by Applications, Market Share (%) and Growth Rate by Applications

Chapter 7: Comprehensive Profiling and Analysis of Manufacturers

Chapter 8: Manufacturing Cost Analysis, Raw Material Analysis, Manufacturing Expense by Region

Chapter 9: Industrial Chain, Sourcing Strategy and Downstream Buyers

Chapter 10: Marketing Strategy Analysis, Distributors/Traders

Chapter 11: Market Effect Factor Analysis

Chapter 12: Market Forecast

Chapter 13: Proctology Table Market Research Findings and Conclusion, Appendix, methodology and data source

Finally, the researchers throw light on the precise analysis of the global proctology tables market dynamics. It also measures enduring trends and platforms that are driving market growth. The degree of competition is also measured in the research report. With the help of SWOT and Porter’s five analyses, the market has been thoroughly analyzed. It also helps in dealing with the risks and challenges faced by businesses. Also, it offers in-depth research on sales approaches.

To note: All of the reports we list tracked the impact of COVID-19. The upstream and downstream of the entire supply chain were taken into account during this operation. Additionally, where possible, we will provide an additional COVID-19 update supplement/report to the third quarter report, please check with the sales team.

Most Popular Reports:

Global Rotary Hydraulic Actuators Market

Global Oil-Water Separator Market

Global offshore inflatable boat market

Global Underblanket Market

Global Hydraulic Sand Fracturing Equipment Market

Global Cbm Drilling Rigs Market

Global home fragrance market

Global gantry waterjet cutting machine market

Global System Etc Market

Global compact street sweeper market

About Us: Market Research Intellect

Market Research Intellect provides syndicated and customized research reports to clients across various industries and organizations with the aim of providing functional expertise. We provide reports for all industries including Energy, Technology, Manufacturing & Construction, Chemicals & Materials, Food & Beverage, and more. These reports provide an in-depth study of the market with industry analysis, market value of regions and countries, and industry-relevant trends.

Contact us:
Mr. Steven Fernandes
Market research intelligence
New Jersey (USA)
Tel: +1-650-781-4080

E-mail: [email protected]

Website: –https://www.marketresearchintellect.com/

read more
Medical products

Disposable Hemostats Market Trend and Forecast 2022-2028 | Key Players – DaySpring Medical Products, Bard Medical, Alpha Industries, Towne Brothers, Fine Science Tools – ManufactureLink

New Jersey, United States,- The Global”Disposable hemostat Market” provides global trade information along with valuable facts and figures. This analysis study intimately explores the global market such as industry chain structures, product suppliers, and production. The Disposable Hemostats Sales market examines the major segments of the GPS Bike Computer Scale market. This good study provides historical knowledge as well as forecast from 2022 to 2028.

The entire price chain and demanding downstream and upstream components are examined during this report. This market report covers the technical knowledge, production facility analysis, and supplied item analysis for the Disposable Hemostat business and conjointly explains the product has the best penetration, profit margins, and market share .

Main Drivers and Obstacles:

High-impacting factors and rendering drivers are studied in the Disposable Hemostat market report to aid in reader perception of the development. Additionally, the report contains restrictions and challenges that will fulfill the gamers method. this can make it easier for the user to listen and build informed professional choices. The experts have jointly verified the following trading prospects.

Click the link for a sample copy of the report: https://www.marketresearchintellect.com/download-sample/?rid=564256

Market segmentation :

Key players:

  • DaySpring Medical Products
  • medical bard
  • Alpha Industries
  • Towne Brothers
  • fine science tools
  • ydm
  • Hu Friedy
  • Ted Shovel

Segment by types:

  • Disposable Straight Hemostat
  • Disposable Curved Hemostat

Segment by applications:

Get | Discount on the purchase of this report @ https://www.marketresearchintellect.com/ask-for-discount/?rid=564256

Scope of Disposable Hemostats Market Report:

Report attribute Details
Market size available for years 2022 – 2029
Base year considered 2021
Historical data 2018 – 2021
Forecast period 2022 – 2029
Quantitative units Revenue in USD Million and CAGR from 2022 to 2029
Segments Covered Types, applications, end users, and more.
Report cover Revenue Forecast, Business Ranking, Competitive Landscape, Growth Factors and Trends
Regional scope North America, Europe, Asia-Pacific, Latin America, Middle East and Africa
Scope of customization Free report customization (equivalent to up to 8 analyst business days) with purchase. Added or changed country, region and segment scope.
Pricing and purchase options Take advantage of personalized purchasing options to meet your exact research needs. Explore purchase options

Disposable Hemostat Market Regional Analysis:

The global Disposable Hemostats Market research report details ongoing market trends, development outlines, and several research methodologies. It illustrates the key factors that directly manipulate the market, for example, production strategies, development platforms, and product portfolio. According to our researchers, even minor changes in product profiles could lead to huge disruptions in the factors mentioned above.

North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia and Italy)
Asia Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia, etc.)
Middle East and Africa (Saudi Arabia, United Arab Emirates, Egypt, Nigeria and South Africa)

Post-covid-19 outlook:

Readers of the section will understand how the Disposable Hemostats market scenario has changed across the globe during the pandemic and post pandemic. The study is carried out keeping in mind the changes in aspects such as production, demand, consumption and supply chain. The market experts have also highlighted the key factors which will help create opportunities for the players and stabilize the overall market in the coming years.

What insights does the Disposable Hemostats market report provide readers?

➜ Fragmentation of disposable hemostat based on product type, end use and region
➜ Comprehensive assessment of upstream raw materials, downstream demand and current market landscape
➜ Collaborations, R&D projects, acquisitions and product launches of each disposable hemostat player
➜ Various regulations imposed by governments on the consumption of Disposable Hemostat in detail
➜ Impact of modern technologies, such as big data and analytics, artificial intelligence, and social media platforms on the global disposable hemostats market.

For more information or query or customization before buying, visit: https://www.marketresearchintellect.com/product/global-disposable-hemostat-market-size-forecast/

There are 13 Sections to show the global Disposable Hemostat market:

Chapter 1: Market Overview, Drivers, Restraints and Opportunities, Segmentation Overview

Chapter 2: Market Competition by Manufacturers

Chapter 3: Production by regions

Chapter 4: Consumption by Regions

Chapter 5: Production, by Types, Revenue and Market Share by Types

Chapter 6: Consumption, by Applications, Market Share (%) and Growth Rate by Applications

Chapter 7: Comprehensive Profiling and Analysis of Manufacturers

Chapter 8: Manufacturing Cost Analysis, Raw Material Analysis, Manufacturing Expense by Region

Chapter 9: Industrial Chain, Sourcing Strategy and Downstream Buyers

Chapter 10: Marketing Strategy Analysis, Distributors/Traders

Chapter 11: Market Effect Factor Analysis

Chapter 12: Market Forecast

Chapter 13: Disposable Hemostats Market Research Findings and Conclusion, Appendix, methodology and data source

Finally, the researchers shed light on the precise analysis of the global Disposable Hemostats market dynamics. It also measures enduring trends and platforms that are driving market growth. The degree of competition is also measured in the research report. With the help of SWOT and Porter’s five analyses, the market has been thoroughly analyzed. It also helps to deal with the risks and challenges faced by businesses. Also, it offers in-depth research on sales approaches.

To note: All of the reports we list tracked the impact of COVID-19. The upstream and downstream of the entire supply chain were taken into account during this operation. Additionally, where possible, we will provide an additional COVID-19 update supplement/report to the third quarter report, please check with the sales team.

Most Popular Reports:

Global Rotary Hydraulic Actuators Market

Global Oil-Water Separator Market

Global offshore inflatable boat market

Global Underblanket Market

Global Hydraulic Sand Fracturing Equipment Market

Global Cbm Drilling Rigs Market

Global home fragrance market

Global gantry waterjet cutting machine market

Global System Etc Market

Global compact street sweeper market

About Us: Market Research Intellect

Market Research Intellect provides syndicated and customized research reports to clients across various industries and organizations with the aim of providing functional expertise. We provide reports for all industries including Energy, Technology, Manufacturing & Construction, Chemicals & Materials, Food & Beverage, and more. These reports provide an in-depth study of the market with industry analysis, market value of regions and countries, and industry-relevant trends.

Contact us:
Mr. Steven Fernandes
Market research intelligence
New Jersey (USA)
Tel: +1-650-781-4080

E-mail: [email protected]

Website: –https://www.marketresearchintellect.com/

read more
Medical products

Financial Survey: Utah Medical Products (NASDAQ: UTMD) and Isoray (NYSE: ISR)


isoray(NYSE: SRIGet a rating) and Utah Medical Products (NASDAQ:UTMDGet a rating) are both small-cap medical companies, but which business is superior? We will compare the two companies based on the strength of their institutional ownership, earnings, dividends, analyst recommendations, valuation, risk and profitability.

Volatility and risk

Isoray has a beta of 1.02, indicating its stock price is 2% more volatile than the S&P 500. In comparison, Utah Medical Products has a beta of 0.25, indicating its stock price is 75% less volatile than the S&P 500.

Benefits and evaluation

This table compares the revenue, earnings per share and valuation of Isoray and Utah Medical Products.

Gross revenue Price/sales ratio Net revenue Earnings per share Price/earnings ratio
Isoray $10.05 million 3.96 -$3.39 million ($0.05) -5.60
Utah Medical Products $49.05 million 6:30 p.m. $14.79 million $4.18 8:31 p.m.

Utah Medical Products has higher revenues and profits than Isoray. Isoray trades at a lower price-to-earnings ratio than Utah Medical Products, indicating that it is currently the more affordable of the two stocks.

Profitability

This table compares the net margins, return on equity and return on assets of Isoray and Utah Medical Products.

Net margins Return on equity return on assets
Isoray -56.86% -9.60% -9.18%
Utah Medical Products 30.34% 14.11% 12.96%

Institutional and insider ownership

12.4% of Isoray shares are held by institutional investors. By comparison, 71.4% of Utah Medical Products’ stock is held by institutional investors. 2.4% of Isoray shares are held by company insiders. By comparison, 6.6% of Utah Medical Products’ stock is held by company insiders. Strong institutional ownership indicates that large fund managers, endowments, and hedge funds believe a stock is poised for long-term growth.

Analyst Recommendations

This is a breakdown of current recommendations for Isoray and Utah Medical Products, as reported by MarketBeat.

Sales Ratings Hold odds Buy reviews Strong buy odds Rating
Isoray 0 0 0 0 N / A
Utah Medical Products 0 0 0 0 N / A

Summary

Utah Medical Products beats Isoray on 10 of 11 factors compared between the two stocks.

About Isoray (Get a rating)

Isoray, Inc., through its subsidiary IsoRay Medical, Inc., develops, manufactures and sells isotope-based medical products and devices for the treatment of cancer and other malignant diseases in the United States and throughout the world. The company offers Cesium-131 ​​CS-1 brachytherapy seeds for the treatment of prostate, brain, lung, head and neck, gynecological, pelvic/abdominal and colorectal cancers. It sells its products to institutions or medical practices that use various surgical facilities. Isoray, Inc. was founded in 1998 and is based in Richland, Washington.

About Utah Medical Products (Get a rating)

Utah Medical Products, Inc. develops, manufactures and distributes medical devices for the healthcare industry. The Company offers fetal monitoring accessories, vacuum assisted delivery systems and other labor and delivery tools; Respiratory hoods for newborns DISPOSA-HOOD; and DELTRAN PLUS blood pressure monitoring systems. It also supplies GESCO umbilical vessel catheters; DIALY-NATE disposable peritoneal dialysis sets; PALA-NATE Silicone Mouthguards; URI-CATH urinary drainage systems; NUTRI-CATHNUTRI-LOK feeding device; MYELO-NATE Lumbar Sampling Kits; HEMO-NATE disposable filters; and catheterization procedure tray of instruments and supplies. Additionally, the Company offers the LETZ System for excision of cervical intraepithelial neoplasia and other lower genital tract lesions; FINESSE+ generators; loop, ball and needle electrodes; FILTRESSE spillways; other electrodes and specialized supplies and gynecological tools; Femcare trocars, cannulas, laparoscopic instruments and accessories; and EPITOME and OptiMicro electrosurgical devices. In addition, it provides Filshie Clip female surgical contraceptive devices; PATHFINDER PLUS endoscopic irrigation devices; suprapubic catheterization; LIBERTY Urinary Incontinence Treatment and Control Systems; ENDOCURETTE, a curette for the removal of uterine endometrial tissue; TVUS/HSG-Cath to assess abnormal or dysfunctional uterine bleeding and other abnormalities of the uterus; and the LUMIN tool for manipulating the uterus in laparoscopic procedures. Additionally, the company offers DELTRAN, a disposable pressure transducer; and pressure monitoring accessories, components and other castings. It serves neonatal intensive care units, labor and delivery wards, women’s health centers in hospitals, outpatient clinics and physicians’ offices through direct customer service and a force sales representatives, independent consultants and manufacturer representatives. The company was incorporated in 1978 and is headquartered in Midvale, Utah.



Get news and reviews for Isoray Daily – Enter your email address below to receive a concise daily summary of breaking news and analyst ratings for Isoray and related companies with MarketBeat.com’s free daily email newsletter.

read more
Medical products

How to design successful medical products

Reading time: 4 minutes

Product design is a unique process that requires collaboration between designers, engineers and scientists. It is a constantly evolving process. And before saying that a design is successful, there are many R&D processes where prototyping plays a vital role these days. Currently, 3D printing is involved in prototyping medical products, but when you have access to bulk production, the injection molding prototype is an efficient process that you should consider to achieve your design.

If you want your product to succeed, it must meet the needs of the people who use it. Efficient and effective product design can help make medical products more accessible, and that’s what this article is about.

If you’re looking to design a new medical product, you’ve probably heard of the importance of market research, product design and development. But what does all this mean? And how does it all come together to create a successful medical product?

First rule – The design should be “less medical”.

As medical research advances, more and more people rely on medical gadgets to maintain their independence. These things can be designed to look amazing, improve quality of life and create a positive perception. Respirators, for example. Oxygen concentrators, pumps and elevators will become commonplace in the future. However, few people want to stand out from the crowd or be identified by their devices.

Design a medical product

Even more popular are gadgets that are used for overall health maintenance and monitoring rather than acute therapy. Individuals tend to be quite secretive about their health, so apps and wearable gadgets that help people maintain their health and fitness certainly don’t want to be too visible. Designers in the medical industry use the injection molding prototype process to make “less medical” designs more available.

Second rule – The device must be easily cleanable

After the design concept, this is the most important part of medical devices – they should be easily cleanable. The device you are about to design can be exposed to acids, alcohols, body fluids, reagents, and various types of bacteria and viruses.

As these are medical devices, they must not contain any harmful elements. Therefore, you must ensure that the design can ensure that users can clean it quickly and effortlessly.

Many products are made using plastic injection molding, which means that there will be tiny gaps between the housings and housings. If these are unavoidable, there are a few mitigation options. Although these seams can be concealed by overlapping elements or false coverings if necessary, the sealed space should be as tight as possible. Revealed deficiencies should be at least fingertip cleanable, depending on the environment in which the product will be used.

Third Rule – Understand User Demand

Medical devices must reconcile function and aesthetics. The device must be able to capture the consumer’s attention. It was not necessary in the past, but now people are more aware of the appearance of the device.

Medical gadgets that are both silent and non-obtrusive are becoming increasingly popular. Keep in mind that designers need to understand consumer needs at all levels, from broad to specific. Based on the information, a designer can create a design and design review form and checklist. This ensures that everyone is on the same page.

Fourth rule – It should be easy to grasp

Rough or abrasive textures are rarely found in a hospital or medical setting. When it comes to holding a product in your hand, it shouldn’t be too smooth or too sticky. The wearable shapes are designed to conform to the curves of the human hand while providing adequate tactile feedback without requiring a firm grip. Matte or lightly sanded textures are functional and appealing to the eye.

Fifth rule – Consumer opinion

People don’t always know what they need. They will be more than happy to tell you how they feel about anything, especially when it comes to their health. You can show them a design prototype and record their thoughts and feelings. You will most likely provide them with the technical side of things, while they provide you with their own opinions and thoughts.

Listen to their suggestions and apply them to improve the design. Find a method to incorporate their suggestions into yours.

Sixth Rule – Apply Color Carefully

Color plays a big role in the design of any product. When it comes to the medical product, you need to use your color smartly. For example, if the device has buttons, the security buttons must

Human beings have a deep emotional relationship with color. Warm hues like golds and yellows provide a sense of peace in prenatal environments designed to stimulate nurturing, while bright primary colors are entertaining and engaging for children in other scenarios. Bright colors provide vitality and excitement, which can be used in fitness or activity related health articles.

Conclusion

We have talked about six rules in this article. But this is not enough. There are other things to consider before designing a medical product. For example, the design should be simple and easy to locate. There are many other factors to consider. But we have discussed some of the main rules. We hope this article has been helpful to new medical product designers and engineers in training.

read more
Medical products

HCMC expects to receive an active procurement mechanism for medical products | Ho Chi Minh City

Chairman of the People’s Committee of Phan Van Mai city speaks during the third session of the National Assembly (NA) of the 15th term.

The proposal was forwarded by the head of the HCMC delegation of NA deputies, chairman of the people’s committee of Phan Van Mai city during the third session of the 15th legislature of the National Assembly (NA) on 25 may.

He reviewed recent positive socio-economic changes after the Covid-19 pandemic was basically under control at HCMC. The city has experienced positive growth over the past four months thanks to the efforts, flexible policies and guidance of the municipal authorities.

The commercial services sector reached positive growth of 0.6% in May. Although key industries are recovering slowly, the tourism sector has rebounded strongly.

The real estate market is still showing signs of slowing due to the slow recovery and the tightening of real estate credit which has restricted speculation and helped the market become more transparent.

The government and ministries should issue instructions for the purchase of medical products, equipment and supplies to help localities actively purchase medicines and health products according to regulations to meet the needs of the people. .

By Anh Phuong – Translated by Kim Khanh

read more
Medical products

Retinal Implants Market Size and Forecast

New Jersey, United States – Comprehensive analyzes of the fastest growing companies Retinal Implants Market provide information that helps stakeholders identify opportunities and challenges. The 2022 markets could be another big year for retinal implants. This report provides an overview of the company’s activities and financial situation (a company profile is required if you want to raise capital or attract investors), recent developments (mergers and acquisitions) and recent SWOT analyses. This report focuses on the Retinal Implants Market over the assessment period 2029. The report also provides an analysis of the growth of the Retinal Implants Market which includes Porter’s Five Factor Analysis and Analysis of the supply chain.

It describes the behavior of the industry. It also outlines a future direction that will help companies and other stakeholders make informed decisions that will ensure strong returns for years to come. The report provides a practical overview of the global market and its changing environment to help readers make informed decisions about market projects. This report focuses on growth opportunities that allow the market to expand its operations in existing markets.

For more information or query or customization before buying, visit @ https://www.verifiedmarketreports.com/product/retinal-implants-market-size-and-forecast/

(Use company email id to get higher priority)

The report helps both major players and new entrants to analyze the market in depth. This helps key players determine their business strategy and set goals. The report provides key market insights including niche growth opportunities along with market size, growth rate and forecast in key regions and countries.

The Retinal Implants report contains data based on rigorous studies in elementary and secondary schools using the best research practices. The report contains exhaustive information which will enable you to evaluate each segment of the Retinal Implants market. This report has been prepared considering various aspects of market research and analysis. It includes market size estimates, market dynamics, and company and market best practices. Entry marketing strategy, positioning, segmentation, competitive landscape and economic forecasts. Industry-specific technology solutions, roadmap analysis, alignment to key buying criteria, in-depth vendor product benchmarking

Key Players Mentioned in the Retinal Implants Market Research Report:

Second Sight Medical Products, Centrasight, Retinal Implant, Boston Retinal Implant Project, Nano Retina

Retinal Implants Market Segmentation:

By Product Type, the market is primarily split into:

• Epiretinal implants
• Subretinal implants

By application, this report covers the following segments:

• Retinal degenerative diseases
• Total blindness
• Others

Get Sample Full PDF Copy of Report: (Including Full TOC, List of Tables & Figures, Chart) @ https://www.verifiedmarketreports.com/download-sample/?rid=481975

Scope of the Retinal Implants Market Report

ATTRIBUTES DETAILS
ESTIMATED YEAR 2022
YEAR OF REFERENCE 2021
FORECAST YEAR 2029
HISTORICAL YEAR 2020
UNITY Value (million USD/billion)
SECTORS COVERED Types, applications, end users, and more.
REPORT COVER Revenue Forecast, Business Ranking, Competitive Landscape, Growth Factors and Trends
BY REGION North America, Europe, Asia-Pacific, Latin America, Middle East and Africa
CUSTOMIZATION SCOPE Free report customization (equivalent to up to 4 analyst business days) with purchase. Added or changed country, region and segment scope.

Geographic segment covered in the report:

The Retinal Implants report provides information on the market area, which is sub-divided into sub-regions and countries/regions. In addition to the market share in each country and sub-region, this chapter of this report also contains information on profit opportunities. This chapter of the report mentions the market share and growth rate of each region, country and sub-region over the estimated period.

• North America (USA and Canada)
• Europe (UK, Germany, France and rest of Europe)
• Asia-Pacific (China, Japan, India and the rest of the Asia-Pacific region)
• Latin America (Brazil, Mexico and rest of Latin America)
• Middle East and Africa (GCC and Rest of Middle East and Africa)

Key questions answered in this Retinal Implants Market report

  1. How much revenue will the Retinal Implants market generate by the end of the forecast period?
  2. Which market segment is expected to have the maximum market share?
  3. What are the influencing factors and their impact on the Retinal Implants market?
  4. Which regions are currently contributing the maximum share of the overall Retinal Implants market?
  5. Which indicators are likely to drive the Retinal Implants market?
  6. What are the key strategies of the major Retinal Implants market players to expand their geographical presence?
  7. What are the key advancements in the Retinal Implants market?
  8. How are regulatory standards affecting the retinal implant market?

Get a discount on the purchase of this report @ https://www.verifiedmarketreports.com/ask-for-discount/?rid=481975

Visualize Retinal Implants Market Using Verified Market Intelligence:-

Verified Market Intelligence is our BI platform for market narrative storytelling. VMI offers in-depth forecast trends and accurate insights on over 20,000 emerging and niche markets, helping you make critical revenue-impacting decisions for a bright future.

VMI provides a global overview and competitive landscape with respect to region, country and segment, as well as key players in your market. Present your market report and findings with an integrated presentation feature that saves you over 70% of your time and resources for presentations to investors, sales and marketing, R&D and development of products. VMI enables data delivery in Excel and interactive PDF formats with over 15+ key market indicators for your market.

Visualize the Retinal Implant Market using [email protected] https://www.verifiedmarketresearch.com/vmintelligence/

Most Popular Reports

Global Ultrasonic Bone Densitometer Market Size and Forecast

Global Bioremediation Technology Market Size and Forecast

Global Hip Reconstruction Devices Market Size and Forecast

Global Energy-Based Hyperhidrosis Devices Market Size and Forecast

Global Sick Bed Market Size and Forecast

Global Neonatal Monitoring Devices Market Size and Forecast

Global External Pacemaker Market Size and Forecast

Global Retinal Implants Market Size and Forecast

Global Adaptive Self-Injection System Market Size and Forecast

Global Animal Pharmaceuticals Market Size and Forecast

About Us: Verified Market Reports

Verified Market Reports is a leading global research and advisory company serving over 5000 global clients. We provide advanced analytical research solutions while delivering information-enriched research studies.

We also provide insight into the strategic and growth analytics and data needed to achieve business goals and critical revenue decisions.

Our 250 analysts and SMEs offer a high level of expertise in data collection and governance using industry techniques to collect and analyze data on over 25,000 high impact and niche markets. Our analysts are trained to combine modern data collection techniques, superior research methodology, expertise and years of collective experience to produce informative and accurate research.

Our research spans a multitude of industries, including energy, technology, manufacturing and construction, chemicals and materials, food and beverage, and more. Having served many Fortune 2000 organizations, we bring a wealth of reliable experience that covers all kinds of research needs.

Contact us:

Mr. Edwyne Fernandes

USA: +1 (650)-781-4080
UK: +44 (753)-715-0008
APAC: +61 (488)-85-9400
US toll free: +1 (800)-782-1768

E-mail: [email protected]

Website: – https://www.verifiedmarketreports.com/

read more
Medical products

Insider Selling: Utah Medical Products, Inc. (NASDAQ: UTMD) Director Sells 2,000 Shares


Utah Medical Products, Inc. (NASDAQ:UTMDGet a rating) Director Barbara A. Payne sold 2,000 shares of Utah Medical Products in a trade dated Wednesday, May 11. The shares were sold at an average price of $85.20, for a total value of $170,400.00. Following the sale, the director now owns 5,338 shares of the company, valued at approximately $454,797.60. The sale was disclosed in an SEC filing, available at this hyperlink.

NASDAQ:UTMD opened at $85.05 on Thursday. The company has a 50-day moving average of $87.51 and a 200-day moving average of $95.57. The company has a market capitalization of $310.86 million, a price-earnings ratio of 20.35 and a beta of 0.25. Utah Medical Products, Inc. has a 1-year low of $81.01 and a 1-year high of $133.87.

The company also recently announced a quarterly dividend, which will be paid on Wednesday, July 6. Investors of record on Friday, June 17 will receive a dividend of $0.29. The ex-dividend date is Thursday, June 16. This represents a dividend of $1.16 on an annualized basis and a yield of 1.36%. Utah Medical Products’ payout ratio is 27.75%.

Separately, StockNews.com began covering Utah Medical Products in a research report on Thursday, March 31. They established a “Strong Buy” rating for the company.

A number of large investors have recently increased or reduced their stakes in UTMD. HealthInvest Partners AB increased its position in Utah Medical Products by 40.0% in Q1. HealthInvest Partners AB now owns 56,000 shares of the medical device supplier worth $5,032,000 after buying an additional 16,000 shares in the last quarter. JPMorgan Chase & Co. increased its position in Utah Medical Products by 16.9% in the 1st quarter. JPMorgan Chase & Co. now owns 101,769 shares of the medical device supplier worth $9,145,000 after buying 14,693 additional shares in the last quarter. FMR LLC increased its position in Utah Medical Products by 2.4% in the 1st quarter. FMR LLC now owns 488,255 shares of the medical device supplier worth $43,089,000 after purchasing an additional 11,248 shares in the last quarter. Allspring Global Investments Holdings LLC purchased a new stake in Utah Medical Products in Q4 for approximately $1,086,000. Finally, James Investment Research Inc. acquired a new stake in Utah Medical Products in Q1 for a value of approximately $384,000. Institutional investors hold 71.44% of the company’s shares.

Utah Medical Products Company Profile (Get a rating)

Utah Medical Products, Inc. develops, manufactures and distributes medical devices for the healthcare industry. The Company offers fetal monitoring accessories, vacuum assisted delivery systems and other labor and delivery tools; Respiratory hoods for newborns DISPOSA-HOOD; and DELTRAN PLUS blood pressure monitoring systems.

Recommended Stories



Receive daily news and reviews for Utah medical products – Enter your email address below to receive a concise daily summary of breaking news and analyst ratings for Utah Medical Products and related companies with MarketBeat.com’s free daily email newsletter.

read more
Medical products

Utah Medical Products, Inc. Declares Quarterly Dividend of $0.29 (NASDAQ: UTMD)


Utah Medical Products, Inc. (NASDAQ:UTMDGet a rating) declared a quarterly dividend on Tuesday, May 10, Zacks reports. Shareholders of record on Friday, June 17 will receive a dividend of 0.29 per share from the medical device supplier on Wednesday, July 6. This represents a dividend of $1.16 on an annualized basis and a yield of 1.37%. The ex-dividend date is Thursday, June 16.

Utah Medical Products has increased its dividend payout by an average of 38.1% per year over the past three years and has increased its dividend each year for the past 1 consecutive years.

NASDAQ UTMD traded down $0.06 during Wednesday’s trading, hitting $84.66. The stock had a trading volume of 9 shares, compared to an average volume of 13,666 shares. The company’s 50-day moving average is $87.58. The company has a market capitalization of $309.43 million, a P/E ratio of 20.24 and a beta of 0.25. Utah Medical Products has a 12-month low of $81.01 and a 12-month high of $133.87.

Separately, StockNews.com began covering Utah Medical Products in a research report on Thursday, March 31. They issued a “Strong Buy” rating on the stock.

A number of large investors have recently increased or reduced their stakes in UTMD. JPMorgan Chase & Co. increased its stake in Utah Medical Products shares by 16.9% in the first quarter. JPMorgan Chase & Co. now owns 101,769 shares of the medical device supplier worth $9,145,000 after buying 14,693 additional shares in the last quarter. Barclays PLC increased its holdings of Utah Medical Products shares by 196.3% in the fourth quarter. Barclays PLC now owns 4,157 shares of the medical device supplier worth $415,000 after buying an additional 2,754 shares in the last quarter. BlackRock Inc. increased its holdings of Utah Medical Products shares by 0.3% in the fourth quarter. BlackRock Inc. now owns 217,007 shares of the medical device supplier worth $21,700,000 after purchasing an additional 748 shares in the last quarter. Citadel Advisors LLC purchased a new stake in Utah Medical Products stock in Q4 for approximately $233,000. Finally, State Street Corp increased its stake in Utah Medical Products shares by 2.4% in the 4th quarter. State Street Corp now owns 68,934 shares of the medical device supplier worth $6,893,000 after buying an additional 1,599 shares in the last quarter. 71.44% of the shares are currently held by institutional investors.

About Utah Medical Products (Get a rating)

Utah Medical Products, Inc. develops, manufactures and distributes medical devices for the healthcare industry. The Company offers fetal monitoring accessories, vacuum assisted delivery systems and other labor and delivery tools; Respiratory hoods for newborns DISPOSA-HOOD; and DELTRAN PLUS blood pressure monitoring systems.

Read more

Dividend history for Utah Medical Products (NASDAQ:UTMD)



Receive daily news and reviews for Utah medical products – Enter your email address below to receive a concise daily summary of breaking news and analyst ratings for Utah Medical Products and related companies with MarketBeat.com’s free daily email newsletter.

read more
Medical products

Innovative Electrocardiogram Electrodes Market Strategy by 2030 | 3M, Shandong Intco Medical Products Corporation Ltd.

Global Electrocardiogram electrodes The market report is an objective and in-depth study of the current state aimed at the main drivers, strategies of the Electrocardiogram Electrodes market and the growth of the key Electrocardiogram Electrodes players. The Electrocardiogram Electrodes study also involves the significant achievements of the Electrocardiogram Electrodes market, the research and development of the Electrocardiogram Electrodes, the launch of the new product of the Electrocardiogram Electrodes, the responses of the Electrocardiogram Electrodes products Electrocardiogram Electrodes and the regional growth of the Electrocardiogram Electrodes industry of the major competitors operating in the market on a universal and local basis. scale. The structured analysis contains a graphical and schematic representation of the global Electrocardiogram Electrodes market with its specific geographical regions.

[Duetothepandemi[email protected][Enraisondelapandémienousavonsinclusunesectionspécialesurl’impactpré[email protected][Duetothepandemi[email protected]Market that would mention how Covid-19 affects EKG electrodes

Get Sample Copy of EKG Leads Report @ jcmarketresearch.com/report-details/1411744/sample

** Values ​​marked with an XX are confidential data. To learn more about the Electrocardiogram Electrodes industry CAGR figures, fill in your information so that our JCMR Business Development Manager can contact you.

Global Electrocardiogram Electrodes Market (Thousand Units) and Revenue (USD Million) Breakdown by Coverage:-

By Type – Fabric Materials – Foam Materials – Tape Materials By Application – Hospital – Clinic – Others

The Electrocardiogram Electrodes research study is segmented by Application such as Laboratory, Electrocardiogram Electrodes Industrial Use, Electrocardiogram Electrodes Utilities and Others with historical and projected market share and a compound annual growth rate.
Global Electrocardiogram Electrodes by Region (2022-2030)

Electrocardiogram Electrodes Market Segmentation By Regions 2015 2017 2019 2020 CAGR (%) (2022-2030)
North America xx xx xx xx% xx%
Europe xx xx xx xx% xx%
AEM xx xx xx xx% xx%
APAC and rest of the world xx xx xx xx% xx%
Total xx xx xx xx% xx%

Geographically, this Electrocardiogram Electrodes report is segmented into several key Regions, with production, consumption, revenue (Million USD) and Electrocardiogram Electrodes market share and growth rate of Electrocardiogram Electrodes electrocardiogram in these regions, from 2015 to 2030 (forecast) covering.

Additionally, EKG electrode export and import policies can have an immediate impact on EKG electrodes. This Electrocardiogram Electrodes study contains a chapter related to EXIM* on Electrocardiogram Electrodes Market and all its associated companies with their profiles, which provides valuable data regarding their prospects in terms of Electrodes industry finances electrocardiogram, electrocardiogram electrodes product portfolios, electrocardiogram electrodes investment plans, and electrocardiogram electrodes marketing and electrocardiogram electrodes business strategies. The Electrocardiogram Electrodes report is an important document for all market enthusiasts, decision makers, investors, and players.

Answers to Key Questions in this Electrocardiogram Electrodes Industry Report – 2030 Data Survey Report

What will be the size of the EKG market in 2030 and what will be its growth rate?
What are the key trends in the Electrocardiogram Electrodes market?
What drives the electrocardiogram electrodes?
What are the growth challenges of the Electrocardiogram Electrodes market?
Who are the main suppliers of electrocardiogram electrodes in space?
What are the key market trends impacting the growth of Electrocardiogram Electrodes?
What are the main results of the analysis of the five forces of electrocardiogram electrodes?

Get Attractive Discount on Electrocardiogram Electrodes Report with Additional Customization @ jcmarketresearch.com/report-details/1411744/discount

There are 15 chapters to display the electrocardiogram electrodes.

Chapter 1, to describe Definition, Specification and Classification of Electrocardiogram Electrodes, Applications of Electrocardiogram Electrodes, Market Segment by Regions;

Chapter 2, to analyze Electrocardiogram Electrodes manufacturing cost structure, Electrocardiogram Electrodes raw materials and suppliers, Electrocardiogram Electrodes manufacturing process, Electrodes industry chain structure electrocardiogram;

Chapter 3, to view the Technical Data and Manufacturing Plants Analysis of Electrocardiogram electrodesEKG electrodes commercial production capacity and date, EKG electrodes manufacturing plant distribution, EKG electrodes R&D status and technology source, EKG electrodes raw material source analysis;

Chapter 4, to show the Global Electrocardiogram Electrodes Market Analysis, Capacity Analysis of Electrocardiogram Electrodes (Company Segment), Electrocardiogram Electrodes Sales Analysis (Company Segment), Company), Electrocardiogram Electrode Sales Price Analysis (Company Segment);

Chapter 5 and 6, to show the Regional Electrocardiogram Electrodes Market Analysis that includes North America, Europe, Asia-Pacific etc, the Electrocardiogram Electrodes Segment Market Analysis electrocardiogram by various segments;

Chapter 7 and 8, to analyze the Electrocardiogram Electrodes Segment Market Analysis (by Application) Major Manufacturers Analysis of Electrocardiogram Electrodes;

Chapter 9, Electrocardiogram Electrodes Market Trend Analysis, Regional Market Trend, Market Trend by Product Types, Market Trend by Applications;

Chapter 10, Electrocardiogram Electrodes Regional Marketing Type Analysis, Electrocardiogram Electrodes International Trade Type Analysis, Electrocardiogram Electrodes Supply Chain Analysis;

Chapter 11, to analyze the Consumers Analysis of Electrocardiogram Electrodes;

Chapter 12, to describe Electrocardiogram Electrodes Research Findings and Conclusion, Appendix, methodology and data source;

Chapter 13, 14 and 15, to describe sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source.

Buy Instant Copy of Full Electrocardiogram Electrodes Research Report: @ jcmarketresearch.com/checkout/1411744

Find more research reports on Electrocardiogram electrode industry. By JC Market Research.

Thank you for reading this article; you can also get individual chapter wise section or region wise report version like North America, Europe or Asia.

About the Author:
JCMR’s global research and market intelligence consulting organization is uniquely positioned to not only identify growth opportunities, but also to empower and inspire you to create visionary growth strategies for the future, through our extraordinary depth and breadth of thought leadership, research, tools, events and experience. that help you make goals a reality. Our understanding of the interplay between industry convergence, megatrends, technologies and market trends provides our clients with new business models and opportunities for expansion. We are focused on identifying the “Accurate Forecast” in each industry we cover so that our clients can reap the benefits of being early market entrants and can achieve their “Goals and Objectives”.

Contact us:
JCMARKETRESEARCH
Mark Baxter (Business Development Manager)
Call:
+1 (925) 478-7203
Email: [email protected]

Connect with us at – LinkedIn

read more
Medical products

Precision Medical Products Announces Steven Ingel as New CEO


We have not been able to process your request. Please try again later. If you continue to have this problem, please contact [email protected]

Precision Medical Products Inc. announced Steven Ingel as the new president and CEO, according to a press release.

Ingel has over 30 years of experience in healthcare, having held several positions in sales, marketing, operations and solutions for Enovis – formerly DJO Global. Ingel succeeds Jeremy Perkins, who will remain with the company as executive chairman of the board.

“I am honored to have the opportunity to lead Precision Medical and to begin working with its exceptional leadership team and talented organization of professionals,” Ingel said in the statement. “There are tremendous opportunities ahead given the company’s existing technologies, robust pipeline and manufacturing platforms, and I look forward to leading its next stage of growth. Together with Jeremy and the team, I am confident that we can continue to set the standards of excellence and drive industry innovation for our customers, patients and employees,” added Ingel.

“Steve Ingel brings extensive medical device and digital health experience with a proven track record of driving growth, margin expansion and overall financial performance,” Perkins said in the release. “His broad and deep industry experience, combined with his respected leadership and team spirit, make him the perfect fit to continue our important work at Precision Medical.”

read more
Medical products

Allied Corp. enters into a sales agreement with a Brazilian distributor of medical products

Canadian cannabis producer Allied company. (OTCQB: ALID) added another list of sales contract recipients for its BC-grown pot.

On Wednesday, the Kelowna-based company announced that under the purchase agreement, US$147,000 of its products would go each month to an unnamed Brazilian distributor who would deliver medical products to Israelita Albert Einstein Hospital in São Paulo.

Cannabis products are intended for thousands of Brazilians undergoing cancer treatment. The sales agreement took four months to approve due to product review, manufacturing specifications and testing.

The company plans to send the first monthly shipments under the contract starting in May this year.

Shares of the company fell 8.3% on Wednesday to US$0.78 on the OTC market.

Albert Einstein Hospital in São Paulo. Photo by Lukaaz–Marcelo via Wikimedia Commons

Read more: Allied Corp. exports dried flowers grown in Colombia to Australia and the United States

Read more: Allied Corp. will send 1 million euros worth of cannabis to its Australian partner

The Israelita Albert Einstein Hospital in São Paulo was founded in 1971 with the mission of providing quality health care, generating knowledge and promoting social responsibility. He specializes in providing complex treatments in oncology and neurology.

According to Forbes, it is among the top 20 hospitals in the world.

The hospital’s research and education institute has already trained around 130,000 professionals and conducts hundreds of studies each year.

Allied’s products will be offered specifically to patients undergoing cancer and neurological treatments.

“With over 200 million people, Brazil is an obvious market for us at Allied. Quality, flavor profiles and supply chain integrity were all considered in bringing the Brazilian partner and Allied together under this agreement,” said Allied CEO Calum. Hughes, in a statement.

“The rigorous review process that Allied underwent in order to meet the standard for a customer of this caliber again demonstrates our manufacturing competence and knowledge of international regulatory compliance,” he said, adding that the revenue this generates will only fuel their future growth. .

Follow Mugglehead on Twitter

Like Mugglehead on Facebook

Follow Natalia Buendia Calvillo on Twitter

[email protected]

read more
Medical products

Veress Needle Market Size, Scope and Outlook

New Jersey, United States – The study is a professional and comprehensive assessment of the Veress needle market with an emphasis on in-depth analysis of market data. The purpose of the study is to provide a quick understanding of the business along with a comprehensive categorization of the Veress Needles market by type, activity, end-use, and region. The study provides specific market statistics for major manufacturers and distributors, as well as an analysis of the outlook for the industry in general. The study examines the global Veress Needles market by considering supply and demand and identifies the variables that will influence the Veress Needles market in each region during the projection period. On the consumer side, market trends, limitations and opportunities as well as an assessment of consumer development are examined.

The study discusses the elements driving the global Veress needles market. Traders and investors can use this data to strategize to increase their market share, and newcomers can use it to locate opportunities and grow in the business. There are also some restrictions on expanding this market. The Veress Needle Market study also provides company biographies, SWOT analysis and business strategies for key industry players. Additionally, the research focuses on major industry players, providing details such as company descriptions, skills, current finances, and company advancements.

Get Sample Full PDF Copy of Report: (Including Full Table of Contents, List of Tables and Figures, Chart) @ https://www.verifiedmarketresearch.com/download-sample/?rid=212073

Key Players Mentioned in the Veress Needle Market Research Report:

CONMED, Fairmont Medical Products Pty Ltd, GRI-Alleset, Grena Ltd., 3-Dmed, Advin Health Care, Changzhou Ankang Medical Instruments Co., Ltd., Duomed Group, Endomed Systems GmbH, Zhejiang Geyi Medical Instrument Co., Ltd. , LOCAMED LIMITED.

Market factors could use prospect information to attract informed prospects in underdeveloped countries. The analysis covers sales, revenue, annual growth and market share of Veress Needle in the global market for the past and future years. Figures for the past year and subsequent years show the sales, revenue, growth rate and customer base of each industry. Veress Needle Market Research has published a report that examines the key physical and chemical growth methodologies employed by companies in the Veress Needle market. Product launches, product endorsements, and intellectual property strategies were among the most common tactics for sustained growth. Partnerships, collaborations and alliances were among the most important tactics for business expansion. Veress Needle Market participants were able to increase their business through these actions.

Segmentation of the Veress needle market:

Veress Needles Market, By Type

• 120mm
• 150mm
• Others

Veress Needles Market, By Application

• Gynecological surgery
• Urological surgery
• General surgery

Get a discount on the purchase of this report @ https://www.verifiedmarketresearch.com/ask-for-discount/?rid=212073

Scope of the Veress Needles Market Report

ATTRIBUTES DETAILS
ESTIMATED YEAR 2022
YEAR OF REFERENCE 2021
FORECAST YEAR 2029
HISTORICAL YEAR 2020
UNITY Value (million USD/billion)
SECTORS COVERED Types, applications, end users, and more.
REPORT COVER Revenue Forecast, Business Ranking, Competitive Landscape, Growth Factors and Trends
BY REGION North America, Europe, Asia-Pacific, Latin America, Middle East and Africa
CUSTOMIZATION SCOPE Free report customization (equivalent to up to 4 analyst business days) with purchase. Added or changed country, region and segment scope.

Determining the pulse of the market becomes easy with this detailed analysis of the Veress Needle market. Key players can find all competitive data and market size of major regions like North America, Europe, Latin America, Asia-Pacific and Middle East. As part of the competitive analysis, certain strategies are profiled which are pursued by key players such as mergers, collaborations, acquisitions and new product launches. These strategies will greatly help industry players to strengthen their position in the market and grow their business.

Answers to key questions in the report:

1. Who are the top five players in the Veress Needle market?

2. How will the Veress needle market evolve over the next five years?

3. Which product and application will occupy the lion’s share of the Veress needle market?

4. What are the drivers and restraints of the Veress Needle Market?

5. Which regional market will show the strongest growth?

6. What will be the CAGR and size of the Veress Needle market throughout the forecast period?

For more information or query or customization before buying, visit @ https://www.verifiedmarketresearch.com/product/veress-needle-market/

Visualize the Veress Needle Market Using Verified Market Intelligence:-

Verified Market Intelligence is our BI platform for market narrative storytelling. VMI offers in-depth forecast trends and accurate insights on over 20,000 emerging and niche markets, helping you make critical revenue-impacting decisions for a bright future.

VMI provides a global overview and competitive landscape with respect to region, country and segment, as well as key players in your market. Present your market report and findings with an integrated presentation feature that saves you over 70% of your time and resources for presentations to investors, sales and marketing, R&D and development of products. VMI enables data delivery in Excel and interactive PDF formats with over 15+ key market indicators for your market.

Visualize the Veress needle market using [email protected] https://www.verifiedmarketresearch.com/vmintelligence/

About Us: Verified Market Research®

Verified Market Research® is a leading global research and advisory firm that for over 10 years has provided advanced analytical research solutions, personalized advice and in-depth data analysis to individuals and businesses seeking accurate research, reliable and up to date. data and technical advice. We provide insight into strategic and growth analytics, the data needed to achieve business goals, and help make critical revenue decisions.

Our research studies help our clients make superior data-driven decisions, understand market forecasts, capitalize on future opportunities, and maximize efficiency by working as a partner to deliver accurate and valuable insights. The industries we cover span a wide spectrum, including technology, chemicals, manufacturing, energy, food and beverage, automotive, robotics, packaging, construction, mining and the gas. Etc.

At Verified Market Research, we help in understanding holistic market indicator factors and most current and future market trends. Our analysts, with their deep expertise in data collection and governance, use industry techniques to gather and review data at all stages. They are trained to combine modern data collection techniques, superior research methodology, subject matter expertise and years of collective experience to produce informative and accurate research.

Having served over 5000 clients, we have provided reliable market research services to over 100 Global Fortune 500 companies such as Amazon, Dell, IBM, Shell, Exxon Mobil, General Electric, Siemens, Microsoft, Sony and Hitachi. We have co-consulted with some of the world’s leading consulting firms such as McKinsey & Company, Boston Consulting Group, Bain and Company for custom research and consulting projects for companies around the world.

Contact us:

Mr. Edwyne Fernandes

Verified Market Research®

USA: +1 (650)-781-4080
UK: +44 (753)-715-0008
APAC: +61 (488)-85-9400
US toll free: +1 (800)-782-1768

E-mail: [email protected]

Website:- https://www.verifiedmarketresearch.com/

read more
Medical products

Benefits of medical products shares on April 28: TMO, BIO and more

The first quarter earnings season for the Medical sector started last week. The last Revenue overview reflects a strong year-over-year improvement in quarterly performance so far in this reporting cycle. According to the industry scorecard, 7% of companies in the medical sector, constituting nearly 27.6% of the sector’s market capitalization, reported profits through April 22. Of these, 100% beat earnings estimates and 75% beat the same for revenue. Profits rose 8.4% year over year on the back of revenue up 13.5%.

This dashboard reflects the current stability in the United States on the continued economic reopening. However, a number of MedTech players faced severe staff shortages and supply chain vagaries in the first quarter, thanks to the emergence of new COVID variants.

Overall, first-quarter medical profits are expected to rise 10.3% on a 13.3% increase in sales. That compares to reported earnings growth of 27.8% and revenue growth of 14.3% in the fourth quarter. It is worth mentioning that the medical sector is expected to be one of the nine sectors that are expected to register profit growth in the first quarter of 2022.

Quarterly summary of medical products

An integral part of the broader medical industry, Zacks’ definition Medical products Collective growth in business activity is expected to have improved compared to last year, with a significant increase in the vaccination campaign and a reduction in COVID-related deaths in the United States and other developed countries. The dynamic nature of the COVID-19 crisis has been a roller coaster ride for the medical products industry over the past few months.

In the recent past, companies in this space had experienced a sharp decline in their core business. However, results for the majority of medical product stocks have so far shown accelerated growth in non-COVID business in the first quarter months compared to 2020 on a reduction in the severity of COVID-19 despite the emergence new virus variants. Overall, the recovery of the companies’ legacy core business during the first quarter months was impressive. Medical product companies like Thermo Fisher Scientific OMT, Bio-Rad Laboratories ORGANIC, LabCorp HL and ResMed RMD is likely to have been impacted by these factors in the first quarter.

It should be mentioned here that disruptions in the form of the emergence of more contagious COVID-19 variants like Delta, Omicron and XE are still evident in many developed countries. A number of MedTech players faced severe staffing shortages and supply chain uncertainties during the first quarter months. As a result, many industry players have witnessed a decline in their business performance on a sequential basis.

In addition, first-quarter results from diagnostic testing companies showed lower demand for testing so far, due to declining cases, which has dampened business growth for many companies.

Let’s take a look at four Medical Products players who are due to announce their results on April 28th.

Thermo Fisher Scientific: During the first quarter months, Thermo Fisher’s analytical instruments segment should have generated strong sales thanks to the flourishing electron microscopy, chromatography and mass spectrometry businesses. The company is expected to record growth driven by a favorable business mix and a strong increase in volumes and productivity enabled by the PPI trading system. (Read more: Thermo Fisher to Release First Quarter Results: What’s in Store?)

Zacks’ consensus estimate for total revenue of $10.63 billion for the first quarter suggests a 7.3% increase over the reported figure for the year-ago quarter. The consensus mark for Thermo Fisher’s earnings of $6.17 per share indicates a decline of 14.4% from the reported figure for the year-ago quarter.

According to our proven model, a title with the combination of a positive effect ESP Earnings and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) has a good chance of beating the estimates. However, this is not the case as you can see below.

TMO has an ESP on earnings of -1.20% and carries a Zacks rank #3. You can discover the best stocks to buy or sell before they’re flagged with our Income ESP filter.

Thermo Fisher Scientific Inc. Prize and EPS Surprise

Thermo Fisher Scientific Inc. price-eps-surprise | Quote from Thermo Fisher Scientific Inc.

You can see the full list of today’s Zacks #1 Rank stocks here.

Bio-Rad Laboratories: Bio-Rad’s life sciences segment has seen robust revenue growth in recent quarters. We expect this growth momentum to continue in the first quarter thanks to continued sales growth in the Polymerase Chain Reaction (PCR), Droplet Digital PCR (dPCR), Process Media and Western Blot businesses. The company also saw strong growth in the biopharmaceutical market for the Droplet Digital PCR platform, which is expected to have made a significant contribution to first quarter revenue. (Read more: Bio-Rad to Report First Quarter Results: What’s in the Charts?)

Zacks’ consensus estimate for Bio-Rad’s first-quarter revenue is set at $678 million, implying a 6.7% decline from the prior year’s figure. The consensus estimate for earnings per share is set at $2.80, suggesting a decline of 46.3% from the figure reported the previous year.

BIO has a Gain ESP of 0.00% and a Zacks Rank #3.

BioRad Laboratories, Inc. EPS Awards and Surprise

BioRad Laboratories, Inc. EPS Awards and Surprise

BioRad Laboratories, Inc. price-eps-surprise | BioRad Laboratories, Inc. Quote

LabCorp: LabCorp recorded a continued rebound in sales in the core business for the Diagnostics and Drug Development segments. However, as the effects of the pandemic fade, we expect demand for COVID-19 testing services to gradually decline, which will impact first quarter sales performance. In the fourth quarter of 2021, the company reported higher adjusted operating income and improved margins within the core business, given organic growth and LaunchPad savings. According to the fourth quarter earnings call, the company has implemented a new LaunchPad business process improvement initiative, which is expected to generate $350 million in savings over the next three years. The new initiative is expected to have helped the company’s margin in the first quarter. (Read more: LabCorp to Report First Quarter Results: What’s in the Cards?)

Zacks’ consensus estimate for first-quarter earnings of $5.88 a share implies a 33.1% drop from the figure reported a year ago. The consensus revenue estimate is set at $4.04 billion, suggesting a 2.9% drop from the figure reported the previous year.

LH has an ESP on Earnings of -0.22% and a #3 Zacks Rank.

Laboratory Corporation of America Holdings award and EPS surprise

Laboratory Corporation of America Holdings award and EPS surprise

Laboratory Corporation of America Holdings price-eps-surprise | Quote from Laboratory Corporation of America Holdings

ResMed: ResMed is expected to have benefited in the third quarter of fiscal 2022 from increased demand for sleep and respiratory care devices thanks to the steady recovery of markets following the impacts of COVID-19 and the recall of products from a competitor. The growth of home medical equipment and home care facilities should have contributed to the revenue growth of the SaaS business. Continued robust adoption of ResMed’s AirSense 10 and AirSense 11 platforms reinforces optimism for the company. These developments likely contributed to the company’s revenue in the upcoming quarter.

Zacks consensus estimate for its fiscal third quarter earnings per share is set at $1.44. Revenue is expected to be $908.7 million.

RMD has an ESP of 0.00% and Zacks Rank #3.

ResMed Inc. Award and EPS Surprise

ResMed Inc. Award and EPS Surprise

ResMed Inc. price-eps-surprise | Quote ResMed Inc.

Stay up to date with upcoming results announcements with the Zacks Earnings Schedule.

Zacks names ‘only one best choice for doubling up’

From thousands of stocks, 5 Zacks experts have each picked their favorite to skyrocket by +100% or more in the coming months. Of these 5, Research Director Sheraz Mian selects one to have the most explosive advantage of all.

It’s a little-known chemical company that’s up 65% year-on-year, but still very cheap. With relentless demand, rising earnings estimates for 2022 and $1.5 billion for stock buybacks, retail investors could jump in at any moment.

This company could rival or surpass other recent Zacks stocks which are expected to double, such as Boston Beer Company which jumped +143.0% in just over 9 months and NVIDIA which jumped +175.9% in one. year.

Free: See our best stock and our 4 finalists >>

Click to get this free report

Laboratory Corporation of America Holdings (LH): Free Stock Analysis Report

Thermo Fisher Scientific Inc. (TMO): Free Inventory Analysis Report

ResMed Inc. (RMD): Free Stock Analysis Report

BioRad Laboratories, Inc. (BIO): Free Stock Analysis Report

To read this article on Zacks.com, click here.

Zacks Investment Research

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

read more
Medical products

Dukal, McKesson Medical-Surgical, DYNAREX, Allmed Medical Products, RICHMOND DENTAL & MEDICAL, – Tiorienteering

the Nonwoven Sponge Market offers an in-depth study of a wide range of features and strategies, as well as potential and future trends. This market study provides a top to bottom assessment of the major global players in the industry. The segmentation is accompanied by tables, graphs and data. This segmentation includes all aspects of the market, from manufacturing to distribution, as well as a behavioral profile of end users. Forecasters have reviewed the Nonwoven Sponge report to learn about market trends and other important details. The Nonwoven Sponge market research provides a complete picture of the target market. Market value and growth rate are assessed along with market size estimates.

Competition Spectrum:
Dukal
McKesson Medical-Surgical
DYNAREX
Allmed medical products
RICHMOND DENTAL AND MEDICAL
InjurySource
Medline Industries
STS Medical Group
Cardinal Health
Medical action
Medical Group Winner
AnQing Jiaxin Medical Technology
Suzhou Upstream Medical Products

This report examines the competitive landscape of the industry and gives information about the products offered by various companies to help clients improve their position in the market. Likewise, this Nonwoven Sponges market study includes insights into current trends and challenges that might hinder the expansion of the market. This will help businesses design strategies to maximize their growth potential. All the elements necessary for your research inquiry are included in the study. Historical and forecasted market statistics, demand, application information, pricing, and regional trends are all covered in the market report. The study supports and addresses a variety of significant challenges, including sourcing and utilizing different growth prospects, among market players such as end users, companies, and distributors.

We have recent updates of the Nonwoven Sponges market in the sample [email protected] https://www.orbisresearch.com/contacts/request-sample/6679056?utm_source=PoojaGIRMe

For the forecast period, the study contains market estimates and forecasts in million tons by region and country, along with market share changes in major geographies. The Nonwoven Sponges Market study examines a variety of highly profitable industries which are impacting the growth of the market. This research piece was created using primary research interviews, structured assessment, and high school data. The Nonwoven Sponges Market analysis report offers in-depth information on market shares, trends and growth. The report also includes expert advice to help customers improve their implementation practices and make the best possible decisions.

The market is roughly divided into:

• Analysis by product type:
Sterile nonwoven sponge
Non-sterile non-woven sponge

• Analysis of applications:
Online sales
Offline sales

• Segmentation by region with details on country-specific developments
North America (United States, Canada, Mexico)
Europe (UK, France, Germany, Spain, Italy, Central and Eastern Europe, CIS)
Asia Pacific (China, Japan, South Korea, ASEAN, India, Rest of Asia Pacific)
Latin America (Brazil, Rest of LA)
Middle East and Africa (Turkey, GCC, Rest of Middle East)

Contents
Chapter One: Presentation of the Report
1.1 Scope of the study
1.2 Key Market Segments
1.3 Players Covered: Nonwoven Sponge Revenue Ranking
1.4 Market Analysis by Type
1.4.1 Nonwoven Sponges Market Size Growth Rate by Type: 2020 VS 2028
1.5 Market by Application
1.5.1 Nonwoven Sponge Market Share by Application: 2020 VS 2028
1.6 Objectives of the study
1.7 years considered

Chapter Two: Growth Trends by Regions
2.1 Nonwoven Sponges Market Outlook (2015-2028)
2.2 Nonwoven Sponge Growth Trends by Regions
2.2.1 Nonwoven Sponges Market Size by Regions: 2015 VS 2020 VS 2028
2.2.2 Nonwoven Sponge Historic Market Share by Regions (2015-2020)
2.2.3 Forecasted Market Size of Nonwoven Sponges by Regions (2021-2028)
2.3 Industry Trends and Growth Strategy
2.3.1 Key Market Trends
2.3.2 Market Drivers
2.3.3 Market challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Nonwoven Sponges Market Growth Strategy
2.3.6 Primary Interviews with Key Nonwoven Sponge Players (Opinion Leaders)

Chapter Three: Competition Landscape by Key Players
3.1 Nonwoven Sponge Key Players by Market Size
3.1.1 Top Nonwoven Sponge Players by Revenue (2015-2020)
3.1.2 Nonwoven Sponge Revenue Market Share by Players (2015-2020)
3.1.3 Nonwoven Sponge Market Share by Company Type (Tier 1, Tier Two Chapter: and Tier 3)
3.2 Nonwoven Sponge Market Concentration Ratio
3.2.1 Nonwoven Sponge Market Concentration Ratio (Chapter Five: and HHI)
3.2.2 Top Chapter Ten: and Top 5 Companies by Non-woven Sponge Revenue in 2020
3.3 Nonwoven Fabrics Key Players Head office and Area Served
3.4 Key Players Nonwoven Sponge Product Solution and Service
3.5 Date of Enter into Nonwoven Sponges Market
3.6 Mergers and acquisitions, expansion plans

Do you have a specific question or requirement? Ask our industry [email protected] https://www.orbisresearch.com/contacts/enquiry-before-buying/6679056?utm_source=PoojaGIRMe

Key points covered in the Nonwoven Sponge market report:
• Complete profiles of major companies in the nonwoven sponge industry.
• An in-depth examination of innovation and other industry developments in the Nonwoven Sponge market.
• In-depth industry value chain and supply chain review
• An in-depth review of key growth drivers, limitations, challenges and development opportunities.
• Identify and assess growth opportunities in key industries and economies.

Reasons to buy this report:
• Reduce opportunities for growth, dangers and valid solutions by examining production techniques, main challenges and valid remedies.
• Obtain an in-depth market analysis along with a comprehensive understanding of Nonwoven Sponges industry trends and commercial landscape.
• Know the production techniques, major problems and solutions.

About Us:
Orbis Research (orbisresearch.com) is a one-stop-shop for all your market research needs. We have an extensive database of reports from leading publishers and authors around the world. We specialize in delivering customized reports according to our clients’ requirements. We have complete information about our publishers and therefore are sure of the accuracy of the industries and verticals of their specialization. This helps our clients map their needs and we produce the perfect market research required for our clients.

Contact us:
Hector Costello
Senior Client Engagement Manager
Central Highway 4144N,
Suite 600, Dallas,
Texas 75204, United States
Telephone number: United States: +1 (972)-362-8199 | IND: +91 895 659 5155

read more
Medical products

Personal Mobility Devices Market Size, Scope and Outlook

New Jersey, United States – The study is a professional and comprehensive assessment of the personal mobility device market with an emphasis on in-depth analysis of market data. The aim of the study is to provide a quick understanding of the business along with a comprehensive categorization of the Personal Mobility Devices market by type, activity, end-use, and region. The study provides specific market statistics for major manufacturers and distributors, as well as an analysis of the outlook for the industry in general. The study examines the global personal mobility device market considering supply and demand and identifies the variables that will influence the personal mobility device market in each region during the projection period. On the consumer side, market trends, limitations and opportunities as well as an assessment of consumer development are examined.

The study discusses the elements driving the global personal mobility device market. Traders and investors can use this data to strategize to increase their market share, and newcomers can use it to locate opportunities and grow in the business. There are also some restrictions on expanding this market. The Personal Mobility Devices market study also provides company biographies, SWOT analysis and business strategies for key industry players. Additionally, the research focuses on major industry players, providing details such as company descriptions, skills, current finances, and company advancements.

Get Sample Full PDF Copy of Report: (Including Full TOC, List of Tables & Figures, Chart) @ https://www.verifiedmarketresearch.com/download-sample/?rid=37564

Key Players Mentioned in the Personal Mobility Devices Market Research Report:

NOVA Medical Products, Performance Health, Drive DeVilbiss Healthcare, Medline Industries Invacare Corporation, Carex Health Brands Kaye Products Rollz International, GF HEALTH PRODUCTS and Briggs Healthcare

Market factors could use prospect information to attract informed prospects in underdeveloped countries. The analysis covers sales, revenue, annual growth and market share of personal mobility devices in the global market for the past and future years. Figures for the past year and subsequent years show the sales, revenue, growth rate and customer base of each industry. Personal Mobility Devices Market research has published a report that examines the key physical and chemical growth methodologies employed by companies in the Personal Mobility Devices market. Product launches, product endorsements, and intellectual property strategies were among the most common tactics for sustained growth. Partnerships, collaborations and alliances were among the most important tactics for business expansion. Participants in the personal mobility device market have been able to increase their business due to these actions.

Personal Mobility Devices Market Segmentation:

Personal Mobility Devices Market, By Product

• Wheel chairs
• Scooters
• Walking aids

Get a discount on the purchase of this report @ https://www.verifiedmarketresearch.com/ask-for-discount/?rid=37564

Scope of the Personal Mobility Devices Market Report

ATTRIBUTES DETAILS
ESTIMATED YEAR 2022
YEAR OF REFERENCE 2021
FORECAST YEAR 2029
HISTORICAL YEAR 2020
UNITY Value (million USD/billion)
SECTORS COVERED Types, applications, end users, and more.
REPORT COVER Revenue Forecast, Business Ranking, Competitive Landscape, Growth Factors and Trends
BY REGION North America, Europe, Asia-Pacific, Latin America, Middle East and Africa
CUSTOMIZATION SCOPE Free report customization (equivalent to up to 4 analyst business days) with purchase. Added or changed country, region and segment scope.

It becomes easy to determine the pulse of the market with this detailed analysis of the Personal Mobility Devices market. Key players can find all competitive data and market size of major regions like North America, Europe, Latin America, Asia-Pacific and Middle East. As part of the competitive analysis, certain strategies are profiled which are pursued by key players such as mergers, collaborations, acquisitions and new product launches. These strategies will greatly help industry players to strengthen their position in the market and grow their business.

Answers to key questions in the report:

1. Who are the top five players in the personal mobility device market?

2. How will the personal mobility device market evolve in the next five years?

3. Which products and applications will capture the lion’s share of the personal mobility device market?

4. What are the drivers and restraints of the Personal Mobility Devices Market?

5. Which regional market will show the strongest growth?

6. What will be the CAGR and size of the Personal Mobility Devices market throughout the forecast period?

For more information or query or customization before buying, visit @ https://www.verifiedmarketresearch.com/product/personal-mobility-devices-market/

Visualize the Personal Mobility Devices Market Using Verified Market Intelligence:-

Verified Market Intelligence is our BI platform for market narrative storytelling. VMI offers in-depth forecast trends and accurate insights on over 20,000 emerging and niche markets, helping you make critical revenue-impacting decisions for a bright future.

VMI provides a comprehensive overview and global competitive landscape with respect to region, country, and segment, as well as key players in your market. Present your market report and results with an integrated presentation function that saves you more than 70% of your time and resources for presentations to investors, sales and marketing, R&D and product development. products. VMI enables data delivery in Excel and interactive PDF formats with over 15+ key market indicators for your market.

Visualize the Personal Mobility Devices Market using [email protected] https://www.verifiedmarketresearch.com/vmintelligence/

About Us: Verified Market Research®

Verified Market Research® is a leading global research and advisory firm that for over 10 years has provided advanced analytical research solutions, personalized advice and in-depth data analysis to individuals and businesses seeking accurate research, reliable and up to date. data and technical advice. We provide insight into strategic and growth analytics, the data needed to achieve business goals, and help make critical revenue decisions.

Our research studies help our clients make superior data-driven decisions, understand market forecasts, capitalize on future opportunities, and maximize efficiency by working as a partner to deliver accurate and valuable insights. The industries we cover span a wide spectrum, including technology, chemicals, manufacturing, energy, food and beverage, automotive, robotics, packaging, construction, mining and the gas. Etc.

At Verified Market Research, we help in understanding holistic market indicator factors and most current and future market trends. Our analysts, with their deep expertise in data collection and governance, use industry techniques to gather and review data at all stages. They are trained to combine modern data collection techniques, superior research methodology, subject matter expertise and years of collective experience to produce informative and accurate research.

Having served over 5000 clients, we have provided reliable market research services to over 100 Global Fortune 500 companies such as Amazon, Dell, IBM, Shell, Exxon Mobil, General Electric, Siemens, Microsoft, Sony and Hitachi. We have co-consulted with some of the world’s leading consulting firms such as McKinsey & Company, Boston Consulting Group, Bain and Company for custom research and consulting projects for companies around the world.

Contact us:

Mr. Edwyne Fernandes

Verified Market Research®

USA: +1 (650)-781-4080
UK: +44 (753)-715-0008
APAC: +61 (488)-85-9400
US toll free: +1 (800)-782-1768

E-mail: [email protected]

Website:- https://www.verifiedmarketresearch.com/

read more
Medical products

Life Wear Technologies donates over 62,000 units of supporting medical products to House of Ukraine

POMPANO BEACH, Florida–(BUSINESS WIRE)–Life Wear Technologies, a leading provider of private label and branded sports medicine products, is pleased to announce a charitable contribution to the House of Ukraine, Inc. a cultural museum in San Diego providing information to the public about the country of Ukraine.

The donation consisted of more than 62,000 medical product units including knee, ankle and wrist braces, back support, elastic bandages, heat, cold packs and more. Regularly reporting on cultural aspects of Ukraine including art, history, traditions and language, House of Ukraine is also currently accepting product donations including military supplies and aid kits to donate to local Ukrainians in kyiv and to refugees.

“As a mass producer in the first aid and pharmacy market, we didn’t hesitate to find a way to support Ukraine with the supplies we have,” said Bradley Waugh, president and CEO of the management of Life Wear Technologies. “We are grateful to be able to offer our products as a useful medical aid, and hope they will even bring a glimmer of relief to those in need.”

the House of Ukraine, Inc. is a member of the House of Pacific Relations International Cottages, Inc, (HPR), Balboa Park, San Diego, California, founded in 1935 and is a nonprofit community organization dedicated to fostering cooperation and understanding among national groups in United States .

Learn more about the House of Ukraine, as well as Life wear technologies can be found at their corresponding links.

About Life Wear Technologies:

Life Wear Technologies, LLC was established in 1974 as one of the first manufacturers of sports medicine products. The company began selling its products to athletic trainers, institutions, sporting goods retailers and professional teams throughout the US market.

After gaining notoriety as a leading sporting goods innovator, the company moved into the growing first aid and pharmacy market. In addition to health supports, Life Wear began manufacturing elastic bandages, athletic bands and eventually hot and cold therapy products to become the first single-source solution for private label sports medicine products.

Today, Life Wear Technologies, LLC is a leading supplier of private label and branded sports medicine products sold through the drug, food and mass merchant distribution chains.

read more
Medical products

Personal Mobility Devices Market Size and Forecast

New Jersey, United States – personal mobility device market Research Report provides you with detailed and accurate analysis to strengthen your position in the market. It provides the latest updates and powerful insights on the Personal Mobility Devices industry to help you improve your business strategy and ensure strong revenue growth for years to come. It elucidates the current and future market scenarios and lets you understand the competitive dynamics of the Personal Mobility Devices market. The market segmentation analysis provided in the research report shows the performance of different product segments, applications, and regions in the Personal Mobility Devices market.

The report includes validated and revalidated market data such as CAGR, gross margin, revenue, price, production growth rate, volume, value, market share and year-on-year growth on the other. We use the latest primary as well as secondary research techniques to compile this comprehensive Personal Mobility Devices Market report. As part of the regional analysis, we studied key markets such as North America, Europe, India, China, Japan and MEA. Profiles of leading companies are based on various factors including markets served, production, revenue, market share, recent developments, and gross profit margins. A section dedicated to market dynamics with in-depth analysis of drivers, restraints, opportunities, influencers, challenges and trends.

Get Sample Full PDF Copy of Report: (Including Full TOC, List of Tables & Figures, Chart) @ https://www.verifiedmarketresearch.com/download-sample/?rid=37564

Key Players Mentioned in the Personal Mobility Devices Market Research Report:

NOVA Medical Products, Performance Health, Drive DeVilbiss Healthcare, Medline Industries Invacare Corporation, Carex Health Brands Kaye Products Rollz International, GF HEALTH PRODUCTS and Briggs Healthcare

The report gives a good overview of the main macroeconomic factors that have a significant impact on the growth of the Personal Mobility Devices market. It also provides absolute dollar opportunity analysis which is essential for identifying opportunities for revenue generation and increasing sales in the Personal Mobility Devices market. Market players can use the qualitative and quantitative analysis provided in the report to fully understand the Personal Mobility Devices market and make great strides in the industry in terms of growth. The overall size of the Personal Mobility Devices market and the overall size of each segment studied in the report are precisely calculated based on various factors.

Personal Mobility Devices Market Segmentation:

Personal Mobility Devices Market, By Product

• Wheel chairs
• Scooters
• Walking aids

The report is the best compilation of different types of segmental analyzes of the Personal Mobility Devices Market performed from different perspectives. The analysts’ pragmatic approach to studying different market segments and top-down and bottom-up approaches to forecasting the size of their markets makes the Personal Mobility Devices research study unique and accurate. Reliable primary sources such as CTOs, Physicians, VPs, CEOs, and supply and demand side industry experts were consulted to validate and revalidate the market and market figures. ‘other information. Secondary sources such as Bloomberg, databases, white papers, press releases and company reports were used to collect market information and data.

Get a discount on the purchase of this report @ https://www.verifiedmarketresearch.com/ask-for-discount/?rid=37564

Scope of the Personal Mobility Devices Market Report

ATTRIBUTES DETAILS
ESTIMATED YEAR 2022
YEAR OF REFERENCE 2021
FORECAST YEAR 2029
HISTORICAL YEAR 2020
UNITY Value (million USD/billion)
SECTORS COVERED Types, applications, end users, and more.
REPORT COVER Revenue Forecast, Business Ranking, Competitive Landscape, Growth Factors and Trends
BY REGION North America, Europe, Asia-Pacific, Latin America, Middle East and Africa
CUSTOMIZATION SCOPE Free report customization (equivalent to up to 4 analyst business days) with purchase. Added or changed country, region and segment scope.

It becomes easy to determine the pulse of the market with this detailed analysis of the Personal Mobility Devices market. Key players can find all competitive data and market size of major regions like North America, Europe, Latin America, Asia-Pacific and Middle East. As part of the competitive analysis, certain strategies are profiled which are pursued by key players such as mergers, collaborations, acquisitions and new product launches. These strategies will greatly help industry players to strengthen their position in the market and grow their business.

Answers to key questions in the report:

1. Who are the top five players in the personal mobility device market?

2. How will the personal mobility device market evolve in the next five years?

3. Which products and applications will capture the lion’s share of the personal mobility device market?

4. What are the drivers and restraints of the Personal Mobility Devices Market?

5. Which regional market will show the strongest growth?

6. What will be the CAGR and size of the Personal Mobility Devices market throughout the forecast period?

For more information or query or customization before buying, visit @ https://www.verifiedmarketresearch.com/product/personal-mobility-devices-market/

Visualize the Personal Mobility Devices Market Using Verified Market Intelligence:-

Verified Market Intelligence is our BI platform for market narrative storytelling. VMI offers in-depth forecast trends and accurate insights on over 20,000 emerging and niche markets, helping you make critical revenue-impacting decisions for a bright future.

VMI provides a global overview and competitive landscape with respect to region, country and segment, as well as key players in your market. Present your market report and results with an integrated presentation function that saves you more than 70% of your time and resources for presentations to investors, sales and marketing, R&D and product development. products. VMI enables data delivery in Excel and interactive PDF formats with over 15+ key market indicators for your market.

Visualize the Personal Mobility Devices Market using [email protected] https://www.verifiedmarketresearch.com/vmintelligence/

About Us: Verified Market Research®

Verified Market Research® is a leading global research and advisory firm that for over 10 years has provided advanced analytical research solutions, personalized advice and in-depth data analysis to individuals and businesses seeking accurate research, reliable and up to date. data and technical advice. We provide insight into strategic and growth analytics, the data needed to achieve business goals, and help make critical revenue decisions.

Our research studies help our clients make superior data-driven decisions, understand market forecasts, capitalize on future opportunities, and maximize efficiency by working as a partner to deliver accurate and valuable insights. The industries we cover span a wide spectrum, including technology, chemicals, manufacturing, energy, food and beverage, automotive, robotics, packaging, construction, mining and the gas. Etc.

At Verified Market Research, we help in understanding holistic market indicator factors and most current and future market trends. Our analysts, with their deep expertise in data collection and governance, use industry techniques to gather and review data at all stages. They are trained to combine modern data collection techniques, superior research methodology, subject matter expertise and years of collective experience to produce informative and accurate research.

Having served over 5000 clients, we have provided reliable market research services to over 100 Global Fortune 500 companies such as Amazon, Dell, IBM, Shell, Exxon Mobil, General Electric, Siemens, Microsoft, Sony and Hitachi. We have co-consulted with some of the world’s leading consulting firms such as McKinsey & Company, Boston Consulting Group, Bain and Company for custom research and consulting projects for companies around the world.

Contact us:

Mr. Edwyne Fernandes

Verified Market Research®

USA: +1 (650)-781-4080
UK: +44 (753)-715-0008
APAC: +61 (488)-85-9400
US toll free: +1 (800)-782-1768

E-mail: [email protected]

Website:- https://www.verifiedmarketresearch.com/

read more
Medical products

Women’s Health Rehabilitation Products Market Size and Forecast

New Jersey, United States – Women’s Health Rehabilitation Products Market Research Report provides you with detailed and accurate analysis to strengthen your position in the market. It provides the latest updates and powerful insights on the Women’s Health Rehabilitation Products industry to help you improve your business strategy and ensure strong revenue growth for years to come. It elucidates the current and future market scenarios and allows you to understand the competitive dynamics of the Women’s Health Rehabilitation Products market. The market segmentation analysis provided in the research report shows the performance of different product segments, applications, and regions in the Women’s Health Rehabilitation Products market.

The report includes validated and revalidated market data such as CAGR, gross margin, revenue, price, production growth rate, volume, value, market share and year-on-year growth on the other. We use the latest primary as well as secondary research techniques to compile this comprehensive Women’s Health Rehabilitation Products Market report. As part of the regional analysis, we studied key markets such as North America, Europe, India, China, Japan and MEA. Profiles of leading companies are based on various factors including markets served, production, revenue, market share, recent developments, and gross profit margins. A section dedicated to market dynamics with in-depth analysis of drivers, restraints, opportunities, influencers, challenges and trends.

Get Sample Full PDF Copy of Report: (Including Full TOC, List of Tables & Figures, Chart) @ https://www.verifiedmarketresearch.com/download-sample/?rid=22158

Key Players Mentioned in the Women’s Health Rehabilitation Products Market Research Report:

Accord Medical Products, BSN medical, Carib Rehab, Cornerstone Chiropractic, DeRoyal, EMS Physio, GE Healthcare, GPC Medical, Meyer Physical Therapy, Midtown Chiropractic, PROSPINE Health and Injury Center, Pelvic Health and Rehabilitation, Pure Health Chiropractic, Sportstek, Win Health Medical, Zynex

The report gives a good overview of the main macroeconomic factors that have a significant impact on the growth of the Women’s Health Rehabilitation Products market. It also provides absolute dollar opportunity analysis which is essential for identifying opportunities to generate revenue and increase sales in the Women’s Health Rehabilitation Products market. Market players can use the qualitative and quantitative analysis provided in the report to fully understand the Women’s Health Rehabilitation Products market and make great strides in the industry in terms of growth. The overall size of the Women’s Health Rehabilitation Products market and the overall size of each segment studied in the report are precisely calculated based on various factors.

Women’s Health Rehabilitation Products Market Segmentation:

Women’s Health Rehabilitation Products Market by Product

• Orthopedic care
• Urinary incontinence
• Breast cancer care
• Pregnancy and postpartum care

Women’s Health Rehabilitation Products Market By Application

• Hospitals
• Clinics

The report is the best compilation of different types of Women’s Health Rehabilitation Products market segmental analysis done from different perspectives. The analysts’ pragmatic approach to studying different market segments and top-down and bottom-up approaches to forecasting their market sizes makes the Women’s Health Rehabilitation Products research study unique and accurate. Reliable primary sources such as CTOs, Physicians, VPs, CEOs, and supply and demand side industry experts were consulted to validate and revalidate the market and market figures. ‘other information. Secondary sources such as Bloomberg, databases, white papers, press releases and company reports were used to collect market information and data.

Get a discount on the purchase of this report @ https://www.verifiedmarketresearch.com/ask-for-discount/?rid=22158

Scope of the Women’s Health Rehabilitation Products Market Report

ATTRIBUTES DETAILS
ESTIMATED YEAR 2022
YEAR OF REFERENCE 2021
FORECAST YEAR 2029
HISTORICAL YEAR 2020
UNITY Value (million USD/billion)
SECTORS COVERED Types, applications, end users, and more.
REPORT COVER Revenue Forecast, Business Ranking, Competitive Landscape, Growth Factors and Trends
BY REGION North America, Europe, Asia-Pacific, Latin America, Middle East and Africa
CUSTOMIZATION SCOPE Free report customization (equivalent to up to 4 analyst business days) with purchase. Added or changed country, region and segment scope.

It becomes easy to determine the pulse of the market with this detailed analysis of the Women’s Health Rehabilitation Products Market. Key players can find all competitive data and market size of major regions like North America, Europe, Latin America, Asia-Pacific and Middle East. As part of the competitive analysis, certain strategies are profiled which are pursued by key players such as mergers, collaborations, acquisitions and new product launches. These strategies will greatly help industry players to strengthen their position in the market and grow their business.

Answers to key questions in the report:

1. Who are the top five players in the Women’s Health Rehabilitation Products Market?

2. How will the women’s health rehabilitation products market develop in the next five years?

3. Which product and application will occupy the lion’s share of the women’s health rehabilitation products market?

4. What are the drivers and restraints of the Women’s Health Rehabilitation Products Market?

5. Which regional market will show the strongest growth?

6. What will be the CAGR and size of the Women’s Health Rehabilitation Products market throughout the forecast period?

For more information or query or customization before buying, visit @ https://www.verifiedmarketresearch.com/product/women-health-rehabilitation-products-market/

Visualize Women’s Health Rehabilitation Products Market Using Verified Market Intelligence:-

Verified Market Intelligence is our BI platform for market narrative storytelling. VMI offers in-depth forecast trends and accurate insights on over 20,000 emerging and niche markets, helping you make critical revenue-impacting decisions for a bright future.

VMI provides a global overview and competitive landscape with respect to region, country and segment, as well as key players in your market. Present your market report and results with an integrated presentation function that saves you more than 70% of your time and resources for presentations to investors, sales and marketing, R&D and product development. products. VMI enables data delivery in Excel and interactive PDF formats with over 15+ key market indicators for your market.

Visualize the Women’s Health Rehabilitation Products Market using [email protected] https://www.verifiedmarketresearch.com/vmintelligence/

About Us: Verified Market Research®

Verified Market Research® is a leading global research and advisory firm that for over 10 years has provided advanced analytical research solutions, personalized advice and in-depth data analysis to individuals and businesses seeking accurate research, reliable and up to date. data and technical advice. We provide insight into strategic and growth analytics, the data needed to achieve business goals, and help make critical revenue decisions.

Our research studies help our clients make superior data-driven decisions, understand market forecasts, capitalize on future opportunities, and maximize efficiency by working as a partner to deliver accurate and valuable insights. The industries we cover span a wide spectrum, including technology, chemicals, manufacturing, energy, food and beverage, automotive, robotics, packaging, construction, mining and the gas. Etc.

At Verified Market Research, we help in understanding holistic market indicator factors and most current and future market trends. Our analysts, with their deep expertise in data collection and governance, use industry techniques to gather and review data at all stages. They are trained to combine modern data collection techniques, superior research methodology, subject matter expertise and years of collective experience to produce informative and accurate research.

Having served over 5000 clients, we have provided reliable market research services to over 100 Global Fortune 500 companies such as Amazon, Dell, IBM, Shell, Exxon Mobil, General Electric, Siemens, Microsoft, Sony and Hitachi. We have co-consulted with some of the world’s leading consulting firms such as McKinsey & Company, Boston Consulting Group, Bain and Company for custom research and consulting projects for companies around the world.

Contact us:

Mr. Edwyne Fernandes

Verified Market Research®

USA: +1 (650)-781-4080
UK: +44 (753)-715-0008
APAC: +61 (488)-85-9400
US toll free: +1 (800)-782-1768

E-mail: [email protected]com

Website:- https://www.verifiedmarketresearch.com/

read more
Medical products

India capitulates to EU over TRIPS waiver for Covid-19 medical products

The compromise reached puts all the odds on its side against the poorest countries. Additionally, eligibility is limited to developing WTO countries that exported less than 10% of global vaccines in 2021. This would exclude Brazil, China, and non-WTO countries such as Kosovo, Palestine, Iran, Serbia and Syria.

Chronology of negotiations

In October 2020, India and South Africa submitted a proposal which called for the relinquishment of patents, but also of industrial designs, copyrights and trade secrets which are protected by the agreement of WTO on TRIPS.

In May 2021, a revised proposal was tabled which specified that the TRIPS waiver would only apply to vaccines, diagnostics, therapeutics, medical devices and personal protective equipment related to COVID-19 and would remain in effect for at least three years. .

In December 2021, the WTO Secretariat convened a meeting between the four parties – South Africa, India, the US and the EU – but it was held in two formats. For one meeting, only quad trade and trade ministers met and in the other meeting, only negotiators from these four countries met. Indian Commerce Minister Piyush Goyal attended these meetings. Normally, negotiators and ministers attend meetings together. In the next round of online meetings, India met the US and South Africa met the EU.

On March 11, 2022, there was a meeting of the four ministers only where the compromise was agreed. This is after EU officials sent a note to their member countries on the compromise reached.

The United States Trade Representative (USTR) released a statement on March 16 indicating that a compromise had been reached but countries had yet to agree on the final test. A little after, WTO Director General, Ngozi Okonjo-Iweala said the details of the deal were not yet settled.

However, India remained silent on the issue after the compromise was reached. In November 2021, a senior Commerce Ministry official had reiterated that India would continue to demand waiver of intellectual property rights for COVID-19 vaccines and supplies. India had affirmed that it would ensure that the interests of developing nations were not compromised.

read more
Medical products

Free offers of medical products – No violation of the prohibition on promotional gifts under Hwg 7(1) when the purchase price is refunded in full

In the case at issue, the plaintiff, on the basis of Sections 8, 3, 3a of the German Unfair Competition Act (UWG) in conjunction with Section 7(1) Nr. 1 of the German Health Advertising Act (HeilmittelwerbegesetzHWG), sought an injunction against defendant’s promotional offer “Incontinence Pants – FREE TRIAL” which was challenged as in violation of competition law.

Specifically, the defendant had affixed a folded sticker containing the words “FREE TRYon the packaging of its medical product. The inside of the sticker contained instructions on how to obtain a refund of the purchase price after purchasing the product by uploading to the defendant’s website a photo of the payment receipt and the promotional package and providing the name, address and bank details, after which the purchase price would be refunded within 14 days.

The Higher Regional Court of Cologne (judgment of 17 December 2021, file no. 6 U 91/51) upheld the decision of the Regional Court of Cologne (judgment of 25 May 2021, file no. 33 O 60/20) to reject the action and dismissed the appeal against said decision.

In his appeal, the plaintiff argued that the defendant could not rely on the exceptions provided for in § 7, paragraph 1, no. 1 of the HWG, because the limit of the lower value is exceeded when the purchase price exceeds at least eight euros. The other exception in Section 7(1) No. 2(a) of the HWG was irrelevant because the public would not view reimbursement of the purchase price as a gift, but rather as acquiring the product. Furthermore, a full refund of the purchase price is not covered by this provision.

The Higher Regional Court, on the other hand, found no violation of Section 7 (1) HWG. According to this provision, it is in principle inadmissible to offer, advertise or grant advantages and other promotional gifts (goods or services). The term “promotional gift” should be interpreted broadly and includes any free gift in connection with the purchase of a product or service. In the opinion of the Tribunal de Grande Instance, the reimbursement of the purchase price described above constitutes such a free gift. However, the the exception under Section 7 (1) No. 2 (a) HWG applies here, whereby the benefit or promotional gift is permitted if granted for a specific amount of money or for an amount of money calculated in a certain way.

In this case, the Cologne courts therefore did not consider the product itself as the gift, but rather the purchase price reimbursed under the conditions described. Therefore, the exception for low value items under Section 7(1) No. 1 HWG was not relevant.

The decisive factor in this respect is that the product must first be fully paid for by the consumer. The consumer therefore does not understand the message on the sticker to mean that the product is given away free of charge. Also, the consumer is informed of similar promotions, so he will take into account the additional information on the reimbursement conditions appearing inside the sticker. In addition, the refund relates to the total purchase price of the product and therefore to a “specified sum of money or for a sum of money calculated in a certain way”. The fact that the full purchase price is refunded is also not in contradiction with this, since the wording of Article 7(1)(2) (a) of the HWG does not provide for any relative or absolute limitation on the amount of the donation. Accordingly, in the opinion of the Higher Regional Court, the except for Section 7 (1) No. 2 (a) HWG does not to fail due to lower limit value of Section 7 (1) No. 1 HWG nor is it in conflict with this provision.

The Higher Regional Court of Cologne thus follows the decision of the Higher Regional Court of Hamburg, which had previously rejected a previous request for an injunction (judgment of 20 June 2019, file no. 3 U 137/18).

The decision concerns an interesting and finely drawn line between the two exceptions to the fundamental prohibition on promotional gifts under Section 7(1) HWG and illustrates the complexity surrounding the legal assessment of promotional activities for drugs and products. medical, in particular in the planning of such promotional activities. It is strongly recommended to seek legal advice here.

This judgment is one of many decisions which raise the bar for the promotion by pharmaceutical companies of corresponding products. Particular attention should always be paid to the prohibition of promotional gifts under Section 7 HWG discussed here. See also the articles “Mandatory information in pharmaceutical advertising” of the September 7, 2021and “Provision of Complimentary Samples to Pharmacies Pursuant to Section 7 HWG” of April 14, 2021.

read more
Medical products

Precision Medical Products, Inc. Announces Steve Ingel as New CEO

New year, new precision medical products: the company will have a new leader, in partnership with the longtime founder and current CEO Jeremy Perkins. Stepping into the shoes of Perkins will be a respected industry veteran Steven Ingelwho will immediately become President and CEO of Precision Medical Products, Inc.

CARROLLTON, TX, April 13, 2022 /PRNewswire/ — Precision Medical Products today announced the appointment of Steven Ingel to the President and CEO of Precision Medical Products, Inc. Ingel’s official start date was April 4, 2022. At that time, he succeeded the current President and CEO of Precision Medical, Jeremy Perkins, who will remain with the company and assume the role of executive chairman of the board. In this new role, Mr. Perkins will identify strategies, business opportunities and new technology architectures to develop precision medical products. “Steve Ingel brings extensive experience in medical devices and digital health with a proven track record of growth, margin expansion and overall financial performance. His broad and deep industry experience, combined with his respected leadership and team spirit, make him the perfect fit to continue our important work at Precision Medical,” said Jeremy Perkins.

read more
Medical products

Brazil’s Viveo to Acquire 3 Medical Products Companies in Expansion Spurt

SAO PAULO, April 12 (Reuters)Brazilian distributor of medicines and medical products Viveo VVEO3.SA has reached an agreement to acquire three companies for a total of 365.5 million reais ($77.86 million) as it pushes for expansion, it said in a securities filing on Tuesday.

The deal includes parenteral nutrition company FAMAP, a supplier of sterile solutions and a distributor of hospital PHD products, Viveo – formerly known as CM Hospitalar SA – said.

Life and FAMAP combined accounted for 58 million reais of earnings before interest, taxes, depreciation and amortization (EBITDA), while PHD is expected to add 17.5 million reais of EBITDA, Viveo added.

Life and PHD are based in the southern city of Porto Alegre, and FAMAP is headquartered in Belo Horizonte. The deal still requires approval from Brazilian antitrust watchdog CADE.

The move comes less than a year after Viveo and its shareholders raised R$2.32 billion in an initial public offering (IPO) that valued the company at R$5.7 billion at the time.

($1 = 4.6944 reais)

(Reporting by Gabriel Araujo; editing by Jason Neely)

(([email protected]; +55 11 5644 7745;))

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

read more
Medical products

Veress Needle Market Size, Trends and Forecasts

New Jersey, United States – Verified Market Research provides an encyclopedic study of Veress needle market with holistic information about important factors and aspects impacting the future growth of the market. The Veress Needles Market has been analyzed for the forecast period 2022-2029 and the historical period 2015-2021. To assist players to gain thorough understanding of the Veress Needles Market and its critical dynamics, the research study provides detailed qualitative and quantitative analysis. Additionally, readers are offered comprehensive and in-depth research on various regions and segments of the Veress Needle market. Almost all industry-specific microeconomic and macroeconomic factors affecting the growth of the global market have been analyzed in the report.

With a comprehensive analysis of the competitive landscape, the authors of the Veress Needle Market report have made a brilliant attempt to study the key developments, pricing and business-related tactics as well as the future plans of the major companies. Along with the Players Veress Needle Market performance in terms of revenue and revenue, analysts shed light on their production, areas served, gross margin, and other important factors. Moreover, Veress Needle report helps players to gain an upper hand in market competition by thoroughly analyzing the market positioning, market growth, and product portfolio of its competitors.

Get Sample Full PDF Copy of Report: (Including Full TOC, List of Tables & Figures, Chart) @ https://www.verifiedmarketresearch.com/download-sample/?rid=212073

Key Players Mentioned in the Veress Needle Market Research Report:

CONMED, Fairmont Medical Products Pty Ltd, GRI-Alleset, Grena Ltd., 3-Dmed, Advin Health Care, Changzhou Ankang Medical Instruments Co., Ltd., Duomed Group, Endomed Systems GmbH, Zhejiang Geyi Medical Instrument Co., Ltd. , LOCAMED LIMITED.

Segmentation of the Veress needle market:

Veress Needles Market, By Type

• 120mm
• 150mm
• Others

Veress Needles Market, By Application

• Gynecological surgery
• Urological surgery
• General surgery

The report is the best compilation of different types of segmental analyzes of the Veress Needle market done from different perspectives. The analysts’ pragmatic approach to studying different market segments and top-down and bottom-up approaches to forecasting the size of their markets makes the Veress Needle study unique and accurate. Reliable primary sources such as CTOs, Physicians, VPs, CEOs, and supply and demand side industry experts were consulted to validate and revalidate the market and market figures. ‘other information. Secondary sources such as Bloomberg, databases, white papers, press releases and company reports were used to collect market information and data.

This research study can be used by all participants of the Veress Needle market as it covers all the major and minor aspects of the current and future competition in the market. It can also prove to be very beneficial for the stakeholders given the training offered and a detailed analysis of the growth strategies expected from the players in the coming years. Newcomers or players who want to make a foray into the Veress Needle market can get useful insights and effective guides from the report. On the other hand, established companies can use the Veress Needle report to keep themselves informed about current and future market scenarios and to plan their future business moves.

Get a discount on the purchase of this report @ https://www.verifiedmarketresearch.com/ask-for-discount/?rid=212073

Scope of the Veress Needles Market Report

ATTRIBUTES DETAILS
ESTIMATED YEAR 2022
YEAR OF REFERENCE 2021
FORECAST YEAR 2029
HISTORICAL YEAR 2020
UNITY Value (million USD/billion)
SECTORS COVERED Types, applications, end users, and more.
REPORT COVER Revenue Forecast, Business Ranking, Competitive Landscape, Growth Factors and Trends
BY REGION North America, Europe, Asia-Pacific, Latin America, Middle East and Africa
CUSTOMIZATION SCOPE Free report customization (equivalent to up to 4 analyst business days) with purchase. Added or changed country, region and segment scope.

Determining the pulse of the market becomes easy with this detailed analysis of the Veress Needle market. Key players can find all competitive data and market size of major regions like North America, Europe, Latin America, Asia-Pacific and Middle East. As part of the competitive analysis, certain strategies are profiled which are pursued by key players such as mergers, collaborations, acquisitions and new product launches. These strategies will greatly help industry players to strengthen their position in the market and grow their business.

Answers to key questions in the report:

1. Who are the top five players in the Veress Needle market?

2. How will the Veress needle market evolve over the next five years?

3. Which product and which application will take the lion’s share of the Veress needle market?

4. What are the drivers and restraints of the Veress Needle Market?

5. Which regional market will show the strongest growth?

6. What will be the CAGR and size of the Veress Needle market throughout the forecast period?

For more information or query or customization before buying, visit @ https://www.verifiedmarketresearch.com/product/veress-needle-market/

Visualize the Veress Needle Market Using Verified Market Intelligence:-

Verified Market Intelligence is our BI platform for market narrative storytelling. VMI offers in-depth forecast trends and accurate insights on over 20,000 emerging and niche markets, helping you make critical revenue-impacting decisions for a bright future.

VMI provides a global overview and competitive landscape with respect to region, country and segment, as well as key players in your market. Present your market report and results with an integrated presentation function that saves you more than 70% of your time and resources for presentations to investors, sales and marketing, R&D and product development. products. VMI enables data delivery in Excel and interactive PDF formats with over 15+ key market indicators for your market.

Visualize the Veress needle market using [email protected] https://www.verifiedmarketresearch.com/vmintelligence/

About Us: Verified Market Research®

Verified Market Research® is a leading global research and advisory firm that for over 10 years has provided advanced analytical research solutions, personalized advice and in-depth data analysis to individuals and businesses seeking accurate research, reliable and up to date. data and technical advice. We provide insight into strategic and growth analytics, the data needed to achieve business goals, and help make critical revenue decisions.

Our research studies help our clients make superior data-driven decisions, understand market forecasts, capitalize on future opportunities, and maximize efficiency by working as a partner to deliver accurate and valuable insights. The industries we cover span a wide spectrum, including technology, chemicals, manufacturing, energy, food and beverage, automotive, robotics, packaging, construction, mining and the gas. Etc.

At Verified Market Research, we help in understanding holistic market indicator factors and most current and future market trends. Our analysts, with their deep expertise in data collection and governance, use industry techniques to gather and review data at all stages. They are trained to combine modern data collection techniques, superior research methodology, subject matter expertise and years of collective experience to produce informative and accurate research.

Having served over 5000 clients, we have provided reliable market research services to over 100 Global Fortune 500 companies such as Amazon, Dell, IBM, Shell, Exxon Mobil, General Electric, Siemens, Microsoft, Sony and Hitachi. We have co-consulted with some of the world’s leading consulting firms such as McKinsey & Company, Boston Consulting Group, Bain and Company for custom research and consulting projects for companies around the world.

Contact us:

Mr. Edwyne Fernandes

Verified Market Research®

USA: +1 (650)-781-4080
UK: +44 (753)-715-0008
APAC: +61 (488)-85-9400
US toll free: +1 (800)-782-1768

E-mail: [email protected]

Website:- https://www.verifiedmarketresearch.com/

read more
Medical products

Women’s Health Rehabilitation Products Market Size, Trends and Forecasts

New Jersey, United States – Verified Market Research provides an encyclopedic study of Women’s Health Rehabilitation Products Market with holistic information about important factors and aspects impacting the future growth of the market. The Women’s Health Rehabilitation Products Market has been analyzed for the forecast period 2022-2029 and the historical period 2015-2021. To assist players to gain thorough understanding of the Women’s Health Rehabilitation Products market and its critical dynamics, the research study provides detailed qualitative and quantitative analysis. Additionally, readers are offered comprehensive and in-depth research on various regions and segments of the Women’s Health Rehabilitation Products market. Almost all industry-specific microeconomic and macroeconomic factors affecting the growth of the global market have been analyzed in the report.

With a comprehensive analysis of the competitive landscape, the authors of the Women’s Health Rehabilitation Products market report have made a brilliant attempt to study the key developments, pricing and business tactics as well as the future plans of major companies. . Along with the Players Women Health Rehabilitation Products market performance in terms of revenue and revenue, the analysts shed light on their production, areas served, gross margin, and other important factors. Moreover, the Women’s Health Rehabilitation Products report helps players to gain an upper hand in the market competition by thoroughly analyzing the market positioning, market growth, and product portfolio of its competitors.

Get Sample Full PDF Copy of Report: (Including Full Table of Contents, List of Tables and Figures, Chart) @ https://www.verifiedmarketresearch.com/download-sample/?rid=22158

Key Players Mentioned in the Women’s Health Rehabilitation Products Market Research Report:

Accord Medical Products, BSN medical, Carib Rehab, Cornerstone Chiropractic, DeRoyal, EMS Physio, GE Healthcare, GPC Medical, Meyer Physical Therapy, Midtown Chiropractic, PROSPINE Health and Injury Center, Pelvic Health and Rehabilitation, Pure Health Chiropractic, Sportstek, Win Health Medical, Zynex

Women’s Health Rehabilitation Products Market Segmentation:

Women’s Health Rehabilitation Products Market by Product

• Orthopedic care
• Urinary incontinence
• Breast cancer care
• Pregnancy and postpartum care

Women’s Health Rehabilitation Products Market By Application

• Hospitals
• Clinics

The report is the best compilation of different types of Women’s Health Rehabilitation Products market segmental analysis done from different perspectives. The analysts’ pragmatic approach to studying different market segments and top-down and bottom-up approaches to forecasting their market sizes makes the Women’s Health Rehabilitation Products research study unique and accurate. Reliable primary sources such as CTOs, Physicians, VPs, CEOs, and supply and demand side industry experts were consulted to validate and revalidate the market and market figures. ‘other information. Secondary sources such as Bloomberg, databases, white papers, press releases and company reports were used to collect market information and data.

This research study can be utilized by all participants of the Women’s Health Rehabilitation Products market as it covers all the major and minor aspects of the current and future market competition. It can also prove to be very beneficial for the stakeholders given the training offered and a detailed analysis of the growth strategies expected from the players in the coming years. Newcomers or players who want to foray into the Women’s Health Rehabilitation Products market can get helpful insights and efficient guides from the report. On the other hand, established businesses can use the Women’s Health Rehabilitation Products report to keep themselves informed with current and future market scenarios and to plan their future business moves.

Get a discount on the purchase of this report @ https://www.verifiedmarketresearch.com/ask-for-discount/?rid=22158

Scope of the Women’s Health Rehabilitation Products Market Report

ATTRIBUTES DETAILS
ESTIMATED YEAR 2022
YEAR OF REFERENCE 2021
FORECAST YEAR 2029
HISTORICAL YEAR 2020
UNITY Value (million USD/billion)
SECTORS COVERED Types, applications, end users, and more.
REPORT COVER Revenue Forecast, Business Ranking, Competitive Landscape, Growth Factors and Trends
BY REGION North America, Europe, Asia-Pacific, Latin America, Middle East and Africa
CUSTOMIZATION SCOPE Free report customization (equivalent to up to 4 analyst business days) with purchase. Added or changed country, region and segment scope.

It becomes easy to determine the pulse of the market with this detailed analysis of the Women’s Health Rehabilitation Products Market. Key players can find all competitive data and market size of major regions like North America, Europe, Latin America, Asia-Pacific and Middle East. As part of the competitive analysis, certain strategies are profiled which are pursued by key players such as mergers, collaborations, acquisitions and new product launches. These strategies will greatly help industry players to strengthen their position in the market and grow their business.

Answers to key questions in the report:

1. Who are the top five players in the Women’s Health Rehabilitation Products Market?

2. How will the women’s health rehabilitation products market develop in the next five years?

3. Which product and application will occupy the lion’s share of the women’s health rehabilitation products market?

4. What are the drivers and restraints of the Women’s Health Rehabilitation Products Market?

5. Which regional market will show the strongest growth?

6. What will be the CAGR and size of the Women’s Health Rehabilitation Products market throughout the forecast period?

For more information or query or customization before buying, visit @ https://www.verifiedmarketresearch.com/product/women-health-rehabilitation-products-market/

Visualize Women’s Health Rehabilitation Products Market Using Verified Market Intelligence:-

Verified Market Intelligence is our BI platform for market narrative storytelling. VMI offers in-depth forecast trends and accurate insights on over 20,000 emerging and niche markets, helping you make critical revenue-impacting decisions for a bright future.

VMI provides a global overview and competitive landscape with respect to region, country and segment, as well as key players in your market. Present your market report and results with an integrated presentation function that saves you more than 70% of your time and resources for presentations to investors, sales and marketing, R&D and product development. products. VMI enables data delivery in Excel and interactive PDF formats with over 15+ key market indicators for your market.

Visualize the Women’s Health Rehabilitation Products Market using [email protected] https://www.verifiedmarketresearch.com/vmintelligence/

About Us: Verified Market Research®

Verified Market Research® is a leading global research and advisory firm that for over 10 years has provided advanced analytical research solutions, personalized advice and in-depth data analysis to individuals and businesses seeking accurate research, reliable and up to date. data and technical advice. We provide insight into strategic and growth analytics, the data needed to achieve business goals, and help make critical revenue decisions.

Our research studies help our clients make superior data-driven decisions, understand market forecasts, capitalize on future opportunities, and maximize efficiency by working as a partner to deliver accurate and valuable insights. The industries we cover span a wide spectrum, including technology, chemicals, manufacturing, energy, food and beverage, automotive, robotics, packaging, construction, mining and the gas. Etc.

At Verified Market Research, we help in understanding holistic market indicator factors and most current and future market trends. Our analysts, with their deep expertise in data collection and governance, use industry techniques to gather and review data at all stages. They are trained to combine modern data collection techniques, superior research methodology, subject matter expertise and years of collective experience to produce informative and accurate research.

Having served over 5000 clients, we have provided reliable market research services to over 100 Global Fortune 500 companies such as Amazon, Dell, IBM, Shell, Exxon Mobil, General Electric, Siemens, Microsoft, Sony and Hitachi. We have co-consulted with some of the world’s leading consulting firms such as McKinsey & Company, Boston Consulting Group, Bain and Company for custom research and consulting projects for companies around the world.

Contact us:

Mr. Edwyne Fernandes

Verified Market Research®

USA: +1 (650)-781-4080
UK: +44 (753)-715-0008
APAC: +61 (488)-85-9400
US toll free: +1 (800)-782-1768

E-mail: [email protected]

Website:- https://www.verifiedmarketresearch.com/

read more
Medical products

Personal Mobility Devices Market Size, Trends and Forecasts

New Jersey, United States – Verified Market Research provides an encyclopedic study of personal mobility device market with holistic information about important factors and aspects impacting the future growth of the market. The Personal Mobility Devices Market has been analyzed for the forecast period 2022-2029 and the historical period 2015-2021. To assist players to gain a thorough understanding of the Personal Mobility Devices market and its critical dynamics, the research study provides detailed qualitative and quantitative analysis. Additionally, readers are offered comprehensive and in-depth research on various regions and segments of the Personal Mobility Devices market. Almost all industry-specific microeconomic and macroeconomic factors affecting the growth of the global market have been analyzed in the report.

With a comprehensive analysis of the competitive landscape, the authors of the Personal Mobility Devices market report have made a brilliant attempt to study the key developments, pricing and business-related tactics as well as the future plans of leading companies. Along with Players Personal Mobility Devices market performance in terms of revenue and revenue, analysts shed light on their production, areas served, gross margin and other important factors. Moreover, the Personal Mobility Devices report helps players to gain an upper hand in the market competition by thoroughly analyzing the market positioning, market growth, and product portfolio of its competitors.

Get Sample Full PDF Copy of Report: (Including Full TOC, List of Tables & Figures, Chart) @ https://www.verifiedmarketresearch.com/download-sample/?rid=37564

Key Players Mentioned in the Personal Mobility Devices Market Research Report:

NOVA Medical Products, Performance Health, Drive DeVilbiss Healthcare, Medline Industries Invacare Corporation, Carex Health Brands Kaye Products Rollz International, GF HEALTH PRODUCTS and Briggs Healthcare

Personal Mobility Devices Market Segmentation:

Personal Mobility Devices Market, By Product

• Wheel chairs
• Scooters
• Walking aids

The report is the best compilation of different types of segmental analyzes of the Personal Mobility Devices Market performed from different perspectives. The analysts’ pragmatic approach to studying different market segments and top-down and bottom-up approaches to forecasting the size of their markets makes the Personal Mobility Devices research study unique and accurate. Reliable primary sources such as CTOs, Physicians, VPs, CEOs, and supply and demand side industry experts were consulted to validate and revalidate the market and market figures. ‘other information. Secondary sources such as Bloomberg, databases, white papers, press releases and company reports were used to collect market information and data.

This research study can be used by all participants of the Personal Mobility Devices market as it covers all the major and minor aspects of the current and future competition in the market. It can also prove to be very beneficial for the stakeholders given the training offered and a detailed analysis of the growth strategies expected from the players in the coming years. Newcomers or players who want to make a foray into the Personal Mobility Devices market can get useful insights and effective guides from the report. On the other hand, established businesses can use the Personal Mobility Devices report to keep themselves informed with current and future market scenarios and to plan their future business moves.

Get a discount on the purchase of this report @ https://www.verifiedmarketresearch.com/ask-for-discount/?rid=37564

Scope of the Personal Mobility Devices Market Report

ATTRIBUTES DETAILS
ESTIMATED YEAR 2022
YEAR OF REFERENCE 2021
FORECAST YEAR 2029
HISTORICAL YEAR 2020
UNITY Value (million USD/billion)
SECTORS COVERED Types, applications, end users, and more.
REPORT COVER Revenue Forecast, Business Ranking, Competitive Landscape, Growth Factors and Trends
BY REGION North America, Europe, Asia-Pacific, Latin America, Middle East and Africa
CUSTOMIZATION SCOPE Free report customization (equivalent to up to 4 analyst business days) with purchase. Added or changed country, region and segment scope.

It becomes easy to determine the pulse of the market with this detailed analysis of the Personal Mobility Devices market. Key players can find all competitive data and market size of major regions like North America, Europe, Latin America, Asia-Pacific and Middle East. As part of the competitive analysis, certain strategies are profiled which are pursued by key players such as mergers, collaborations, acquisitions and new product launches. These strategies will greatly help industry players to strengthen their position in the market and grow their business.

Answers to key questions in the report:

1. Who are the top five players in the personal mobility device market?

2. How will the personal mobility device market evolve in the next five years?

3. Which products and applications will capture the lion’s share of the personal mobility device market?

4. What are the drivers and restraints of the Personal Mobility Devices Market?

5. Which regional market will show the strongest growth?

6. What will be the CAGR and size of the Personal Mobility Devices market throughout the forecast period?

For more information or query or customization before buying, visit @ https://www.verifiedmarketresearch.com/product/personal-mobility-devices-market/

Visualize the Personal Mobility Devices Market Using Verified Market Intelligence:-

Verified Market Intelligence is our BI platform for market narrative storytelling. VMI offers in-depth forecast trends and accurate insights on over 20,000 emerging and niche markets, helping you make critical revenue-impacting decisions for a bright future.

VMI provides a global overview and competitive landscape with respect to region, country and segment, as well as key players in your market. Present your market report and results with an integrated presentation function that saves you more than 70% of your time and resources for presentations to investors, sales and marketing, R&D and product development. products. VMI enables data delivery in Excel and interactive PDF formats with over 15+ key market indicators for your market.

Visualize the Personal Mobility Devices Market using [email protected] https://www.verifiedmarketresearch.com/vmintelligence/

About Us: Verified Market Research®

Verified Market Research® is a leading global research and advisory firm that for over 10 years has provided advanced analytical research solutions, personalized advice and in-depth data analysis to individuals and businesses seeking accurate research, reliable and up to date. data and technical advice. We provide insight into strategic and growth analytics, the data needed to achieve business goals, and help make critical revenue decisions.

Our research studies help our clients make superior data-driven decisions, understand market forecasts, capitalize on future opportunities, and maximize efficiency by working as a partner to deliver accurate and valuable insights. The industries we cover span a wide spectrum, including technology, chemicals, manufacturing, energy, food and beverage, automotive, robotics, packaging, construction, mining and gas. Etc.

At Verified Market Research, we help in understanding holistic market indicator factors and most current and future market trends. Our analysts, with their deep expertise in data collection and governance, use industry techniques to gather and review data at all stages. They are trained to combine modern data collection techniques, superior research methodology, subject matter expertise and years of collective experience to produce informative and accurate research.

Having served over 5000 clients, we have provided reliable market research services to over 100 Global Fortune 500 companies such as Amazon, Dell, IBM, Shell, Exxon Mobil, General Electric, Siemens, Microsoft, Sony and Hitachi. We have co-consulted with some of the world’s leading consulting firms such as McKinsey & Company, Boston Consulting Group, Bain and Company for custom research and consulting projects for companies around the world.

Contact us:

Mr. Edwyne Fernandes

Verified Market Research®

USA: +1 (650)-781-4080
UK: +44 (753)-715-0008
APAC: +61 (488)-85-9400
US toll free: +1 (800)-782-1768

E-mail: [email protected]

Website:- https://www.verifiedmarketresearch.com/

read more
Medical products

FDA Releases Draft MDUFA V 2023 – Medical Product Supply Chain Week in Review | Alston and bird

Over the past few weeks, the FDA has continued to focus its attention on supply chain issues. The agency has released draft guidance on the expectations of its supply chain business partner verification system for prescription drugs and a draft of what manufacturers can expect in changes to drug fees. Device Use (MDUFA V) 2023. The Center for Devices and Radiological Health (CDRH) has released a fact sheet to inform the public of its plans to prevent future medical device shortages. The FDA has submitted its 2023 budget to Congress. In a similar vein, the FDA updated its device shortage and discontinuation list and sent a letter to medical personnel detailing retention strategies. Representatives Mike Gallagher (R-WI) and Mark Pocan (D-WI) introduced a bill in an effort to strengthen the supply chain for medical products. In other developments, investments continue to be made in cold chain monitoring as consumer lifestyles and habits change. Please see details of these and other supply chain developments below:

  • On March 10, the FDA published draft guidance on agency expectations of drug supply chain business partners, “Verification Systems Under the Drug Supply Chain Security Act for Certain Prescription Drugs.” These follow-up guidelines clarify the expectations of manufacturers, repackers, wholesale distributors and dispensers to prepare for the implementation of Section 202 of the Security of the Medicines Supply Chain Act of 2013. Specifically, the draft guidance focuses on expectations of system requirements and what system activities it expects to see from each supply chain trading partner. Emphasis is placed on what is necessary to ensure adequate assessment processes for suspect and illegitimate products to either release them to market or safely remove them from the supply chain to prevent future distribution.
  • On March 17, the FDA published a fact sheet, “Mitigate and Prevent Medical Device Shortages and Prioritize Public Health,” designed to inform the public of the steps CDRH is taking to prevent future device shortages. Under the authority granted by the CARES Act, the FDA worked with manufacturers and other entities to expedite the review of device submissions and address supply chain vulnerabilities. Going forward, the FDA is seeking legislation requiring manufacturers to notify the agency of impending shortages, whether or not a public health emergency exists.
  • On March 21, the FDA added 0.9% sodium chloride IV lock/flush prefilled syringes (product code NGT – saline, vascular access flush) to the appliance shortage list and the device abandon list. The FDA has issued a Letter to health personnel provide recommendations, including storage strategies, for syringes. The FDA has also added certain discontinued surgical garments (product codes FME, FXP, FYF, LYU, and OEA) to the device discontinuation list.
  • On March 23, the FDA published the draft MDUFA V 2023, which outlines the responsibilities FDA commits to for manufacturers of medical products that require oversight. The agency plans to hire additional staff to facilitate compliance. Timelines attempt to manage expectations of increased submissions by providing timelines in which the agency will respond with the appropriate next step. The shared results objectives are:
    • Average total decision time for premarket approval submissions and panel pathway supplements of 290 and 285 calendar days for fiscal year 2023-2024 and for years 2025-2027, respectively.
    • For 510(k) submissions, the shared outcome targets are total decision time of 118 days for fiscal year 2023, 124 days for fiscal year 2024, and 112 days for years 2025-2027.
    • The FDA will also continue the Q-Submission program, which allows for pre-submission meetings with the agency for feedback. The FDA commits to a maximum response time of 15 calendar days for acceptability and 70 calendar days (or five before a meeting) for written comments.

    The terms of the agreement ask the FDA to commit to 90% timeliness for pre-submissions for FY2023 if the cohort is below 3,585 and 75% if the cohort is above (up to 4,300). For fiscal year 2024, the commitment is 90% for less than 4,060 and 80% for more (up to 4,300). For the years 2025 to 2027, the engagement target is 90% for a maximum of 4,300 pre-submissions. The specific objectives of the agency are stated in the letter.

  • On March 24, Rep. Mike Gallagher (R-WI), with Rep. Mark Pocan (D-WI) as co-sponsor, presented HR 7208, the Medical Supply Chain Security Act, which would amend federal food, drug and cosmetic law. As submitted, this bipartisan bill would require manufacturers to provide additional reporting on the supply and composition of drugs and medical devices and potential and impending shortages and allow expedited review of devices that traditionally require approval. prior to marketing. Manufacturers may be concerned about additional requirements that may increase the regulatory burden; however, the potential trade-off is the ability to more effectively market potential products considered life-saving. The bill was referred to the Energy and Commerce Committee.
  • On March 28, the FDA released its 2023 budget ask Congress. The application’s priorities indicate that the agency wants to increase its oversight power and is looking for ways to become more effective. Specifically, the FDA wants to require manufacturers to participate in remote interactive assessments and wants greater oversight to implement cybersecurity measures on devices, remove products from the market when no confirmatory data has been produced, removing barriers to competing generic drug approvals, overseeing dietary supplement ingredient lists, extending expiry dates for pharmaceutical products in the event of shortages, and ordering the destruction of imported products and payment for the action of destruction by manufacturers. The request also includes some elements relating to drug shortages. The agency is asking for the ability to require companies to report when a shortage of medical devices is expected and also to require companies to conduct risk assessments of their supply chain. It is expected that not all applications will be approved; however, they could be included in future legislation.
  • The FDA published its FY 2021 Medical Countermeasures Initiative (MCMi) program update. The objective of the program is to promote “the development of and access to safe and effective MCMs”. For fiscal year 2021, approximately 470 EUAs were issued for approximately 750 products. The agency has also approved, licensed, or cleared more than 1,000 generic drugs and about 500 PPE products. Additionally, in a signal that it intends to vigorously exercise its oversight authority, the FDA has identified approximately 1,500 fraudulent products. As a result, 260 warning letters were sent and 393 fraudulent test kits were reported. For this effort, the agency advises its partners in fiscal year 2021 that it has exercised its authority to “advance the FDA’s capabilities to monitor the MCM supply chain to identify product shortages and distribution of mislabelled/counterfeit products”.
  • Companies have been execution their own solutions for disruptions in the pharmaceutical supply chain. Three companies, Swoop Aero, Skyports and BD Rowa, have joined efforts to develop drone delivery systems for pharmaceuticals using healthcare technology solutions. Drone companies, Swoop Aero and Skyports, will provide the drone infrastructure. Swoop Aero has extensive mapping and video technology, and Skyports is developing vertiports for drone activities. BD Rowa will bring its automated technology to healthcare. The hope is that this joint venture can help eliminate touch points in the supply chain and improve efficiency and access to pharmaceuticals.
  • Consumption and consumer needs, including pharmaceuticals and farm-to-fork food trends, are driving demand for global monitoring of the cold chain, which encompasses the use of software and hardware to monitor refrigeration. It is estimated that by 2026, the market will reach $10.9 billion, driven largely by the United States and China, as companies invest in facilities and emerging technologies for their products. Growth is also visible in the Asia-Pacific region. With the expected growth, this is a business opportunity for manufacturers of software applications and hardware devices to grow and expand to meet incoming needs worldwide.

[View source.]

read more
Medical products

Veress Needle Market Size, Growth and Forecast

New Jersey, United States – This Veress needle market The report provides detailed market insights to help companies make better business decisions and build growth plans based on market forecasts and trends. The research focuses on group research of data from primary and secondary sources. This Veress Needle Market report explores new developments, trends, and prospects, and forecasts the current status and future prospects of the market from 2022 to 2029. It dives deep into the industry in terms of current and future situations. The research examines a variety of elements, such as degrees of advancement, technical breakthroughs, and various strategies employed by the current major players in the market.

Furthermore, the objective of this market report is to provide a related assessment of key players along with the costs and benefits of the programmed market. It also uses charts to focus on industry standards to help businesses progress smoothly. This market report makes it easy to determine the impact of COVID-19 on the market growth. The main objective of this Veress Needle market report is to include quantitative data in the form of tables and graphs. Knowledge of market fundamentals is presented in a simple and understandable manner for the benefit of readers. This well-planned market analysis provides all readers as well as suppliers, buyers, and stakeholders with a detailed understanding of market conditions and industry environment.

Get Sample Full PDF Copy of Report: (Including Full TOC, List of Tables & Figures, Chart) @ https://www.verifiedmarketresearch.com/download-sample/?rid=212073

Key Players Mentioned in the Veress Needle Market Research Report:

CONMED, Fairmont Medical Products Pty Ltd, GRI-Alleset, Grena Ltd., 3-Dmed, Advin Health Care, Changzhou Ankang Medical Instruments Co., Ltd., Duomed Group, Endomed Systems GmbH, Zhejiang Geyi Medical Instrument Co., Ltd. , LOCAMED LIMITED.

This Veress Needle Market report also assesses the economic landscapes of the organization to better understand market dynamics at the international as well as regional levels. This study uses benchmarking to uncover up-to-date information about the target market. The best trading techniques are provided in this report which helps to better understand the market. The latest advancements, growth factors, and competitive analysis are all covered in this Veress Needle market report. He highlighted some of the most effective marketing strategies to drive economic development and help big players reap significant profits.

Segmentation of the Veress needle market:

Veress Needles Market, By Type

• 120mm
• 150mm
• Others

Veress Needles Market, By Application

• Gynecological surgery
• Urological surgery
• General surgery

The market research analysis further talks about the industry forces to shape the market. Important drivers and end user expectation are also discussed in Veress Needle market report to get solutions. The forecast of associated revenue is also made in the report. The main purpose of the report is to categorize opportunities. It also explains what business models are used, what is the current level of success, what is the market share and size, and what is the current level of competition in the market. It also sheds light on the functional areas of the business. This Veress Needle market report also shows how dead inventory affects profits and how product losses can be eliminated. With the business tactics provided here, it is possible to experience accelerated growth in your business. It also provides a clear picture of how different business sectors are experiencing the negative impact of COVID-19.

Get a discount on the purchase of this report @ https://www.verifiedmarketresearch.com/ask-for-discount/?rid=212073

Scope of the Veress Needles Market Report

ATTRIBUTES DETAILS
ESTIMATED YEAR 2022
YEAR OF REFERENCE 2021
FORECAST YEAR 2029
HISTORICAL YEAR 2020
UNITY Value (million USD/billion)
SECTORS COVERED Types, applications, end users, and more.
REPORT COVER Revenue Forecast, Business Ranking, Competitive Landscape, Growth Factors and Trends
BY REGION North America, Europe, Asia-Pacific, Latin America, Middle East and Africa
CUSTOMIZATION SCOPE Free report customization (equivalent to up to 4 analyst business days) with purchase. Added or changed country, region and segment scope.

Determining the pulse of the market becomes easy with this detailed analysis of the Veress Needle market. Key players can find all competitive data and market size of major regions like North America, Europe, Latin America, Asia-Pacific and Middle East. As part of the competitive analysis, certain strategies are profiled which are pursued by key players such as mergers, collaborations, acquisitions and new product launches. These strategies will greatly help industry players to strengthen their position in the market and grow their business.

Answers to key questions in the report:

1. Who are the top five players in the Veress Needle market?

2. How will the Veress needle market evolve over the next five years?

3. Which product and which application will take the lion’s share of the Veress needle market?

4. What are the drivers and restraints of the Veress Needle Market?

5. Which regional market will show the strongest growth?

6. What will be the CAGR and size of the Veress Needle market throughout the forecast period?

For more information or query or customization before buying, visit @ https://www.verifiedmarketresearch.com/product/veress-needle-market/

Visualize the Veress Needle Market Using Verified Market Intelligence:-

Verified Market Intelligence is our BI platform for market narrative storytelling. VMI offers in-depth forecast trends and accurate insights on over 20,000 emerging and niche markets, helping you make critical revenue-impacting decisions for a bright future.

VMI provides a global overview and competitive landscape with respect to region, country and segment, as well as key players in your market. Present your market report and results with an integrated presentation function that saves you more than 70% of your time and resources for presentations to investors, sales and marketing, R&D and product development. products. VMI enables data delivery in Excel and interactive PDF formats with over 15+ key market indicators for your market.

Visualize the Veress needle market using [email protected] https://www.verifiedmarketresearch.com/vmintelligence/

About Us: Verified Market Research®

Verified Market Research® is a leading global research and advisory firm that for over 10 years has provided advanced analytical research solutions, personalized advice and in-depth data analysis to individuals and businesses seeking accurate research, reliable and up to date. data and technical advice. We provide insight into strategic and growth analytics, the data needed to achieve business goals, and help make critical revenue decisions.

Our research studies help our clients make superior data-driven decisions, understand market forecasts, capitalize on future opportunities, and maximize efficiency by working as a partner to deliver accurate and valuable insights. The industries we cover span a wide spectrum, including technology, chemicals, manufacturing, energy, food and beverage, automotive, robotics, packaging, construction, mining and the gas. etc

At Verified Market Research, we help in understanding holistic market indicator factors and most current and future market trends. Our analysts, with their deep expertise in data collection and governance, use industry techniques to gather and review data at all stages. They are trained to combine modern data collection techniques, superior research methodology, subject matter expertise and years of collective experience to produce informative and accurate research.

Having served over 5000 clients, we have provided reliable market research services to over 100 Global Fortune 500 companies such as Amazon, Dell, IBM, Shell, Exxon Mobil, General Electric, Siemens, Microsoft, Sony and Hitachi. We have co-consulted with some of the world’s leading consulting firms such as McKinsey & Company, Boston Consulting Group, Bain and Company for custom research and consulting projects for companies around the world.

Contact us:

Mr. Edwyne Fernandes

Verified Market Research®

USA: +1 (650)-781-4080
UK: +44 (753)-715-0008
APAC: +61 (488)-85-9400
US Toll Free: +1 (800)-782-1768

E-mail: [email protected]

Website:- https://www.verifiedmarketresearch.com/

read more
Medical products

Swabs Market Size, Growth and Forecast

New Jersey, United States – This swab market The report provides detailed market insights to help companies make better business decisions and build growth plans based on market forecasts and trends. The research focuses on group research of data from primary and secondary sources. This Swab Market report explores new developments, trends, and outlook, and forecasts the current status and future outlook of the market from 2022 to 2029. It dives deep into the industry in terms of current and future situations. The research examines a variety of elements, such as degrees of advancement, technical breakthroughs, and various strategies employed by the current major players in the market.

Furthermore, the objective of this market report is to provide a related assessment of key players along with the costs and benefits of the programmed market. It also uses charts to focus on industry standards to help businesses progress smoothly. This market report makes it easy to determine the impact of COVID-19 on the market growth. The main objective of this Swab market report is to include quantitative data in the form of tables and graphs. Knowledge of market fundamentals is presented in a simple and understandable manner for the benefit of readers. This well-planned market analysis provides all readers as well as suppliers, buyers, and stakeholders with a detailed understanding of market conditions and industry environment.

Get Sample Full PDF Copy of Report: (Including Full Table of Contents, List of Tables and Figures, Chart) @ https://www.verifiedmarketresearch.com/download-sample/?rid=23805

Key Players Mentioned in the Swabs Market Research Report:

Puritan Medical Products, Sarstedt, MWE, SARSTEDT AG & Co, Lab M Limited., Clean Cross Co. Ltd., GPC medical ltd., Citotest Labware Manufacturing Co., Ltd. and Q-TIPS, ELMEX.

This Swabs Market report also assesses the economic landscapes of the organization to better understand the market dynamics at the international as well as regional levels. This study uses benchmarking to uncover up-to-date information about the target market. The best trading techniques are provided in this report which helps to better understand the market. The latest advancements, growth factors, and competitive analysis are all covered in this Swab Market report. He highlighted some of the most effective marketing strategies to drive economic development and help big players reap significant profits.

Swabs Market Segmentation:

Swabs Market, By Application

• Pharmaceutical
• Microbiological
• Laboratory
• Others

Swab market, by well

• Aluminum
• Polypropylene
• Others

Swabs Market, By Test Type

• DNA test
• Urine test
• Saliva test
• Others

The market research analysis further talks about the industry forces to shape the market. Important drivers and end user expectation are also discussed in the Swabs market report to get solutions. The forecast of associated revenue is also made in the report. The main purpose of the report is to categorize opportunities. It also explains what business models are used, what is the current level of success, what is the market share and size, and what is the current level of competition in the market. It also sheds light on the functional areas of the business. This Swabs market report also shows how dead inventory affects profits and how product losses can be eliminated. With the business tactics provided here, it is possible to experience accelerated growth in your business. It also provides a clear picture of how different business sectors are experiencing the negative impact of COVID-19.

Get a discount on the purchase of this report @ https://www.verifiedmarketresearch.com/ask-for-discount/?rid=23805

Scope of Swabs Market Report

ATTRIBUTES DETAILS
ESTIMATED YEAR 2022
YEAR OF REFERENCE 2021
FORECAST YEAR 2029
HISTORICAL YEAR 2020
UNITY Value (million USD/billion)
SECTORS COVERED Types, applications, end users, and more.
REPORT COVER Revenue Forecast, Business Ranking, Competitive Landscape, Growth Factors and Trends
BY REGION North America, Europe, Asia-Pacific, Latin America, Middle East and Africa
CUSTOMIZATION SCOPE Free report customization (equivalent to up to 4 analyst business days) with purchase. Added or changed country, region and segment scope.

It becomes easy to determine the pulse of the market with this detailed analysis of the swabs market. Key players can find all competitive data and market size of major regions like North America, Europe, Latin America, Asia-Pacific and Middle East. As part of the competitive analysis, certain strategies are profiled which are pursued by key players such as mergers, collaborations, acquisitions and new product launches. These strategies will greatly help industry players to strengthen their position in the market and grow their business.

Answers to key questions in the report:

1. Who are the Top Five Swab Market Players?

2. How will the swab market evolve over the next five years?

3. Which product and application will occupy the lion’s share of the swab market?

4. What are the Swab Market drivers and restraints?

5. Which regional market will show the strongest growth?

6. What will be the CAGR and size of the Swab market throughout the forecast period?

For more information or query or customization before buying, visit @ https://www.verifiedmarketresearch.com/product/swab-market/

Visualize the swab market using verified market intelligence:-

Verified Market Intelligence is our BI platform for market narrative storytelling. VMI offers in-depth forecast trends and accurate insights on over 20,000 emerging and niche markets, helping you make critical revenue-impacting decisions for a bright future.

VMI provides a global overview and competitive landscape with respect to region, country and segment, as well as key players in your market. Present your market report and results with an integrated presentation function that saves you more than 70% of your time and resources for presentations to investors, sales and marketing, R&D and product development. products. VMI enables data delivery in Excel and interactive PDF formats with over 15+ key market indicators for your market.

Visualize Swab Market using [email protected] https://www.verifiedmarketresearch.com/vmintelligence/

About Us: Verified Market Research®

Verified Market Research® is a leading global research and advisory firm that for over 10 years has provided advanced analytical research solutions, personalized advice and in-depth data analysis to individuals and businesses seeking accurate research, reliable and up to date. data and technical advice. We provide insight into strategic and growth analytics, the data needed to achieve business goals, and help make critical revenue decisions.

Our research studies help our clients make superior data-driven decisions, understand market forecasts, capitalize on future opportunities, and maximize efficiency by working as a partner to deliver accurate and valuable insights. The industries we cover span a wide spectrum, including technology, chemicals, manufacturing, energy, food and beverage, automotive, robotics, packaging, construction, mining and the gas. etc

At Verified Market Research, we help in understanding holistic market indicator factors and most current and future market trends. Our analysts, with their deep expertise in data collection and governance, use industry techniques to gather and review data at all stages. They are trained to combine modern data collection techniques, superior research methodology, subject matter expertise and years of collective experience to produce informative and accurate research.

Having served over 5000 clients, we have provided reliable market research services to over 100 Global Fortune 500 companies such as Amazon, Dell, IBM, Shell, Exxon Mobil, General Electric, Siemens, Microsoft, Sony and Hitachi. We have co-consulted with some of the world’s leading consulting firms such as McKinsey & Company, Boston Consulting Group, Bain and Company for custom research and consulting projects for companies around the world.

Contact us:

Mr. Edwyne Fernandes

Verified Market Research®

USA: +1 (650)-781-4080
UK: +44 (753)-715-0008
APAC: +61 (488)-85-9400
US toll free: +1 (800)-782-1768

E-mail: [email protected]

Website:- https://www.verifiedmarketresearch.com/

read more
Medical products

Personal Mobility Devices Market Size, Growth and Forecast

New Jersey, United States – This personal mobility device market The report provides detailed market insights to help companies make better business decisions and build growth plans based on market forecasts and trends. The research focuses on group research of data from primary and secondary sources. This Personal Mobility Devices Market report explores the new developments, trends and prospects, and forecasts the current status and future prospects of the market from 2022 to 2029. It dives deep into the industry in terms of current and future situations . The research examines a variety of elements, such as degrees of advancement, technical breakthroughs, and various strategies employed by the current major players in the market.

Furthermore, the objective of this market report is to provide a related assessment of key players along with the costs and benefits of the programmed market. It also uses graphics to focus on industry standards to help businesses progress smoothly. This market report makes it easy to determine the impact of COVID-19 on the market growth. The main objective of this Personal Mobility Devices market report is to include quantitative data in the form of tables and graphs. Knowledge of market fundamentals is presented in a simple and understandable manner for the benefit of readers. This well-planned market analysis provides all readers as well as suppliers, buyers, and stakeholders with a detailed understanding of market conditions and industry environment.

Get Sample Full PDF Copy of Report: (Including Full TOC, List of Tables & Figures, Chart) @ https://www.verifiedmarketresearch.com/download-sample/?rid=37564

Key Players Mentioned in the Personal Mobility Devices Market Research Report:

NOVA Medical Products, Performance Health, Drive DeVilbiss Healthcare, Medline Industries Invacare Corporation, Carex Health Brands Kaye Products Rollz International, GF HEALTH PRODUCTS and Briggs Healthcare

This Personal Mobility Devices Market report also assesses the economic landscapes of the organization to better understand market dynamics at international and regional levels. This study uses benchmarking to uncover up-to-date information about the target market. The best trading techniques are provided in this report which helps to better understand the market. The latest advancements, growth factors, and competitive analysis are all covered in this Personal Mobility Devices market report. He highlighted some of the most effective marketing strategies to drive economic development and help big players reap significant profits.

Personal Mobility Devices Market Segmentation:

Personal Mobility Devices Market, By Product

• Wheel chairs
• Scooters
• Walking aids

The market research analysis further talks about the industry forces to shape the market. Important drivers and end user expectation are also covered in the Personal Mobility Devices market report to get solutions. The forecast of associated revenue is also made in the report. The main purpose of the report is to categorize opportunities. It also explains what business models are used, what is the current level of success, what is the market share and size, and what is the current level of competition in the market. It also sheds light on the functional areas of the business. This Personal Mobility Devices market report also shows how dead stock affects profits and how product losses can be eliminated. With the business tactics provided here, it is possible to experience accelerated growth in your business. It also provides a clear picture of how different business sectors are experiencing the negative impact of COVID-19.

Get a discount on the purchase of this report @ https://www.verifiedmarketresearch.com/ask-for-discount/?rid=37564

Scope of the Personal Mobility Devices Market Report

ATTRIBUTES DETAILS
ESTIMATED YEAR 2022
YEAR OF REFERENCE 2021
FORECAST YEAR 2029
HISTORICAL YEAR 2020
UNITY Value (million USD/billion)
SECTORS COVERED Types, applications, end users, and more.
REPORT COVER Revenue Forecast, Business Ranking, Competitive Landscape, Growth Factors and Trends
BY REGION North America, Europe, Asia-Pacific, Latin America, Middle East and Africa
CUSTOMIZATION SCOPE Free report customization (equivalent to up to 4 analyst business days) with purchase. Added or changed country, region and segment scope.

It becomes easy to determine the pulse of the market with this detailed analysis of the Personal Mobility Devices market. Key players can find all competitive data and market size of major regions like North America, Europe, Latin America, Asia-Pacific and Middle East. As part of the competitive analysis, certain strategies are profiled which are pursued by key players such as mergers, collaborations, acquisitions and new product launches. These strategies will greatly help industry players to strengthen their position in the market and grow their business.

Answers to key questions in the report:

1. Who are the top five players in the personal mobility device market?

2. How will the personal mobility device market evolve in the next five years?

3. Which products and applications will capture the lion’s share of the personal mobility device market?

4. What are the drivers and restraints of the Personal Mobility Devices Market?

5. Which regional market will show the strongest growth?

6. What will be the CAGR and size of the Personal Mobility Devices market throughout the forecast period?

For more information or query or customization before buying, visit @ https://www.verifiedmarketresearch.com/product/personal-mobility-devices-market/

Visualize the Personal Mobility Devices Market Using Verified Market Intelligence:-

Verified Market Intelligence is our BI platform for market narrative storytelling. VMI offers in-depth forecast trends and accurate insights on over 20,000 emerging and niche markets, helping you make critical revenue-impacting decisions for a bright future.

VMI provides a global overview and competitive landscape with respect to region, country and segment, as well as key players in your market. Present your market report and results with an integrated presentation function that saves you more than 70% of your time and resources for presentations to investors, sales and marketing, R&D and product development. products. VMI enables data delivery in Excel and interactive PDF formats with over 15+ key market indicators for your market.

Visualize the Personal Mobility Devices Market using [email protected] https://www.verifiedmarketresearch.com/vmintelligence/

About Us: Verified Market Research®

Verified Market Research® is a leading global research and advisory firm that for over 10 years has provided advanced analytical research solutions, personalized advice and in-depth data analysis to individuals and businesses seeking accurate research, reliable and up to date. data and technical advice. We provide insight into strategic and growth analytics, the data needed to achieve business goals, and help make critical revenue decisions.

Our research studies help our clients make superior data-driven decisions, understand market forecasts, capitalize on future opportunities, and maximize efficiency by working as a partner to deliver accurate and valuable insights. The industries we cover span a wide spectrum, including technology, chemicals, manufacturing, energy, food and beverage, automotive, robotics, packaging, construction, mining and the gas. etc

At Verified Market Research, we help in understanding holistic market indicator factors and most current and future market trends. Our analysts, with their deep expertise in data collection and governance, use industry techniques to gather and review data at all stages. They are trained to combine modern data collection techniques, superior research methodology, subject matter expertise and years of collective experience to produce informative and accurate research.

Having served over 5000 clients, we have provided reliable market research services to over 100 Global Fortune 500 companies such as Amazon, Dell, IBM, Shell, Exxon Mobil, General Electric, Siemens, Microsoft, Sony and Hitachi. We have co-consulted with some of the world’s leading consulting firms such as McKinsey & Company, Boston Consulting Group, Bain and Company for custom research and consulting projects for companies around the world.

Contact us:

Mr. Edwyne Fernandes

Verified Market Research®

USA: +1 (650)-781-4080
UK: +44 (753)-715-0008
APAC: +61 (488)-85-9400
US toll free: +1 (800)-782-1768

E-mail: [email protected]

Website:- https://www.verifiedmarketresearch.com/

read more
Medical products

Surgical Swabs Market Impact and Recovery Analysis Puritan Medical Products, 3M, Dynarex, Copan Diagnostics, BD – Business Merseyside

The research report on Surgical Swabs Market is a professional asset that provides dynamic and statistical insights into the regional and global markets. It includes an in-depth study of the current scenario to safeguard market trends and prospects. Surgical swab research reports also keep track of future technologies and developments. Detailed information about new products, regional and market investments are provided in the report. This surgical swab research report also examines all the elements businesses need to gain unbiased data to help them understand the threats and challenges facing their business. The Healthcare Industry report further includes market gaps, stability, growth drivers, restraining factors, and opportunities over the forecast period.

Get a sample report with table and charts: www.a2zmarketresearch.com/sample?reportId=529762

“Surgical Swab is growing at a good CAGR over the forecast period. The growing interest of individuals in the healthcare industry is one of the main reasons for the expansion of this market. »

Major Companies in this report are: Puritan Medical Products, 3M, Dynarex, Copan Diagnostics, BD, Advacare Pharma, DLS Medical, FL MEDICAL srl

Presentation of the report:

* The report analyzes regional growth trends and future opportunities.

* Detailed analysis of each segment provides relevant information.

* The data collected in the report is researched and verified by analysts.

* This report provides realistic information on supply, demand and future forecasts.

Surgical Swabs Market Overview:

This systematic research study provides an in-depth assessment of the Surgical Swabs market while offering significant fragments of knowledge, chronic information, and measurably maintained industry-approved healthcare market conjecture. Additionally, a controlled and formal set of assumptions and strategies were used to construct this in-depth review.

Segmentation

The report offers an in-depth assessment of the Surgical Swabs market strategies, geographic and business segments of major market players.

Type

Cotton swabs, foam swabs, non-woven swabs, others

Application

Hospitals and clinics, laboratories and diagnostic centers, research institutes

During the crafting of this Surgical Swabs research report, the driving factors of the market are studied. It also provides information on market constraints to help clients build successful businesses. The report also discusses key opportunities.

Get a discount: www.a2zmarketresearch.com/discount/529762

This report provides an in-depth and broad understanding of the surgical swab. With precise data covering all the key characteristics of the current market, the report offers detailed data from key players. An audit of the state of the market is mentioned as accurate historical data for each segment is available during the forecast period. The driving force, restraints, and opportunities are provided to help provide an improved picture of this investment in the market over the forecast period 2022-2027.

Some Key Objectives of the Surgical Swabs Market Research Report:

oh Vital developments: The Custom Survey provides the critical Surgical Swabs Market improvements including R&D, shipment of new items, coordinated efforts, development rate, partnerships, joint efforts, and local development of rivals working on the global and regional healthcare market.

oh Market characteristics: The report contains Surgical Swabs Market Highlights, Revenue, Boundary, Boundary Utilization Rate, Value, Net, Creation Rate, Generation, Utilization, Import, Trade, supply, demand, cost, part of the industry in general, CAGR and gross margin. Likewise, the market report offers an exhaustive investigation of the most recent elements and their patterns, as well as fragments and sub-sections of the Healthcare market.

oh Survey tools: This market report incorporates the precisely considered and assessed information about the major established players and their extension in the Surgical Swabs market by methods. Systematic tools and methodologies for example Porter’s Five Powers Survey, Possibility Study, and many other statistical survey methods have been used to analyze the development of major players working in the Surgical Swabs market .

oh Convincingly, the Surgical Swabs report will give you an unequivocal perspective on every market reality without the need to allude to any other research report or information source. This report will provide you all with the realities of the past, present and future fate of the healthcare market.

Buy exclusive reports: www.a2zmarketresearch.com/buy?reportId=529762

If you have any special requirements, please let us know and we will offer you the report you want.

Contact us:

Roger Smith

1887 WHITNEY MESA DR HENDERSON, NV 89014

[email protected]

+1 775 237 4147

Related reports:

Patent and Trademark Renewal Services Market Share Forecast Global Impact of Competitors

Global Industrial Analytics Market Research Forecast Impact

Global Cleanroom Robots Market Research Forecast Impact

Emulsion Explosives Market Impact, Share Discount Industry Competitors Globally | Orica, IPL, MAXAM, AEL

Emulsion Explosives Market 2022: Business Development, Size, Share and Opportunities 2026

Targeted Therapeutics Market 2022

Reabastecimiento de combustible aire-aire Market 2022: Desarrollo de Negocios, Tamaño, Participación y Oportunidades 2026 Omega Air Refueling Services, Eaton Corporation, Airbus SAS

Spatial Augmented Reality (SAR) Market 2022: Business Development, Size, Share and Opportunities 2026 Intermap Technologies, Autodesk, Cybercity 3D

Dispositivos de oncología interventionista Market 2022: Desarrollo de Negocios, Tamaño, Participación y Oportunidades 2026 Cook Medical, Merit Medical Systems, Boston Scientific Corporation

read more
Medical products

Laser manufacturing of high precision medical products

By Matthew Nipper, Spectrum Plastics Group, Director of Engineering

Laser micromachining is one of the highest precision processes used in the manufacturing of medical devices. In fact, lasers are often the only option capable of producing certain delicate features, especially in thin or sensitive materials. Lasers can quickly cut micron-sized features to sub-micron tolerances without defects, thereby reducing or eliminating secondary finishing processes, shortening cycle times and accelerating time to market. Because of these advantages, lasers are quickly becoming the preferred method for micro-machining miniaturized and/or complex parts and products for medical devices, in virtually any shape or pattern.

Innovative product designs that require microscopic features are often best produced using laser machining, for example, catheters, medical balloons, and devices for neurovascular, cardiovascular, and diagnostic procedures. Features produced in polymers can be as small as 10 microns in width, with tolerances as tight as 1-2 microns.

Polymers are the material of choice for many medical devices. These materials are mechanically robust, bioinert and have excellent insulating properties. Polymers can be engineered to exhibit specific mechanical and chemical characteristics, to improve biocompatibility and performance, and can be extruded, injection molded or additively manufactured. Virtually any thermoplastic or thermoset polymer material can be laser processed with high precision, including polycarbonate, polyurethanes, ABS, FEP, polyamides, polyimides, PEEK, PTFE, PMMA, polyester , nylon, PE and acrylics.

laser methods

As products become smaller and more complex, engineers must use their technical skills, materials knowledge, and experience to design processes that can create tiny, high-precision features that enhance product functionality, which can ultimately improving or saving the lives of patients.

Here are examples of commonly used high-precision laser methods:

laser removal

Lasers can be programmed to remove or “vaporize” material from surfaces with sub-micron precision. Ablation selectively removes substrate or coating layers from the surface of fabricated parts, with little or no negative thermal or structural impacts on the surrounding material.

Laser cut

Laser cutting is ideal for manufacturing/industrial applications that require a powerful, highly precise cutting tool that creates sharp features on a microscopic scale. As products become smaller, with more functionality, complexity and tight tolerances, laser cutting is often the only method that can produce the high precision features these devices require.

Laser drilling

Many manufactured parts today require microscopic features that can only be created with laser drilling. This highly adaptable, versatile and reliable microfabrication process is used in a wide range of industries. Laser fabrication and post-laser processing can be customized to meet unique drilling needs, optimizing applications such as micro-holes, hole arrays, blind holes and specialty portals. Micron-scale holes can be laser drilled in a variety of patterns with the utmost precision, with no burrs or residual material to clog the holes.

wire stripping

Wire stripping removes sections of insulation or shielding from wires and cables to provide electrical contact points for termination. Conventional stripping methods make physical contact with the conductor, which can damage the wire and slow processing speed. Laser wire stripping is much faster, offers excellent accuracy and process control, and eliminates wire contact, allowing the processing of gauges as small as 46 AWG (0.0015 inches in diameter).

Ultra-fast lasers

Ultra-fast lasers are in high demand due to their speed, accuracy, and lack of thermal or structural damage to the material being processed. With an average pulse width of 150 femtoseconds (150 quadrillionths of 1 second), there is virtually no heat transfer beyond the dimensions of the cut, making it a “cold” process. Therefore, secondary processing is usually not required to remove burrs from cutters or improve edge quality, saving time and money.

Components and laser technology

Precision laser processing can be used for extruded medical tubing, catheters and drug delivery products, medical balloons, injection molding and flexible films. For example:

  • Extruded medical tube. Lasers are high-precision machining instruments that cut micron-scale features in extruded tubing that enable specific medical applications, such as intravascular delivery of drugs or stents. Extruded medical tubing is a commonly used component in medical devices. It is made from a variety of materials and in a wide range of shapes and sizes. Important chemical and mechanical properties include heat and chemical resistance, lubricity, flexibility, kink resistance, and drug eluting capabilities.
  • Catheter technologies. The lasers, which offer high speeds, incredible precision and the ability to process without thermally altering the surrounding material, are ideal for removing material by ablation or drilling a variety of micron-sized features in tubing. catheter and other materials. As medical catheters become smaller and more complex, lasers are often the only manufacturing technology capable of providing the precision needed.
  • Medical balloons. Lasers play a vital role in creating detailed, high-precision medicine ball features that no other method can replicate, including; texturing, grooving and section thinning. With the latest laser technologies, tools, and materials, medicine balloons can be fabricated with microscale features, from a wide variety of materials, for neurovascular, cardiovascular, gastrointestinal, urology, and catheterization procedures. increasingly innovative.
  • Injection molding. For injection molded products, lasers can be used to create micron-sized features in molds, process molded ophthalmic implants, and improve osseointegration of injection molded bioresorbable implants. Because ultra-fast lasers cause no thermal damage, they are ideal for treating sensitive implantable and bioresorbable materials.
  • Flexible films. Laser processing can be used for a variety of film applications. For example, lasers can be used to create surface micro-texture patterns on thin films increasing adhesion in delicate bonding applications. Lasers are also ideal for drilling small features, such as dense arrays of holes in filters or spargers. These are often made from thermoplastic materials, which are very heat sensitive.

Spectrum laser processing

As a full-service laser solutions provider, Spectrum can manufacture high-precision parts to exact specifications in the most efficient and cost-effective manner. Spectrum excels at turning even seemingly impossible designs into high-value products that exceed customer expectations.

Not only is Spectrum a contract manufacturer of high precision laser products, but we also supply ready made laser die tubes and laser cut marking tapes online at online store.spectrumplastics.com, which can be used to speed up the development phase of your next project. For more information on Spectrum’s services and laser processing capabilities, visit www.spectrumplastics.com or call 404-564-8560.

Content sponsored by Spectrum Plastics Group

read more
Medical products

Counterfeit medical products increased by 47% between 2020 and 2021, report says

Fueled by the COVID-19 pandemic, incidents of substandard and falsified (SF) medical products increased nearly 47% between 2020 and 2021, according to a report by the Association of Authentication Solution Providers ( ASPA), a non-profit organization that deals with anti-counterfeiting awareness.

The report said the incidents found were mostly related to medical products related to COVID-19, including vaccines, drugs, COVID test kits, antibiotics, face masks and disinfectants. During the peak of COVID-19, incidents of SF medical products were seen in 23 out of 29 states and 7 union territories of India.

“Criminals have seen the pandemic crisis as an opportunity to sell more and more substandard and falsified medical products, taking advantage of the vulnerability of people in need. The huge negative impact of the huge increase in circulation counterfeit medicines and essential medical products on the The fight against the COVID-19 pandemic has gone almost unnoticed.It is unfortunate that criminals manufacture ineffective or harmful products in packages that appear identical to the genuine products, which makes them difficult to detect,” said Nakul Pasricha, ASPA President.

“The circulation and use of these SF medical products violates the right to health and slows down the pace of providing the quality health services that people deserve. It is high time to act firmly to stem this threat. If preventive measures are taken now, we will be in a better position to provide effective healthcare to patients,” Pasricha added.

Despite the guidelines, the circulation of SF medical products has been an under/under-treated problem in India. The government has recently taken the decision to make QR codes on Active Pharmaceutical Ingredients (APIs) mandatory. APIs are the main raw materials used in the manufacture of medicines – capsules, tablets, syrups and others.

National authentication and traceability projects have seen an international trend in recent years, with China, Brazil, Turkey, the United States and the EU being the pioneers in this field. It has helped these countries reduce the parallel market in various industries, improve tax collection, and significantly reduce business losses from counterfeit products and illegal trade. India should also implement these measures in other sectors to join the league of advanced digital economies, observes the report.

Despite the Union government’s efforts to deliver real coronavirus vaccines through transparent procurement and procurement systems and the technology-backed CoWin administration platform, the global monitoring and surveillance system The World Health Organization (WHO) control for substandard and counterfeit medical products in August 2021 had also identified fake versions of the COVID-19 Covishield vaccine in India and Uganda. The apex global public health agency also this month reported the circulation of a fake drug Remdisvir used for the management of COVID-19.

Also read: CBI has made ‘substantial progress’ in investigation of NSE collocation cases: FM Sitharaman

Also Read: PE/VC Investors Raise a Record $41.3 Billion Through Exits in 2021

read more
Medical products

Hot Extrusion Medical Products Market Trend, Impact of COVID-19, Current Industry Figures with Demand by Countries and Future Growth 2026

The latest economic intelligence report on Hot Extrusion Medical Products Market elaborates on the factors responsible for the growth of the industry such as key growth enablers, restraints, and opportunities. Moreover, it expands past years data and current business scenario to infer the performance of the industry over the period 2020-2025.

To calculate the size of the industry on a global level, an exhaustive analysis of how this business sphere operates on a regional and national level is incorporated into the report. Going further, the research literature scrutinizes the dominant players and assesses the strategies adopted by them to stay in the competitive arena. Additionally, the current and projected impact of the Covid-19 pandemic was taken into consideration with a focus on revenue generation prospects and methodologies to deal with the changing landscape.

Main highlights of the table of contents:

Request a sample copy of this report @ https://www.runningafrica.com/request-sample/2952

Product land

  • Product range: Films, taste masking, drug eluting devices and others
  • Forecasts of the growth rate of each product type over the forecast period.
  • Returns earned and market share held by each product category.

Scope

  • Application spectrum: Research laboratory, contract manufacturing organization and pharmaceutical companies
  • Estimates of product demand and market share for each type of application.
  • Annual growth rate of each application segment over the forecasted schedule.

Regional outlook

  • Geographic bifurcation: North America, Europe, Asia-Pacific, Latin America and Middle East and Africa.
  • Figures relating to total sales and net income accumulated by each regional market.
  • Annual growth rate of each region over the forecast period.

Competitive landscape

  • Main contenders: AbbVie Formex BASF Pharma Omipa Biogrund Lubrizol
  • Assessment of the market concentration ratio.
  • Portfolio of products and services of listed companies.
  • Manufacturing units of key players in operating regions.
  • Financial attributes such as pricing model, sales, profit margins, and market share for each company.
  • Updates on the latest mergers, acquisitions and expansion proposals.

To summarize, the report authors have inspected the Hot Melt Extrusion Medical Devices market through several segmentations followed by in-depth discussion on industry supply and sales channel including upstream basics and downstream to help companies effectively deploy their products and solutions to market. .

The Hot Extrusion Medical Products market report is summarized as follows:

Industry with market definition, key elements such as market restraints, drivers, potential opportunities, challenges, Medical Hot Melt Extrusion Products market trends, etc.

Hot Extrusion Medical Products Market Segmentation Based on Product, Application, Geographic Region and Competitive Market Share

Hot Extrusion Medical Products Market Size, Approximations, Forecast for the said Period

Hot Melt Extrusion Medical Products Market Distribution Channel Assessment

Competitive analysis of crucial Hot Melt Extrusion Medical Products Market manufacturers, trends, company profiles, strategies, etc.

Factors responsible for the growth of the hot extrusion medical products market

The in-depth geographic market assessment of the leading hot melt extrusion medical products market

Customization request on this report @ https://www.runningafrica.com/request-for-customization/2952

read more
Medical products

Swabs Market Size and Forecast

New Jersey, United States,- The latest research report provides a comprehensive assessment of the swab market for the forecast year 2022-2029, which is beneficial for businesses regardless of their size and revenue. This survey report covers key market insights and industry approach related to COVID-19 (Omicron) in the coming years. The Swab market report provides data and information on investment structure development, technological enhancements, market trends and developments, abilities, and in-depth information about major Swab market players. The market strategies followed globally with respect to the current and future scenario of the industry have also been detailed in the study.

The report begins with a brief introduction and overview of the Swabs market, current market landscape, market trends, major market players, product type, application, and region. It also covers the impact of COVID-19 (Omicron) on Swabs Market trends, future forecasts, growth opportunities, end-user industries, and market players. It also provides historical data, current market scenarios and future information on the Swab Market. This study provides a comprehensive understanding of the market value with product price, demand, gross margin, and supply of the Swabs market. The Competitive Perspective section of the report provides a clear insight into the market share analysis of key industry players.

Get Sample Full PDF Copy of Report: (Including Full TOC, List of Tables & Figures, Chart) @ https://www.verifiedmarketresearch.com/download-sample/?rid=23805

Key Players Mentioned in the Swabs Market Research Report:

Puritan Medical Products, Sarstedt, MWE, SARSTEDT AG & Co, Lab M Limited., Clean Cross Co. Ltd., GPC medical ltd., Citotest Labware Manufacturing Co., Ltd. and Q-TIPS, ELMEX.

Swabs market is segmented by Product and Type. All of these segments were examined individually. The detailed study helps to evaluate the factors affecting the Swabs market. Experts analyzed the nature of development, investments in research and development, changing consumption patterns and the growing number of applications. In addition, analysts have also assessed the development of the economy around the Swab market, which is likely to impact its price.

Swabs Market Segmentation:

Swabs Market, By Application

• Pharmaceutical
• Microbiological
• Laboratory
• Others

Swab market, by well

• Aluminum
• Polypropylene
• Others

Swabs Market, By Test Type

• DNA test
• Urine test
• Saliva test
• Others

The regional analysis section of the report allows players to focus on high growth regions and countries that could help them expand their presence in the swabs market. Besides expanding their presence in the swabs market, regional analysis helps players increase their sales while gaining a better understanding of customer behavior in specific regions and countries. The report provides CAGR, revenue, production, consumption and other important statistics and figures in global and regional markets. It shows how different types, applications, and regional segments of the Swabs market are progressing in terms of growth.

Get a discount on the purchase of this report @ https://www.verifiedmarketresearch.com/ask-for-discount/?rid=23805

Scope of Swabs Market Report

ATTRIBUTES DETAILS
ESTIMATED YEAR 2022
YEAR OF REFERENCE 2021
FORECAST YEAR 2029
HISTORICAL YEAR 2020
UNITY Value (million USD/billion)
SECTORS COVERED Types, applications, end users, and more.
REPORT COVER Revenue Forecast, Business Ranking, Competitive Landscape, Growth Factors and Trends
BY REGION North America, Europe, Asia-Pacific, Latin America, Middle East and Africa
CUSTOMIZATION SCOPE Free report customization (equivalent to up to 4 analyst business days) with purchase. Added or changed country, region and segment scope.

It becomes easy to determine the pulse of the market with this detailed analysis of the swabs market. Key players can find all competitive data and market size of major regions like North America, Europe, Latin America, Asia-Pacific and Middle East. As part of the competitive analysis, certain strategies are profiled which are pursued by key players such as mergers, collaborations, acquisitions and new product launches. These strategies will greatly help industry players to strengthen their position in the market and grow their business.

Answers to key questions in the report:

1. Who are the top five Swab market players?

2. How will the swab market evolve over the next five years?

3. Which product and application will occupy the lion’s share of the Swab market?

4. What are the Swab Market drivers and restraints?

5. Which regional market will show the strongest growth?

6. What will be the CAGR and size of the Swab market throughout the forecast period?

For more information or query or customization before buying, visit @ https://www.verifiedmarketresearch.com/product/swab-market/

Visualize the swab market using verified market intelligence:-

Verified Market Intelligence is our BI platform for market narrative storytelling. VMI offers in-depth forecast trends and accurate insights on over 20,000 emerging and niche markets, helping you make critical revenue-impacting decisions for a bright future.

VMI provides a global overview and competitive landscape with respect to region, country and segment, as well as key players in your market. Present your market report and results with an integrated presentation function that saves you more than 70% of your time and resources for presentations to investors, sales and marketing, R&D and product development. products. VMI enables data delivery in Excel and interactive PDF formats with over 15+ key market indicators for your market.

Visualize Swab Market using [email protected] https://www.verifiedmarketresearch.com/vmintelligence/

About Us: Verified Market Research®

Verified Market Research® is a leading global research and advisory firm that for over 10 years has provided advanced analytical research solutions, personalized advice and in-depth data analysis to individuals and businesses seeking accurate research, reliable and up to date. data and technical advice. We provide insight into strategic and growth analytics, the data needed to achieve business goals, and help make critical revenue decisions.

Our research studies help our clients make superior data-driven decisions, understand market forecasts, capitalize on future opportunities, and maximize efficiency by working as a partner to deliver accurate and valuable insights. The industries we cover span a wide spectrum, including technology, chemicals, manufacturing, energy, food and beverage, automotive, robotics, packaging, construction, mining and the gas. etc

At Verified Market Research, we help in understanding holistic market indicator factors and most current and future market trends. Our analysts, with their deep expertise in data collection and governance, use industry techniques to gather and review data at all stages. They are trained to combine modern data collection techniques, superior research methodology, subject matter expertise and years of collective experience to produce informative and accurate research.

Having served over 5000 clients, we have provided reliable market research services to over 100 Global Fortune 500 companies such as Amazon, Dell, IBM, Shell, Exxon Mobil, General Electric, Siemens, Microsoft, Sony and Hitachi. We have co-consulted with some of the world’s leading consulting firms such as McKinsey & Company, Boston Consulting Group, Bain and Company for custom research and consulting projects for companies around the world.

Contact us:

Mr. Edwyne Fernandes

Verified Market Research®

USA: +1 (650)-781-4080
UK: +44 (753)-715-0008
APAC: +61 (488)-85-9400
US toll free: +1 (800)-782-1768

E-mail: [email protected]

Website:- https://www.verifiedmarketresearch.com/

read more
Medical products

Scoliosis Management Market 2022-2030, by Top Key Players – Aspen Medical Products, Boston Orthotics & Prosthetics, LA Brace, Charleston Bending Brace, Spinal Technology

The Scoliosis Management Market report is a perfect basis for people who are looking for comprehensive study and analysis of the Scoliosis Management Market. This report contains study and miscellaneous information which will help you to understand your niche and focus major market channels in the regional and global Scoliosis Management market. To understand the competition and take action based on your key strengths, market size, current and future years demand, supply chain information, business concerns, competitive analysis and prices as well as supplier information will be presented to you. The report also includes information about the major market players, Scoliosis Management applications, its type, trends and overall market share.

To put your business plan into action based on our detailed report, you will also receive comprehensive and accurate forecasts and projected figures for the future. This will provide an overview of the market and help design solutions to leverage key profitable elements and gain market clarity to develop strategic plans. The data present in the report comes from different publications in our archives as well as many reputable paid databases. Moreover, the data is gathered with the help of dealers, raw material suppliers, and customers to ensure that the end result covers every minute detail regarding the Scoliosis Management market, making it a perfect tool for serious buyers of this study.

Scoliosis Management Market: Competition Landscape

The Scoliosis Management Market report includes information on product launches, sustainability, and outlook from key vendors including: (Aspen Medical Products, Boston Orthotics & Prosthetics, LA Brace, Charleston Bending Brace, Spinal Technology, Inc., Optec USA, Inc., Pro-Tech Orthopedics, DJO Global, UNYQ, Lawall Prosthetics and Orthotics, Chaneco, Trulife, Össur, Ortholutions GmbH & Co. KG, Ottobock)

Click the link for a free sample report @ https://crediblemarkets.com/sample-request/scoliosis-management-market-385291?utm_source=Amruta&utm_medium=SatPR

Scoliosis Management Market: Segmentation

By types

Thoraco-lumbo-sacral orthosis (TLSO)
Sacral Lumbar Thoracic Cervical Orthosis (CTLSO)
Lumbosacral orthosis (OSL)
Scoliosis brace
Others

By apps

Online pharmacies
Hospitals & Clinics
Retail pharmacies

Scoliosis Management Market: Regional Analysis

The whole regional segmentation has been studied based on recent and future trends, and the market is forecast through the forecast period. The countries covered in the regional analysis of the Global Scoliosis Management Market report are USA, Canada & Mexico North America, Germany, France, UK, Russia , Italy, Spain, Turkey, Netherlands, Switzerland, Belgium and the rest of Europe in Europe, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, China, Japan, India, South Korea, Rest of Asia Pacific (APAC) in Asia Pacific (APAC), Saudi Arabia, United Arab Emirates, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as part of the Middle East and Africa (MEA), and Argentina, Brazil and the rest of South America as part of South America.

Key benefits of the report:

  • This study presents the analytical representation of the global Scoliosis Management industry together with current trends and future estimations to determine impending pockets of investment.
  • The report presents information related to key drivers, restraints, and opportunities, along with a detailed analysis of the global Scoliosis Management market share.
  • Current market is quantitatively analyzed from 2021 to 2028 to highlight the growth scenario of the global Scoliosis Management market.
  • Porter’s five forces analysis illustrates the power of buyers and suppliers in the marketplace.
  • The report provides a detailed analysis of the Global Scoliosis Management Market based on the competitive intensity and how the competition will shape in the coming years.

Directly buy this market research report now @ https://crediblemarkets.com/reports/purchase/scoliosis-management-market-385291?license_type=single_user;utm_source=Amruta&utm_medium=SatPR

Main points covered in the table of contents:

Market overview: It includes six sections, research scope, key manufacturers covered, market fragments by type, Scoliosis Management market shares by application, study objectives and years considered.

Market landscape:Here, the global Scoliosis Management market opposition is dissected, by value, revenue, transactions, and pie slice by organization, market rate, fierce circumstances Latest landscape and patterns, consolidation, development, obtaining and parts of the entire industry from top organizations.

Manufacturer Profiles: Here, the driving players of the global Scoliosis Management market are considered dependent on region of deals, key elements, net benefit, revenue, cost, and creation.

Market Status and Outlook by Region: In this segment, the report examines net benefit, transactions, revenue, creation, global industry share, CAGR and market size by region. Here, the Global Scoliosis Management Market is thoroughly examined based on regions and countries like North America, Europe, China, India, Japan, and MEA.

Application or end user: This segment of the exploration study demonstrates how extraordinary end-customer/application sections are added in the global Scoliosis Management market.

Market forecast: Production side : In this part of the report, the creators focused on the conjecture of creation and creation esteem, the gauge of the main manufacturers and the estimation of the creation and creation esteem by type .

Research results and conclusion: This is one of the last segments of the report where the findings of the investigators and the end of the exploratory study are given.

Answers to key questions in the report:

  • What will be the market development pace of the Scoliosis Management market?
  • What are the key factors driving the Global Scoliosis Management Market?
  • Who are the main manufacturers on the market?
  • What are the market openings, market risks and market outline?
  • – What are sales volume, revenue, and price analysis of top manufacturers of Scoliosis Management market?
  • Who are the distributors, traders and dealers of Scoliosis Management Market?
  • What are the Scoliosis Management market opportunities and threats faced by the vendors in the global Scoliosis Management Industries?
  • What are the deals, revenue, and value review by market types and uses?
  • What are the transactions, revenue and value review by business areas?

About Us

Credible Markets is a new era market research company with a firm grip on the pulse of global markets. Credible Markets has become a trusted source for business market research needs in a short period of time. We’ve partnered with leading market intelligence publishers and our report pool coverage spans all key industry verticals and thousands of micro-markets. The massive repository allows our clients to choose from recently released reports from a range of publishers who also provide in-depth analysis by region and country. Moreover, pre-booked research reports are among our best offers.

The collection of market intelligence reports is regularly updated to provide visitors with quick access to the latest market information. We provide round-the-clock support to help you reuse search parameters and benefit from a full range of reserved reports. After all, it’s about helping you make an informed strategic decision on purchasing the right report that meets all your market research demands.

Contact us

Credible market analyzes
99 Wall Street 2124 New York, NY 10005
E-mail: [email protected]

read more
Medical products

South Korea to deliver non-lethal military medical products to Ukraine

On the 15th, the South Korean government said it would provide non-lethal military supplies to Ukraine, which is fighting the Russian incursion. “The government has agreed to deliver non-lethal military supplies to Ukraine,” Boo Seung-chan, spokesman for the Ministry of National Defense, said during a regular briefing. “As for details, including transportation and other matters, conversations are ongoing,” spokesman Boo said. A total of 20 goods will be sent to Ukraine. Military supplies include combat helmets, blankets, emergency snacks and military folding beds, which total 12 items. Medical supplies are among the other items. The total amount of supplies provided to Ukraine is estimated at around 1 billion won.

Military supplies should be shipped by air. From this week or next week at least, the supplies will be sent to Ukraine. Meanwhile, the Ministry of National Defense announced on the 15th that a direct communication channel with the Russian Navy and Air Force would be opened. Spokesman Boo said: “We were informed earlier this year that the Russian communication network has been installed. The official opening is expected to take place after a test call between the two countries.

Summary of news:

  • South Korea to deliver non-lethal military medical products to Ukraine
  • Check out all the news and articles from the latest global news updates.
Disclaimer: If you need to update/edit this article, please visit our Help Center. For the latest updates, follow us on gohohgIand News
read more
Medical products

The Definitive Guide 2021 – Second Sight Medical Products LLC, Nano Retina Ltd., Nidek Co. Ltd., MetaModal LLC, Bionic Vision Technologies, Biomedical Technologies SL – The Bollywood Post

The Global bionic eye market report focused on the comprehensive analysis of the current and future outlook of the Bionic Eye industry. This report is a consolidation of primary and secondary research, which provides market size, share, dynamics and forecasts for various segments and sub-segments considering macro and micro environmental factors. An in-depth analysis of past trends, future trends, demographics, technological advancements, and regulatory requirements of the Bionic Eye market has been performed to calculate the growth rates of each segment and sub-segments.

The influence of the latest government directives is also analyzed in detail in the report. It studies the Bionic Eyes market’s trajectory between forecast periods. The cost analysis of the Global Bionic Eyes Market has been done while considering manufacturing expense, labor cost, and raw materials along with their market concentration rate, suppliers, and price trend.

Sample Free Report + All Related Charts & Graphs @ https://www.adroitmarketresearch.com/contacts/request-sample/1651?utm_source=PT14

Major Bionic Eyes Market Players Including:

Second Sight Medical Products LLC, Nano Retina Ltd., Nidek Co. Ltd., MetaModal LLC, Bionic Vision Technologies, Biomedical Technologies SL, Monash Vision Group and Pixium Vision

This report in this research study provides the current economic state of the Bionic Eye industry in both local and . The market study is a valuable source of information for market players including policy makers, professionals, R&D experts, academics, suppliers, manufacturers and all market players interested in the Eye Care market bionic. The strongest single-level segments of the Bionic Eye market are highlighted in the report, representing their market share, market size, annual sales, revenue in terms of Million US$ and future scope of these markets.

In addition, new technologies incorporated into these segments to increase productivity and efficiency are studied in detail. Different standard methodologies are applied to collect the data and measure the current status and development of the Eye Bionics Market. The specific objective of data collection is to analyze the most innovative and productive sectors of the Bionic Eye market. The research is supplemented with data from various surveys and industry associations. The report presents all important market information such as business scenarios, cost structure, cost benchmarking, top performing application and product segments and those about to experience growth quick. The report estimates the revenue generated by these products and their contribution to market output.

The report discusses the segments and its products or services that are dominating the market and have immense growth potential in the market. Also, the production cost, competition, and which companies are investing significant funds to make the product or service more attractive are detailed in the report. Data and product or service distribution and market response are included in the report. Price patterns, target markets for the same product and reasons for price fluctuations for the same product or service in different markets are discussed in the report.

Bionic Eyes Market Segment By Type:

By technology (electronic, mechanical) Type (external eye, implanted eye) End use (hospitals, eye clinics, other)

Bionic Eyes Market Segment By Application:

N / A

Why B2B companies around the world rely on us to grow and maintain revenue:

• Obtain a clear understanding of the Bionic Eye market, how it works and the different stages of the value chain.
• Understand the current market situation and future growth potential of the Eye Bionics Market throughout the forecast period.
• Develop marketing strategies, market entry, market expansion and other business plans by understanding the factors influencing market growth and buyer purchasing decisions.
• Understand your competitors’ business structures, strategies and prospects and react accordingly.
• Make more informed business decisions using insightful primary and secondary research sources.

This report provides:

A detailed overview of the global Bionic Eye Market.
Assessment of global industry trends, historical data from 2011, projections for the coming years and anticipation of compound annual growth rates (CAGR) by the end of the forecast period.
Discoveries of new market insights and targeted marketing methodologies for Global Bionic Eye
Discussion on R&D and demand for new product launches and applications.
Varied company profiles of major industry players.
The composition of the market, in terms of dynamic molecule types and targets, highlighting the key industry resources and players.
The growth of patient epidemiology and market revenue for the global market and among key players and market segments.
Study the market in terms of generic and premium product revenues.
Determine business opportunities in the market sales scenario by analyzing trends in licensing and co-development agreements.

Contents:

1 Scope of the report
1.1 Market Overview
1.2 Research objectives
1.3 Years considered
1.4 Market research methodology
1.5 Economic indicators
1.6 Currency considered
2 Executive Summary
3 Global Bionic Eye by Players
4 Bionic Eye by Regions
4.1 Bionic Eyes Market Size by Regions
4.2 Americas Bionic Eyes Market Size Growth
4.3 APAC Bionic Eyes Market Size Growth
4.4 Europe Bionic Eyes Market Size Growth
4.5 Middle East & Africa Bionic Eyes Market Size Growth
5 Americas
6 APACs
7Europe
8 Middle East and Africa
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market trends
10 Global Bionic Eyes Market Forecast
Analysis of the 11 key players
12 Research findings and conclusion

Do you have a specific question or requirement? Ask our industry expert @ https://www.adroitmarketresearch.com/contacts/enquiry-before-buying/1651?utm_source=PT14

ABOUT US:

Adroit Market Research is an India-based business analytics and consulting company. Our target audience is a wide range of businesses, manufacturing companies, product/technology development institutions and industry associations who need to understand market size, key trends, participants and future prospects of an industry. We intend to become our clients’ knowledge partner and provide them with valuable market insights to help them create opportunities that increase their revenue. We follow a code – Explore, learn and transform. At our core, we are curious people who enjoy identifying and understanding industry patterns, creating insightful study around our findings, and crafting lucrative roadmaps.

CONTACT US:

ryan johnson
Global Account Manager
3131 McKinney Ave Ste 600, Dallas,
TX 75204, USA
Phone number: USA: +1.210.667.2421/ +91 9665341414

read more
Medical products

Hot Extrusion Medical Products Market Trends by 2026 with Major Key Players – BASF Pharma, Formex, Omipa, Biogrund, AbbVie and Lubrizol

This global Hot Extrusion Medical Products Market is an attempt to analyze the global opportunities in the field of the global industry, its current capabilities and the potential of selected countries and regions in the market. The report to businesses and companies provides a better understanding of their ability to invest in the market. The report provides the most business-critical issues of the leading organizations in the Global Hot Melt Extrusion Medical Devices Market globally. The report aims to explain to market players the business outlook, key developments and drivers of the global hot melt extrusion medical products market.

The challenges and opportunities of the Hot Melt Extrusion Medical Products market are presented in the report. The report highlights critical value chain destinations of the global hot extrusion medical products market. The report also highlights issues and concerns of local and foreign market players and provides recommendations for policy makers and actions for industrials to grow in the global Medical Hot Melt Extrusion Products market. The report makes projections based on the current global economic scenario. The uncertainties and difficulties faced by the Hot Extrusion Medical Devices market players are included.

Request a sample report: https://www.orbisresearch.com/contacts/request-sample/6239962?utm_source=Sgir

Major Players of Global Hot Extrusion Medical Products Market:

AbbVie
Formex
BASF Pharmaceuticals
omipa
Biogrund
Lubrizol

Points covered in the Hot Melt Extrusion Medical Products Market report:

• Overview of the global hot melt extrusion medical products market by studying different segments.
• The employment contribution of the global hot melt extrusion medical products market to economies around the world.
• The economic contribution of the global hot melt extrusion medical products market to economies around the world.
• Key players’ marketing approaches to attract foreign markets for hot extrusion medical products.
• Domestic and global regulatory constraints faced by the Hot Extrusion Medical Products market players.
• Global and/or regional trends in the medical hot melt extrusion industry in selected countries.
• Financial information and capital market information of hot melt extrusion medical products are provided in the report.

Type of hot extrusion medical products industry includes:

Movies
Taste masking
Drug eluting devices
Others

Hot extrusion medical products industry applications consist of:

Research Laboratory
Contract manufacturing organization
Pharmaceutical companies

This report analyzes the recent Hot Melt Extrusion Medical Devices industry trends along with the production chain, consumption patterns, regional and international level business activities and other industry related fields. The report emphasizes the potential of the global hot extrusion medical products market in developed countries. The data used to study all the factors of the global hot extrusion medical products market uses data from 2010 to 2020 also considering the latest year for performing the analysis. The report compares the growth rates of the strongest segments and consumption and production patterns. The report provides a detailed study of the performance of major Hot Melt Extrusion Medical Products market on the domestic and global fronts. Additionally, the report highlights the countries with the greatest potential for future growth.

Investigate before accessing the report at: https://www.orbisresearch.com/contacts/enquiry-before-buying/6239962?utm_source=Sgir

Why Buy This Hot Melt Extrusion Medical Products Market Report?

• This report helps the Hot Melt Extrusion Medical Products market players to strengthen their market position, improve their business, reach markets and gain competitive advantages.
• The Hot Melt Extrusion Medical Products report focuses on the strategies implemented by manufacturers in their operations, purchasing, and supply chain management.
• The report leverages the capabilities of Hot Melt Extrusion Medical Devices market players to seize new opportunities.
• The report offers supply chain visibility to enable improvisation for Hot Melt Extrusion Medical Devices market players who wish to expand their business into new international markets.
• The Hot Melt Extrusion Medical Products report compares the growth rates of the strongest segments and consumption and production patterns.
• The supply chain visibility provided in this report aids in understanding the drivers of the Global Hot Melt Extrusion Medical Devices Market and helps them maintain their leading position in the Global Hot Melt Extrusion Medical Devices Market over the course of years of forecasting.

About Us:

Orbis Research (orbisresearch.com) is a one-stop-shop for all your market research needs. We have an extensive database of reports from leading publishers and authors around the world. We specialize in delivering customized reports according to our clients’ requirements. We have complete information about our publishers and therefore are sure of the accuracy of the industries and verticals of their specialization. This helps our clients map their needs and we produce the perfect market research required for our clients.

Contact us:

Hector Costello
Senior Manager – Client Engagements
Central Highway 4144N,
Suite 600, Dallas,
Texas – 75204, USA
Telephone number: United States: +1 (972)-362-8199 | IND: +91 895 659 5155
Email ID: [email protected]

Buy the full report at: https://www.orbisresearch.com/contact/purchase-single-user/6239962?utm_source=Sgir

read more
Medical products

This week’s big story: Stop banning medical product exports, report says

A new report from the National Academies of Sciences, Engineering and Medicine in the United States calls for an international treaty to prevent countries from banning exports of medical products, in a bid to prevent supply shortages.

The paper, called Strengthen the resilience of the country’s medical product supply chains, cites the restrictions that a number of countries have imposed on the export of medical products during the pandemic. Many of these still remain, as according to the World Trade Organization (WTO), 45 countries still had more than 70 restrictions in place in 2021, many of which applied to medical products.

The authors of the article go on to warn that export restrictions “can be dangerously counterproductive. What makes sense in an isolated emergency can be seriously detrimental in a global crisis.”

Globalization and the pharmaceutical industry

The pandemic has highlighted how dependent countries have become on imports to ensure they can meet domestic drug demand. China produces most of the active pharmaceutical ingredients (APIs) needed to manufacture common drugs such as penicillin and acetaminophen. India, in turn, relies heavily on imports from China to manufacture drugs for the US market, where it is the largest supplier of generic drugs.

The Russian invasion of Ukraine also raises fears that global supply chains could be disrupted. Russia signed an executive order this week banning exports of medical products from a list of countries it has deemed “unfriendly”, including the UK, EU, Canada, New Zealand, US States, Switzerland and Japan. This ban will apply to products stored in warehouses in Russia, or which pass through customs controls.

The need for collaboration

In the paper, the authors urge the US federal government to consider a multilateral agreement with major exporters of medical products that would be overseen by the World Trade Organization (WTO). They also suggest that the WTO could impose sanctions on countries that have not joined the agreement.

The 336-page document calls for greater international cooperation to prevent supply chain disruptions. It also contains detailed recommendations to prevent national shortages, such as pharmacy teams working with hospitals to inform them of a potential shortage and suggest alternative forms of treatment.

Earlier this year, the US Food and Drug Administration (FDA) made permanent its guidance to prevent supply shortages in the wake of the Covid-19 pandemic. This included requiring manufacturers to submit a notification at least six months before a product is permanently discontinued.

Also in the news:

google launched a new campaign featuring women entrepreneurs in Africa, including the story of Vivian Nwakah who launched Medsaf, a pharmaceutical supply chain solution to help Nigerians access quality pharmaceutical healthcare.
Pharmaceutical Logistics IQ has launched a new survey with SkyCell to get your perspective on the issues facing pharmaceutical supply chains today and the role hybrid container solutions could play. Share your thoughts with us and enter our draw to win a $100 Amazon gift card.

Get exclusive access to articles, reports, videos, interviews, webinars and other members-only premium content from industry experts and thought leaders by signing up for Pharma Logistics IQ here.

read more
Medical products

“Shortage” of medical products in Ukraine – WHO

There is a “shortage” of essential medical supplies in Ukraine, health officials have warned in condemning at least 16 attacks on health services in the country.

The World Health Organization (WHO) said there had been 16 attacks on health services, including damage to facilities and hospitals, as well as the commandeering of ambulances and the hijacking of ambulances from ’emergency.

These attacks left nine dead and 16 injured, according to the WHO.

The European branch of the global health body also said there was a shortage of essential supplies in Ukraine, including oxygen, insulin, surgical supplies and blood.

(PA graphics)

(PA graphics)

Experts have also warned that Covid deaths will rise due to a lack of oxygen supply in the region – with 731 deaths reported last week.

Meanwhile, health officials have raised concerns about cases of hypothermia – where a person’s body temperature becomes dangerously low – among refugees in cold weather.

They also highlighted fears over maternity care for pregnant Ukrainian women, with around 80,000 women expected to give birth in the country in the next three months.

During a press briefing on the humanitarian crisis that resulted from the conflict, Dr Hans Henri Kluge, WHO Regional Director for Europe, said: “It is now 13 days since the military offensive began in Ukraine, and today in the country, we see a healthcare system under great pressure, and beyond its borders, the fastest growing refugee crisis in Europe for more than 75 years.

“Life-saving essential medicines, such as oxygen and insulin, personal protective equipment, surgical supplies, anesthetics and safe blood products, are in short supply.”

He said 76 tons of trauma and emergency health supplies are in transit in Ukraine, with more on the way.

WHO is also working to ensure that refugees crossing the border have access to health care and that those who remain in the country also receive support.

Dr Kluge added: “It should not be necessary to say that health workers, hospitals and other medical establishments should never be a target at any time, including during crises and conflicts. To date, we have 16 confirmed reports of health incidents in Ukraine, with more being verified.



We know from previous conflicts that when more doors close, health diplomacy becomes key

Dr Hans Henri Kluge, WHO Regional Director for Europe

“WHO strongly condemns these attacks on health services.”

Dr Catherine Smallwood, WHO Europe Incident Manager for Covid-19, said: “We have documented or verified 16 attacks with varying levels of certainty.

“These have, to our knowledge, caused at least nine deaths and 16 injuries, and they have occurred in various major cities and around conflict zones.

“This includes direct attacks on health facilities or hospitals that have been damaged.

“It also includes the appropriation of health infrastructure such as ambulances, it includes the diversion of ambulances and their use for purposes not directly related to the provision of health care.”

Dr Kluge praised Ukrainian health officials for continuing to monitor the spread of Covid-19, but added that “731 Covid-19 deaths were reported to WHO from Ukraine last week, and unfortunately, that number will increase as oxygen shortages continue.”

He said: “Older people will be disproportionately affected because their access to healthcare is disrupted and because only a third of those over 60 are fully protected with a full course of vaccines.”

Asked about the humanitarian corridors, Dr Kluge said: “Time is running out, so in that sense, willy-nilly, we need to get whatever we can to the affected areas.

(PA graphics)

(PA graphics)

“We know from previous conflicts that when more doors close, health diplomacy becomes key.

“Our principle is health for all and our top priority is to get life-saving humanitarian medical supplies to people in need.”

On maternity care, Dr Isabel Yordi Aguirre, WHO Europe Technical Officer for Gender and Human Rights, said: “The estimate from UNFPA (United Nations Population Fund ) that 80,000 women will give birth in the next three months in Ukraine means that these women may have gone from a life-changing experience to a life-threatening experience.

“The UNHCR (UN Refugee Agency) predicts that by July this year we will have four million refugees, which will mean around 1,000 births per week that will be anticipated.

“That’s why we must ensure that sexual and reproductive health services are at the heart of our assistance to women – refugees crossing borders and women left behind.”

Tarik Jasarevic, WHO Field Representative in Ukraine, said at the briefing: “It is heartbreaking to see hundreds, if not thousands, of people on the border between Ukraine and Poland – mainly women and children seeking treatment and seeking safety.



Health facilities need supplies, they need electricity, they need water

Tarik Jasarevic, WHO representative in Ukraine

He added: “In the east, hundreds of health facilities are either areas that have changed control or are along the battle lines or within 10 kilometers of them.

“Health facilities need supplies, they need electricity, they need water.

“I have just spoken to a doctor who is in contact with his colleagues in the most affected areas in the East and she was telling me that people cannot access health centers and hospitals because of security and the structural damage.

“And this is not just the case for patients but also for health workers who risk their lives to get to their place of work.”

read more
Medical products

Stereotactic Biopsy Table Market Size 2022-2029

New Jersey, United States,-Global Stereotactic Biopsy Table Market Size, Status and Forecast 2022-2028. This research report covers key aspects of the Stereotactic Biopsy Table market including drivers, limitations, past and current trends, regulatory scenarios, and technological developments. An in-depth study of industry’s role in the COVID-19 outbreak. A comprehensive risk assessment and industry recommendations have been made for market research reports and industry analysis over a specific period of time. The report compares the market before Corona 19 and after Corona 19. The impact of COVID-19 on the local economy is also considered in the study.

Get | Download a sample copy with table of contents, graphics and list of [email protected] https://www.marketresearchintellect.com/download-sample/?rid=448109

The term Based Stereotactic Biopsy Table market study provides helpful insights such as studying the effects on significant aspects, alternatives, and restraints. Graphical analysis of the Emotion Detection and Recognition demand forecasts for the predicted periods can demonstrate the financial requirements of the global Emotion Detection and Recognition industry. Likewise, the study highlights features which limit demand growth, adequately predict Stereotactic Biopsy Table Market quantities, and have long term effects over the predicted period.

The impact of the Corona 19 outbreak on the global Emotion Sensing and Awareness industry, growth rates, correct supply chain analysis, scale in various scenarios, and responses Corporate critiques of the outbreak are all examined in research on emotion sensing and sensitization. The research focuses on emotion detection and recognition in global markets, particularly in North America, Europe and the Asia-Pacific region, as well as South America, the Middle East and Africa. The study divides the market into four parts: manufacturer, region, type and application.

Major Players Covered in Stereotactic Biopsy Tables Markets:

  • MPI Medical
  • Devicor medical products
  • Siemens
  • Aurora imaging technology
  • Hological
  • Planmeca
  • Metaltronics

Stereotactic Biopsy Tables Market Split By Type:

  • Mechanically operated stereotactic biopsy table
  • Electronically controlled stereotactic biopsy table

Stereotactic Biopsy Tables Market Split By Applications:

  • Hospital
  • diagnostic center
  • Others

The Stereotactic Biopsy Table market report has been segregated into distinct categories such as product type, application, end-user, and region. Each segment is valued based on CAGR, share, and growth potential. In the regional analysis, the report highlights the prospective region, which is expected to generate opportunities in the global Stereotactic Biopsy Tables Market in the coming years. This segmental analysis will surely prove to be a useful tool for readers, stakeholders, and market players to get a complete picture of the global Stereotactic Biopsy Tables market and its growth potential in the coming years.

Get | Discount on the purchase of this report @ https://www.marketresearchintellect.com/ask-for-discount/?rid=448109

Scope of the Stereotactic Biopsy Tables Market Report

Report attribute Details
Market size available for years 2022 – 2029
Base year considered 2022
Historical data 2019 – 2021
Forecast period 2022 – 2029
Quantitative units Revenue in USD Million and CAGR from 2023 to 2029
Segments Covered Types, applications, end users, and more.
Report cover Revenue Forecast, Business Ranking, Competitive Landscape, Growth Factors and Trends
Regional scope North America, Europe, Asia-Pacific, Latin America, Middle East and Africa
Scope of customization Free report customization (equivalent to up to 8 analyst business days) with purchase. Added or changed country, region and segment scope.
Pricing and purchase options Take advantage of personalized purchasing options to meet your exact research needs. Explore purchase options

Regional Market Analysis Stereotaxic Biopsy Chart can be represented as follows:

Each regional Stereotaxic Biopsy Table sector is carefully researched to understand its current and future growth scenarios. This helps players strengthen their position. Use market research to get a better perspective and understanding of the market and target audience and ensure you stay ahead of the competition.

Based on geography, the global stereotaxic biopsy table market has been segmented as follows:

    • North America includes the United States, Canada and Mexico
    • Europe includes Germany, France, UK, Italy, Spain
    • South America includes Colombia, Argentina, Nigeria and Chile
    • Asia Pacific includes Japan, China, Korea, India, Saudi Arabia and Southeast Asia

For more information or query or customization before buying, visit @ https://www.marketresearchintellect.com/product/global-stereotactic-biopsy-table-market-size-and-forecast/

About Us: Market Research Intellect

Market Research Intellect provides syndicated and customized research reports to clients from various industries and organizations, in addition to the goal of providin